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Summary 
In Mediterranean countries, sheep and goat’s milk production has 
traditionally been destined for the manufacture of cheese, often as raw milk. Cheese 
quality is closely related to milk composition but also to hygienic aspects such as 
somatic cell count, bacteriology or presence of antibiotic residues, currently 
regulated by European legislation. 
The implications of the presence of antibiotic residues in milk as a result of 
veterinary treatments include negative effects on consumer’s health such as 
allergies or antibiotic resistance and problems on the manufacturing processes of 
fermented products. For the screening of milk samples for antimicrobial residues, 
there are various methods available, microbial inhibitor tests and assays based on 
specific receptors, both widely used, especially in farms, the dairy industry and 
control laboratories. Screening methods have been validated for the use in raw milk 
from cows, but information on the performance of these tests in sheep and goat’s 
milk is rather limited. 
The aim of this study was to evaluate the performance of some microbial and 
receptor-binding screening tests to detect antibiotics in sheep and goat’s milk 
according to Commission Decision 2002/657/EC to determine their suitability to 
monitor the presence of antibiotic residues in milk and establish the most convenient 
analytical strategy in Spain. 
The Detection capability (CCβ) of microbial screening tests, the BRT MRL, 
the Delvotest MCS SP-NT, the Delvotest MCS Accelerator and the Eclipse 100, was 
at or below the maximum residue limits (MRLs) for most beta-lactam antibiotics 
assessed and other non-beta-lactam drugs such as neomycin, tylosin, sulfadiazine 
and sulfadimethoxine. However, they were less sensitive in the detection of 
quinolones and tetracyclines at safety levels. When individual milk samples were 
analysed, microbiological tests showed a higher occurrence of non-compliant results 
in sheep milk than in goat’s milk, being related in all cases to an elevated somatic 
cell count (SCC). 
The microbiological system consisting of two complemetary microtiter plates 
containing Geobacillus stereathermophilus var. calidolactis and Bacillus subtilis, 
respectively, allows improving the detection level in sheep milk with respect to the 
use of a single commercial test using G. stearothermophilus, detecting some 
quinolone and macrolide substances more closely related to their respective MRLs. 
The rapid receptor-binding assays (the Betastar Combo, the Charm MRL 
BLTET, the SNAP Betalactam, the SNAP Tetracycline and the TwinsensorBT) were 
able to detect most beta-lactams and tetracyclines at or below MRLs (CCβ ≤ MRL). 
A higher specificity of the rapid receptor tests was obtained in all cases even when 
individual milk samples were analysed. Only the TwinsensorBT test presented non-
  
compliant results when antibiotic-free milk samples from individual animals were 
analysed, especially in the last weeks of lactation. No cross-reactions were found 
when drugs belonging to antimicrobial groups other than beta-lactams or 
tetracyclines were present in milk. Azidiol, used as a preservative, had no effect on 
the performance of the rapid receptor tests. Moreover, differences between the 
visual and instrumental classification of the test results were not found. 
Taking into account the frequency of use of antibiotics commonly employed 
in Spain and the screening test sensitivity at MRLs equivalent to antibiotic 
concentrations, total detection rates have been calculated. In general, the use of a 
single test allows detecting 62.8-82.4 % of the antibiotics employed. For sheep milk, 
the total detection range achieved with microbial tests was significantly higher than 
that reached with rapid receptor tests. However, no significant differences between 
the two types of tests were found when goat's milk was analysed. In both types of 
milk, the simultaneous use of two screening tests with a different analytical basis 
increases the total detection range significantly, reaching values ≥ 90 % in some 
cases. 
However, antibiotics such as enrofloxacin, marbofloxacin, spiramycin, and 
streptomycin also used to treat mastitis and other infectious diseases could not be 
detected by the screening tests assessed. Therefore, the improvement of the 
analytical strategy through the periodical implementation of screening tests able to 
detect these substances at safety levels would be recommended. 
  
Resumen 
En los países mediterráneos, la producción de leche de oveja y de cabra se 
ha destinado tradicionalmente a la fabricación de queso, a menudo a partir de leche 
cruda. La calidad del queso está estrechamente relacionada con la composición de 
la leche pero también con aspectos higiénicos actualmente regulados por la 
legislación europea, como el recuento de células somáticas, la bacteriología o la 
presencia de residuos de antibióticos. 
Las implicaciones de la presencia de residuos de antibióticos en la leche, 
como resultado de los tratamientos veterinarios, incluyen efectos negativos sobre la 
salud del consumidor tales como alergias o resistencias bacterianas a los 
antibióticos y, también, problemas en la fabricación de productos lácteos 
fermentados. Para la detección de residuos de antibióticos en las muestras de leche 
existen varios métodos de cribado disponibles siendo los métodos basados en la 
inhibición del crecimiento microbiano y los ensayos a base de receptores 
específicos los más utilizados en granjas, industrias lácteas y laboratorios de 
control. Estos métodos de cribado han sido validados para su uso en leche cruda 
de vaca, pero la información sobre los resultados de estas pruebas en leche de 
oveja y cabra es bastante limitada. 
El objetivo de este estudio ha sido evaluar el funcionamiento de algunos 
métodos microbiológicos y ensayos rápidos de receptores para la detección de 
antibióticos en leche de oveja y cabra según la Decisión 657/2002/CE, con objeto 
de determinar su idoneidad para controlar la presencia de residuos de antibióticos 
en la leche y establecer la estrategia analítica más conveniente en España. 
La Capacidad de detección (CCβ) de los métodos microbiológicos de 
cribado, BRT MRL, Delvotest MCS SP-NT, Delvotest MCS Accelerator y Eclipse 
100, fue igual o inferior a los límites máximos de residuos (LMRs) establecidos por 
la legislación europea para la mayor parte de antibióticos betalactámicos estudiados 
y otros no betalactámicos como neomicina, tilosina, sulfadiazina y sulfadimetoxina. 
Sin embargo, fueron menos sensibles para detectar quinolonas y tetraciclinas a sus 
respectivos niveles de seguridad. Cuando se analizaron muestras de leche 
individuales, los tests microbiológicos presentaron una mayor ocurrencia de 
resultados no conformes para la leche de oveja que estuvo relacionada en todos los 
casos, con un recuento elevado de células somáticas (RCS). 
El Sistema microbiológico formado por dos microplacas complementarias 
basadas en la utilización de Geobacillus stearothermophilus var. calidolactis and 
Bacillus subtilis, respectivamente, permite mejorar los niveles de detección en leche 
de oveja con respecto al uso de un único test comercial empleando G. 
stearothermophilus, al detectar algunas sustancias del grupo de las quinolonas y de 
los macrólidos a concentraciones más próximas a sus respectivos LMRs. 
  
Los ensayos rápidos de receptores (Charm MRL BLTET, Betastar Combo, 
SNAP Betalactam, SNAP Tetracycline y TwinsensorBT) fueron adecuados para 
detectar la mayor parte de betalactámicos y tetraciclinas a concentraciones iguales 
o inferiores a los LMRs (CCβ ≤ MRL). La especificidad de los tests de receptores 
fue elevada en todos los casos incluso cuando se analizaron muestras de leche 
individuales. Únicamente el test TwinsensorBT presentó resultados no conformes 
cuando se analizaron muestras libres de antibióticos procedentes de animales 
individuales, especialmente en las últimas semanas de lactación. No se observaron 
reacciones cruzadas con la presencia de sustancias pertenecientes a otras familias 
de antibióticos distintas a las de betalactámicos y tetraciclinas en la leche. El 
conservante azidiol no tuvo ningún efecto sobre la respuesta de los tests de 
receptores. Además, no se encontraron diferencias entre la interpretación visual y la 
instrumental de los resultados. 
Teniendo en cuenta la frecuencia de uso de los antibióticos comúnmente 
empleados en España y la sensibilidad de los métodos a una concentración de 
antibiótico equivalente al LMR, se calcularon los ratios totales de detección en el 
cribado. En general, el uso de un solo test permite detectar 62.8-82.4 % de los 
antibióticos empleados. Para la leche de oveja, el rango total de detección 
alcanzado con los métodos microbiológicos fue significativamente mayor que el 
alcanzado con las pruebas rápidas de receptores. Sin embargo, no se encontraron 
diferencias significativas entre los dos tipos de tests cuando se analizó leche de 
cabra. En ambos tipos de leche, el uso simultáneo de dos tests de cribado con 
diferente base analítica, incrementó significativamente el rango total de detección 
alcanzando valores ≥ 90 % en algunos casos. 
Sin embargo, antibióticos tales como enrofloxacina, marbofloxacina, 
espiramicina y estreptomicina que también se utilizan para tratar la mamitis y otras 
enfermedades infecciosas del ganado, no son detectadas por los tests de cribado 
evaluados. Por tanto, la mejora de la estrategia analítica a través de la aplicación 
periódica de pruebas capaces de detectar la presencia de estas sustancias a los 
niveles de seguridad establecidos sería recomendable. 
  
Resum 
En els països mediterranis, la producció de llet d'ovella i de cabra s'ha 
destinat tradicionalment a la fabricació de formatge, sovint a partir de llet crua. La 
qualitat del formatge està estretament relacionada amb la composició de la llet però 
també amb aspectes higiènics actualment regulats per la legislació europea, com el 
recompte de cèl·lules somàtiques, la bacteriologia o la presència de residus 
d'antibiòtics. 
Les implicacions de la presència de residus d'antibiòtics en la llet, com 
resultat dels tractaments veterinaris, inclouen efectes negatius sobre la salut del 
consumidor com ara al·lèrgies o resistències bacterianes als antibiòtics i, també, 
problemes en la fabricació de productes lactis fermentats. Per a la detecció de 
residus d'antibiòtics en les mostres de llet hi ha diversos mètodes de garbellament 
disponibles sent els mètodes basats en la inhibició del creixement microbià i els 
assajos a base de receptors específics els més utilitzats en granges, indústries 
làcties i laboratoris de control. Estos mètodes de garbellament han sigut validats per 
al seu ús en llet crua de vaca, però la informació sobre els resultats d'estes proves 
en llet d'ovella i cabra és prou limitada. 
L'objectiu d'este estudi ha sigut avaluar el funcionament d'alguns mètodes 
microbiològics i assajos ràpids de receptors per a la detecció d'antibiòtics en llet 
d'ovella i cabra segons la Decisió 657/2002/CE, a fi de determinar la seua idoneïtat 
per a controlar la presència de residus d'antibiòtics en la llet i establir l'estratègia 
analítica més convenient a Espanya. 
La Capacitat de detecció (CCβ) dels mètodes microbiològics de 
garbellament, BRT MRL, Delvotest MCS SP-NT, Delvotest MCS Accelerator i 
Eclipse 100, va ser igual o inferior als límits màxims de residus (LMRs) establits per 
la legislació europea per a la major part d'antibiòtics betalactàmics estudiats i altres 
no betalactàmics com neomicina, tilosina, sulfadiazina i sulfadimetoxina. No obstant 
això, van ser menys sensibles per a detectar quinolones i tetraciclines als seus 
respectius nivells de seguretat. Quan es van analitzar mostres de llet individuals, els 
tests microbiològics van presentar una major incidència de resultats no conformes 
per a la llet d'ovella que va estar relacionada en tots els casos, amb un recompte 
elevat de cèl·lules somàtiques (RCS). 
El Sistema microbiològic format per dos microplaques complementàries 
basades en la utilització de Geobacillus stearothermophilus var. calidolactis i 
Bacillus subtilis, respectivament, permet millorar els nivells de detecció en llet 
d'ovella respecte a l'ús d'un únic test comercial emprant G. stearothermophilus, al 
detectar algunes substàncies del grup de les quinolones i dels macròlids a 
concentracions més pròximes als seus respectius LMRs. 
  
Els assajos ràpids de receptors (Charm MRL BLTET, Betastar Combo, 
SNAP Betalactam, SNAP Tetracycline i TwinsensorBT) van ser adequats per a 
detectar la major part de betalactàmics i tetraciclines a concentracions iguals o 
inferiors als LMRs (CCβ ≤ MRL). L'especificitat dels tests de receptors va ser 
elevada en tots els casos inclús quan es van analitzar mostres de llet individuals. 
Únicament el test TwinsensorBT va presentar resultats no conformes quan es van 
analitzar mostres lliures d'antibiòtics procedents d'animals individuals, especialment 
en les últimes setmanes de lactació. No es van observar reaccions encreuades amb 
la presència de substàncies pertanyents a altres famílies d'antibiòtics diferents de 
les de betalactàmics i tetraciclines en la llet. El conservant azidiol no va tindre cap 
efecte sobre la resposta dels tests de receptors. A més, no es van trobar diferències 
entre la interpretació visual i la instrumental dels resultats. 
Tenint en compte la freqüència d'ús dels antibiòtics comunament empleats a 
Espanya i la sensibilitat dels mètodes a una concentració d'antibiòtic equivalent al 
LMR, es van calcular els ràtios totals de detecció en el garbellament. En general, 
l'ús d'un sol test permet detectar 62.8-82.4 % dels antibiòtics empleats. Per a la llet 
d'ovella, el rang total de detecció aconseguit amb els mètodes microbiològics va ser 
significativament major que l'aconseguit amb les proves ràpides de receptors. No 
obstant això, no es van trobar diferències significatives entre els dos tipus de tests 
quan es va analitzar llet de cabra. En ambdós tipus de llet, l'ús simultani de dos 
tests de garbellament amb diferent base analítica, va incrementar significativament 
el rang total de detecció aconseguint valors ≥ 90 % en alguns casos. 
No obstant això, antibiòtics com ara enrofloxacina, marbofloxacina, 
espiramicina i estreptomicina que també s'utilitzen per a tractar la mamitis i altres 
malalties infeccioses del bestiar, no són detectades pels tests de garbellament 
avaluats. Per tant, la millora de l'estratègia analítica a través de l'aplicació periòdica 
de proves que detectaren la presència d'estes substàncies als nivells de seguretat 
establits seria recomanable. 
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 5 
time, prevent and minimize adverse reactions provoked by the use of these 
substances. 
More recently, the International Dairy Federation also published the “IDF Guide 
to Prudent Use of Antimicrobial Agents” (IDF, 2013b) in order to provide a generic 
framework to support the responsible use of antimicrobial agents on dairy farms. The 
guidelines recognize that a coordinated whole-of-supply chain approach is required to 
manage the food safety risks associated with modern food production. 
1.2. Use of antibiotics in dairy sheep and goats 
In the last decades, the farming of dairy sheep and goats has evolved towards 
more intensive production systems in which a high concentration of animals in a 
confined spaces is more common, increasing the risk of the occurrence of diseases 
and, thus, the use of veterinary medicinal products, especially antimicrobial drugs has 
therefore increased, too. 
Table 1 summarizes the antimicrobial substances most commonly used to treat 
and prevent infectious diseases in veterinary medicine grouped according to their 
chemical structure, and including the main features of each of the groups of drugs 
considered. 
Concerning the use of antibiotics in dairy sheep and goats, Berruga et al. (2008) 
conducted a study for the Ministerio de Medio Ambiente, Rural y Marino (MARM), 
currently Ministerio de Agricultura, Alimentación y Medio Ambiente (MAGRAMA), on 
the most commonly drugs and treatments applied by veterinarians in Spain to study the 
possible causes of the presence of antimicrobial residues in milk from these species. 
Mastitis is the main pathology requiring antimicrobial therapy in dairy sheep and 
goats. According to Berruga et al. (2008), a high percentage of veterinarians (72 % for 
sheep and 76.9 % for goats) usually treat clinical mastitis cases during the lactation 
period. 
For the treatment of clinical mastitis in dairy sheep veterinarians primarily use 
beta-lactam drugs (56.8 %); macrolides being the second group of antimicrobials 
applied (Figure 3). Regarding lactating goats, mastitis is also treated using mainly beta-
lactams (53.3 %) and macrolides (18.3 %). Compared with sheep, there is a greater 
tendency to use tetracyclines in goats (13.3 and 3.9 %, respectively) although their 
percentage of usage for this pathology is relatively low in comparison with the two other 
groups of antibiotics. 
6T
An
Be
Am
Li
M
Te
Q
Su
 
able 1. Classific
timicrobial group 
ta-lactams 
inoglycosides 
ncosamides 
acrolides 
tracyclines 
uinolones 
lphonamides 
ation of the anti
Features 
 Natural antibio
 Broad spectrum
 beta-lactam rin
 Natural antibio
 Amino-sugars 
ring 
 Natural antibio
 Natural antibio
 Macrocyclic lac
 Natural antibio
 Broad-spectrum
 Four hydrocarb
 Synthetic antim
 Broad-spectrum
 Synthetic antim
 Sulphonamide 
microbial substa
tics 
 
g 
tics 
and aminocyclitol 
tics 
tics 
tone ring 
tics 
 
on rings 
icrobials 
 
icrobials 
functional group 
nces employed
Structu
 
 
 in veterinary m
re Ba
co
B
B
B
edicine 
cterial effect Me
Bactericide C
Bactericide P
Linked to 
ncentration 
applied 
P
acteriostatic P
acteriostatic P
Bactericide s
acteriostatic s
chanism of action
ell wall synthesis 
inhibitors 
rotein synthesis 
inhibitors 
rotein synthesis 
inhibitors 
rotein synthesis 
inhibitors 
rotein synthesis 
inhibitors 
Acid nucleic 
ynthesis inhibitors
Acid nucleic 
ynthesis inhibitors
Su
 Penicillins: am
benzylpenicilli
 Cephalosporin
cefoperazone,
gentamicin, ka
strept
clindamycin, linc
eritromycin, s
ty
chlortetracyc
tetracycline, dox
d
enrofloxac
norfl
sulfadiazine
sulfametazi
bstances 
oxicillin, ampicillin, 
n, cloxacillin, etc. 
s:cephalexin, ceftio
 cefquinome, etc. 
namycin, neomyci
omycin, etc. 
omicin, pirlimycin, 
piramycin, tilmicosi
losin, etc. 
line, oxitetracycline
ycycline (semisynth
erivate) 
in, marbofloxacin, 
oxacin, etc. 
, sulfadimethoxine,
ne, sulfatiazol, etc. 
fur, 
n, 
etc.  
n, 
, 
etic 
 
 Fig
that t
as in
Figu
diges
rumin
grou
ure 3. Freq
With reg
hey usually
 clinical ma
re 4. Frequ
In additio
tive diseas
ants. To t
p of choice
uency of u
ard to antib
 applied th
stitis treatm
ency of us
n to intra-m
es, among
reat patholo
 by veterina
se (%) of a
goats ma
Source: 
iotic dry-of
em (82 % 
ents, beta-
e (%) of an
Sourc
ammary i
 others, t
gies other
rians both
ntimicrobia
stitis during
Berruga et
f therapy, 
for sheep a
lactams an
timicrobials
e: Berruga
nfections, t
hat require
 than mast
 in dairy sh
l groups in t
 lactation 
 al. (2008)
most surve
nd 73 % f
d macrolide
 in dry-off t
 et al. (200
here are re
 antimicrob
itis, tetracy
eep (53 %
he treatme
yed veterin
or goats) u
s in either 
herapy in s
8) 
spiratory, r
ial therapy
clines are t
) and goats
nt of sheep
arians indi
sing mainly
case (Figu
heep and g
eproductive
 in small 
he antimic
 (43.6 %); 
7 
 and 
cated 
, just 
re 4). 
oats 
 and 
dairy 
robial 
beta-
8 
lactams (Berruga et al., 2008), being the second most commonly antimicrobial group 
applied (23.3 and 26.3 %, respectively). 
An important aspect to be emphasized with respect to the use of antibiotics in 
dairy sheep and goats is that due to the low volume of business which represents milk 
production, in comparison with cow's milk, there is evidently a limited availability of 
drugs registered for these species, especially for goats (Veterindustria, 2012). This is 
forcing veterinarians to employ unregistered drugs to treat certain pathologies and, 
although legally the exceptional use of medicines is considered (Directive 2004/28/EC 
and Directive 2001/82/EC), implies a great responsibility for veterinarians as there is an 
increased risk of incidence of residues, given the lack of knowledge on the behaviour of 
these medications at pharmacokinetic and metabolic levels. 
In addition, studies carried out in dairy sheep and goats (Molina et al., 2003a; 
Ferrini et al., 2010; Pergov et al., 2009) show that the withdrawal period of 7 days laid 
down in legislation for off-label treatments is not always sufficient to ensure the 
absence of antimicrobial residues in milk. 
In this sense, Berruga et al. (2008) indicate that 67 % of veterinarians treating 
ovines and 76.9 % of veterinarians treating caprines admit the off-label use of 
antimicrobials, the application of veterinary drugs without record for the species being 
the most common practice (Table 2). The substances applied in off-label treatments 
include, in both species, cephalosporins, macrolides and quinolones. 
Table 2. Exceptional use* of veterinary drugs in ovine and caprine 
 Ovine (%) 
Caprine 
(%) 
Use of drugs registered for species other than sheep and goats 86.8 95.0 
Administration through a pathway other than the one indicated 18.4 10 
Use of drugs in doses other than those indicated 15.8 10 
Applying a withdrawal period other than that recommended 5.2 7.5 
*: Total number of veterinarians surveyed who admit the exceptional use of antimicrobial drugs 
Source: Berruga et al. (2008) 
Regarding the occurrence of antibiotic residues in sheep milk produced in 
Spain, sporadic studies have been carried out, in particular in the Castile and León, 
and Castile-La Mancha regions, using microbial inhibitor tests in all cases (Table 3). 
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Table 3. Occurrence of antibiotic residues in sheep milk produced in Spain 
Spanish 
Region Year 
Microbial 
test 
Positive 
results 
Groups of drug 
residues identified Reference 
Castile-La 
Mancha 1999 BRT 6.1 % 
Beta-lactams 4 % Althaus et al. 
(2007) Sulphonamides 1.2 % 
Castile and 
León - 
Eclipse 
100 11 % - 
Esnal et al. 
(2002) MMS1 
(5 plates)
22.7 % 
Beta-lactams 
Macrolides 
Tetracyclines  
Castile-La 
Mancha 
2002-
2003 
Delvotest 
SP 1.3 % Beta-lactams 29.8 % 
Yamaki et al. 
(2004) 
Eclipse 
100ov 0.9 %  Beta-lactams 25 % 
Yamaki et al. 
(2006) 
1MMS: Microbiological multiplate system 
More recent reports have shown that the scenario has considerably improved 
and, currently, the occurrence in the main Spanish sheep milk-producing regions 
indicate incidences ≤ 0.15 % (Brusa and Safigueroa, 2005; Gonzalo et al., 2013). 
These low values are similar to those presently seen in cow milk, which verifies the 
improvement of the quality of sheep milk in recent years with regard to the presence of 
inhibitors. 
Studies on the incidence of inhibitor residues in goat’s milk are very scarce. In a 
study conducted by Marco et al. (2001) 12.7 % positive samples were obtained in the 
Murcia region, one of the main producers of goat's milk in Spain. In goat’s milk, just as 
in sheep milk, the occurrence of positive results has been reduced in recent years. 
Gonzalo et al. (2012), in a study performed in the Castile and León region, indicate a 
decrease in the occurrence of antibiotic residues in bulk milk samples from goats from 
0.3 % in the year 2005 to less than 0.001 % in 2011 evidencing the improvements 
made in the sector. 
1.3. Effect of the presence of antibiotic residues in milk 
The consumption of milk containing residues of antibiotics can produce harmful 
effects on human health, causing transient disturbances in the intestinal flora and 
allergic reactions which can, in extreme cases, lead to anaphylaxis (Tollefson et al., 
10 
2004; Demoly and Romano, 2005; Sanders et al., 2011). There is also the concern that 
the presence of antibiotics in foodstuff may be responsible for the development of 
bioresistance (Swarchz et al., 2001; Philips et al., 2004; Oliver et al., 2011). In this 
sense, during the last decade, the World Health Organization and the Organization 
World Animal Health together with the United Nations Organization for Food and 
Agriculture and the Codex Alimentarius Commission have addressed the potential risk 
posed by the use of antimicrobials for the treatment of diseases of animals intended for 
food production that appear and extend organisms resistant to antimicrobial agents. 
In addition, some of these substances are not destroyed with heat treatments 
commonly applied to milk in the dairy industry in order to reduce the microbial load and 
eliminate pathogens and enzymes, which can reach the consumer even after having 
undergone these treatments (Zorraquino et al., 2008, 2009, 2011; Roca et al., 2010). 
Neither do the manufacturing processes of yoghurt and cheese seem to influence the 
concentration and activity of some antibiotic residues (Grundwald and Petz, 2003; 
Adetunji, 2011). 
On the other hand, from a technological point of view, the presence of 
antimicrobial residues in milk may inhibit the bacterial processes required for the 
elaboration of fermented products such as cheeses and yoghurt (Cogan, 1972; 
Packham et al., 2001; Berruga et al., 2007). Technological damage produced by 
residues depends on the type of antibiotics, its concentration in the milk and the type of 
product manufactured (Mäyrä-Mäkinen, 1995). This is a very important aspect when 
considering that milk from sheep and goats is primarily intended for the manufacture of 
milk products especially cheese and yoghurt. 
Many regions of the Mediterranean basin are characterized by a great tradition 
of sheep and goat’s milk production that is intended for the manufacture of pure cheese 
of these species, many of them under the protected designation of origin (PDO) and 
other brands of quality of international recognition. In Spain there are many PDOs for 
sheep (Manchego, Idiazábal, Roncal, Zamorano, La Serena, Torta del Casar) and 
goat’s (Ibores, Murcia, Palmero, Majorero) cheeses representing significant economic 
value for the regions of production. 
Another important aspect to consider is the possible economic impact of the 
presence of antibiotics in milk for the farmer because it can lead to a ban by the 
competent authorities, if the marketing of raw milk is considered "unfit for human 
consumption". The possible restriction of the commercialization of the contaminated 
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has designated four reference laboratories for the detection of residues of certain 
substances, as well as the corresponding national laboratories designated by each 
member state. 
After passing Regulation (EC) Nº 178/2002 laying down the general principles 
and requirements of food law, establishing the European Food Safety Authority and 
defining procedures in matters of food safety, the EU began the publication of an 
extensive legislative framework in the field of food hygiene, which constitutes the 
general, basic and common principles for the production and marketing of all foodstuffs 
according to hygienic standards, and in particular, in the field of the production of raw 
milk from sheep and goats. 
Also, the responsibility of other operators of the food chain in the production of 
safe food was reaffirmed. Regulations (EC) Nº 852/2004 on the hygiene of foodstuffs, 
and (EC) Nº 853/2004 lay down specific rules of hygiene of foodstuffs of animal origin, 
in particular, general and specific standards of hygiene for the production of various 
food including raw milk of sheep and goat. To ensure compliance with these hygienic 
rules the European Union also published Regulation (EC) Nº 854/2004 setting up 
specific rules for the organisation of official controls on products of animal origin 
intended for human consumption. 
2.2. Maximum Residue Limits 
In order to protect public health, maximum residue limits (MRLs) of 
pharmacologically active substances in foodstuffs of animal origin have been 
established in accordance with procedures provided by Regulation (EC) Nº 470/2009 
repealing Council Regulation (EEC) Nº 2377/90 and amending Directive 2001/82/EC 
and Regulation (EC) Nº 726/2004. This Regulation defines the MRL as the maximum 
concentration of a residue of a pharmacologically active substance which may be 
permitted in food of animal origin. 
The MRLs established apply the concept of acceptable daily intake (ADI) which 
corresponds to the amount of a residue that a human being may ingest on a daily basis 
with food along their lifetime without suffering any type of harm. The ADI is used 
together with data on pharmacokinetics, depletion of residues and the knowledge 
concerning the marker residue and target tissues to establish the MRLs, both for the 
pure substance, and its metabolites, in food of animal origin (muscle, fat, liver, kidney, 
milk, honey and eggs). The calculation of the MRL depends on the animal tissue and 
species considered and the amounts of each of them that can be ingested by 
consumers on average. 
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For pharmacologically active substances prohibited or not regulated by the EU, 
Regulation (EC) Nº 470/2009 has also set up a procedure to establish “the reference 
values for purposes of intervention”, defined as the lowest concentration of a residue 
that can be detected and confirmed by an official laboratory, previously known as 
minimum required performance limits (MRPLs). 
Commission Regulation (EU) Nº 37/2010 lists the MRLs established for different 
substances in foodstuff of animal origin, classified into two groups: allowed substances 
and prohibited substances. Some antimicrobials, grouped by families, for which MRLs 
in milk from different species have been established, are shown in Table 3. 
Tabla 3. Maximum residue limits (MRLs) established in the EU for antimicrobial 
substances in milk from different species. 
1All= all food producing species; 2All rum= All ruminants; 3BOC= Bovine, ovine, caprine 
Source: Regulation (EU) Nº 37/2010 
Substance MRL (g/kg) 
Type of 
milk 
 Substance MRL (g/kg) 
Type of 
milk 
Beta-lactams    Aminoglycosides   
Amoxicillin 4 All1  Gentamicin 100 Bovine 
Ampicillin 4 All  Kanamycin 150 All 
Benzylpenicillin 4 All  Neomycin 1,500 All 
Cloxacillin 30 All  Spectinomycin 200 All 
Dicloxacillin 30 All  Streptomycin 200 All rum 
Nafcillin 30 All rum2     
Oxacillin 30 All  Quinolones   
Cefacetrile 125 Bovine  Danofloxacin 30 BOC 
Cefalexin 100 Bovine  Enrofloxacin 100 BOC 
Cefalonium 20 Bovine  Flumequine 50 BOC 
Cefazoline 50 BOC3  Marbofloxacin 75 Bovine 
Cefoperazone 50 Bovine     
Cefquinome 20 Bovine  Sulphonamides   
Ceftiofur 100 All  Sulfadiazine 100 Bovine 
Cephapirin 60 Bovine  Sulfadimethoxine 100 Bovine 
Penethamate 4 All  Sulfadoxine 100 Bovine 
    Sulfanilamide 100 Bovine 
Tetracyclines    Sulfametazine 100 Bovine 
Chlortetracycline 100 All  Sulfatiazol 100 Bovine 
Oxitetracycline 100 All     
Tetracycline 100 All  Others   
    Bacitracin 100 Bovine 
Macrolides    Baquiloprim 30 Bovine 
Erytrhomycin 40 All  Clavulanic acid 200 Bovine 
Spiramycin 200 Bovine  Colistin 50 All 
Tylosin 50 All  Novobiocin 50 Bovine 
    Rifaximin 60 Bovine 
Lincosamides    Thiamphenicol 50 All 
Lincomycin 150 All     
Pirlimycin 100 Bovine     
14 
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In addition, in order to ensure compliance with the hygienic requirements 
referred to in regulations (EC) Nº 852 and 853/2004 ensuring that official controls of the 
presence of residues in animal products intended for human consumption covered by 
regulations (EC) Nº 854 and 882/2004, Real Decreto 1728/2007 establishes the basic 
rules of control to be met by operators in the dairy sector and amending Real Decreto 
217/2004, which regulates the identification and registration of agencies, 
establishments and entities involved in the dairy sector, and recording the movements 
of milk. 
Subsequently, Real Decreto 752/2011, which allows the development of 
Community regulations at a national level with regard to raw sheep and goat's milk 
production, was published establishing mandatory minimum controls to be performed 
by food-producing agencies, as the harmonisation of the conditions required from 
laboratories for the analysis of raw milk from sheep and goats, and the homogenous 
activity thereof before sampling, analysis and communication to the competent organ. 
Additionally, the obligation to transmit the results generated in the implementation of 
the checks carried out to the "Letra Q database" was extended to the dairy sheep and 
goat sector. 
Monitoring the presence of antimicrobials in raw milk from sheep and goats is 
included among the tests to be carried out in farms before loading milk onto the 
collection tanker, if there is suspicion or certainty of the presence of drug residues in 
milk. Screening for antibiotic residues in situ prior to the discharge of milk into the 
storage silos is mandatory in the dairy centres. In both cases, Real Decreto 752/2011 
requires the use of methods capable of detecting, at least, beta-lactam antibiotics. The 
actions to be taken according to the result of the test for the detection of antibiotics in 
situ are outlined in Figure 7. 
As for the screening test of antibiotic residues that should be performed in 
control laboratories, annex IV of this regulation establishes that, for all milk samples 
received methods able to detect, at least, beta-lactam residues must be employed. 
All official laboratories shall communicate to the “letra Q database”, the results 
obtained for the analysis of samples from self-control in farms before loading milk, and 
the results corresponding to the samples from the tankers prior to their discharge in 
storage silos, at dairies. The "Letra Q database" will generate alarms or warnings to the 
competent authorities of the autonomous communities to communicate breaches in 
somatic cell counts and bacteriology monthly and positive results to the test of 
16 
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Qualitative methods are used for screening antibiotic residues in milk, microbial 
inhibitor tests being the most frequently used in control laboratories to detect the 
presence/absence of antibiotic residues in milk above the safety limits legally 
established. Screening methods also include qualitative specific methodologies that 
allow a preliminary confirmation of residues. 
Microbial screening methods are based primarily on evidence of inhibition of the 
growth of a specific organism, using for the detection of this inhibition, different systems 
as indicators of pH, redox, bioluminescence. These methods primarily take advantage 
of the ability of bacteria to produce acid, reduce dyes or produce inhibition halos in a 
culture medium, so that the result can be interpreted visually. 
The microorganisms used in these methods include among others: Geobacillus 
stearothermophilus var. calidolactis (Carlsson and Björck, 1987), Bacillus cereus 
(Suhren et al., 1993), Bacillus subtilis (Aureli et al., 1996) and Streptococcus 
thermophilus (Mourot and Loussouron, 1981). During the incubation period milk spread 
through the culture medium and if it contains sufficient quantity of antimicrobial 
substances the microorganism growth will be reduced or inhibited. 
Currently, commercial microbiological tests most frequently applied in the 
screening of antibiotics in milk use Geobacillus steraothermophilus var. calidolactis as 
microorganism-test as it is very sensitive to beta-lactam antibiotics. Thus, the BRT 
(Analytik in Milch Produktions-und Vertriebs-GmbH, Germany), Delvotest (DSM Food 
Specialties, the Netherlands), and Eclipse 100 (Zeulab, Spain) tests, some of the most 
commonly used tests in Spain, having detection capabilities near their respective MRLs 
for a great number of substances belonging to this group of antimicrobials. However, 
the same does not applied to other groups of antibiotics such as tetracyclines, 
aminoglycosides, quinolones and sulphonamides (Le Bréton et al., 2007; Stead et al., 
2008). 
On the other hand, among the specific qualitative methods used in the 
screening stage, there are currently commercially available different types of 
enzymatic, immunological and receptor-binding assays, allowing detection of antibiotic 
residues in milk in a specific and usually in a much faster manner. 
Receptor-binding assays using lateral flow technology are the most usually 
employed for screening antibiotics in farms and dairies as they are easy to use and 
rapid response (<10 min). Some of the most commonly used in Spain are the ROSA 
Charm (Charm Sciences Inc., MA, USA), Betastar (Neogen Corporation, MI, USA), 
SNAP (IDEXX Laboratories, ME, USA), and TwinsensorBT (Unisensor, Belgium) tests, 
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having versions able to detect individual or simultaneously, antibiotics belonging to 
beta-lactam and tetracycline groups. 
These tests are based on the union of the antibiotic present in milk to proteic 
receptors, conjugated to an enzym, that are specific for an antibiotic or a certain group 
of antibiotics. All tests permit the visual interpretation of the test results by comparison 
of coloured lines or spots appearing as a result of the interaction of the analyte and the 
receptors contained in the test, but they also offer the possibility of reading results 
using automatic equipment which provide readings more objectively. 
As for the confirmation phase, physico-chemical methods able to provide full or 
complementary information enabling the substance to be unequivocally identified and if 
necessary quantified at the level of interest are used. Numerous methodologies for the 
quantitative analysis of antimicrobial residues in milk have been developed. In general, 
physico-chemical methods for the confirmation of antimicrobials are based on the 
chromatographic separation of residues, especially Liquid Chromatography (LC), 
followed by spectroscopic quantification, such as UV, fluorescence or mass 
spectrometry (MS). 
Despite the associated costs, mass spectrometric methods have been used 
more and more in last years for very selective and specific multi-compound detection; 
the LC-MS analytical method being most employed in milk and other foods (Cháfer–
Pericás et al., 2010). 
Table 4 summarizes the various types of antibiotic testing methods: principle, 
typical techniques involved, specificity and precision as well as practical details on 
equipment, cost, time and operator skills required. 
3.2. Criteria for the validation of methods for the detection of antibiotics 
As shown previously, the different control purposes require different categories 
of methods. Commission Decision 2002/65/CE establish the performance 
characteristics that should be verified for the validation of the analytical methods used 
for the detection of antibiotic residues in milk (Table 5). 
Screening methods are used to detect the presence of a substance or class of 
substances at the level of interest. In agreement with Commission Decision 
2002/657/EC they are characterised by high sample throughput and are used to sift 
large numbers of samples for potential non-compliant results. They are also specifically 
designed to avoid false compliant results. The performance characteristics that should 
be evaluated for their validation are explained as follows. 
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Table 4. Antibiotic testing methods: principles and results delivered 
 Screening Confirmation 
Result Qualitative = positive/negative Semi-quantitative with an estimated concentration 
Quantitative with an 
accurate concentration 
Confirms antibiotic 
identity and accurate 
concentration 
Detection Biological Biochemical Biological Biochemical Physico-chemical Physico-chemical 
Principle 
Detects cellular 
metabolic 
responses to 
analytes 
Detects molecular 
interactions between 
antibiotics and ligands 
(antibody or receptor 
protein) 
Detects cellular 
metabolic responses 
to analytes 
Detects molecular 
interactions between 
antibiotics and ligands 
(antibody or receptor 
protein) 
Separation of 
individual antibiotics 
and physical detection 
Separation of 
individual antibiotics 
and physical detection 
Typical techniques Bacterial growth inhibition Immunoassay  
Bacterial growth 
inhibition Immunoassay  
Chromatography + 
spectrometry  
Chromatography + 
mass spectrometry  
Methods 
Incubation with 
bacteria in solution 
or on plates or 
ampoules 
Lateral flow, ELISA, 
biochip or 
Radioimmunoassay 
Plate test / inhibition 
zone Specific ELISA 
LC-UV, LC-FL, LC-
ECD, LC-MS, GC-FID 
LC-MS/MS  
or LC-HRMS 
Interpretation 
Visual or 
colorimetric (pH or 
redox indicator)  
Readers available 
Visual or colorimetric 
Readers available 
Visual  
based on size of 
inhibition zone 
Quantitative 
estimation possible 
only if known 
substance 
Colorimetric (labelling) 
with calibration curve  
Micro plate reader 
UV or FL-spectrometry 
with calibration curve 
Mass spectrometry  
with calibration curve 
Analysis time 1-3,5 h 2-10 min to 3 h Several hours  2-4 h 1-2 h 1-2 h 
Precision - - Low  Medium  High High 
Specificity 
Not specific 
Broad spectrum, 
several antibiotics 
and one or several 
families 
Specific  
for one or several 
antibiotics or families 
Not specific 
Antibiotic families 
Specific  
for one single antibiotic 
Identification 
determination of 
individual antibiotics 
Spectrometric 
identification and 
determination of 
individual antibiotics 
Antibiotics range 
analysed 
simultaneously 
Large range Single antibiotic or  one or more families 
Medium to large 
range Single antibiotic 
Small to medium 
range Medium to large range 
Cost Cheap Cheap/medium Cheap Medium Medium/expensive Expensive 
Sample preparation None or simple None or simple Medium  Simple to complex  Complex Complex 
Equipment/complexity Simple Simple or medium Simple Medium Medium High  
User skills / training  Low Low/Medium Low Medium Medium/high High  
Typical application 
level From farm to dairy From farm to dairy 
Collection Center to 
dairy Dairy silo Dairy silo Finished product 
Source: IDF (2013a)
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Table 5. Classification of analytical methods by the performance characteristics that have to 
be determined 
 
Detection 
limit 
(CCß) 
Decision 
limit 
(CCα) 
Trueness/
recovery Precision 
Selectivity/ 
specificity 
Applicability/ 
ruggedness/ 
stability 
Qualitative 
methods 
S + - - - + + 
C + + - - + + 
Quantitative 
methods 
S + - - + + + 
C + + + + + + 
S= screening methods; C= confirmatory methods; += determination is mandatory 
Source: Commission Decision 2002/657/EC 
Detection capability (CCβ) 
Detection capability (CCβ) means the smallest content of the substance that may be 
detected, identified and/or quantified in a sample with an error probability of β. In the case of 
substances for which no permitted limit has been established, the detection capability is the 
lowest concentration at which a method is able to detect truly contaminated samples with a 
statistical certainty of 1 – β. In the case of substances with an established permitted limit, this 
means that the detection capability is the concentration at which the method is able to detect 
permitted limit concentrations with a statistical certainty of 1 – β (Commission Decision 
2002/657/EC). 
For the calculation of the CCβ of a microbial test or receptor-binding assay for 
screening antibiotic residues in milk, the International Dairy Federation (ISO/IDF 2002 and 
2003, respectively) recommends a calculation procedure that includes the use of different 
concentrations of antibiotic, in order to build a dose-response curve (Figure 9) from the 
positive frequencies for each concentration assessed, making a total of 10-20 replicates if 
the interpretation of the test results is made visually, and 3-5 if it is photometric. 
Test concentrations must include a negative control (antibiotic-free milk sample), a 
concentration at least, 1.5 to 2 times higher than the concentration that is expected to be 
positive and a concentration equivalent to the maximum residue limit (MRL), calculating the 
limit of detection (CCβ) as the concentration which corresponds to the intersection of the 
dose-response curve with the line that represents the 95 of positive results (Figure 9). 
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This parameter is, therefore, associated with the presence of false-positive results 
and is of great interest to evaluate the analytical capacity of a test. For its determination a 
large number of milk samples from animals not treated with veterinary medicinal products 
should be analysed (ISO/IDF, 2002 and 2003). 
In specific screening tests such as receptor-binding assays, specificity is related to 
positive results obtained when found in milk substances belonging to other groups of 
antimicrobials that could interfere with the test response (cross reactivity). For its calculation 
large amounts of potentially interfering substances are added into milk samples, and 
analysed in search of non-compliant results. 
Therefore, a good screening method must be designed to present high values of 
specificity, i.e. a low percentage of false-positives. 
Ruggedness 
Ruggedness means the susceptibility of an analytical method to changes in 
experimental conditions which can be expressed as a list of the sample materials, analytes, 
storage conditions, environmental and/or sample preparation conditions under which the 
method can be applied as presented or with specified minor modifications. For all 
experimental conditions which could in practice be subject to fluctuation (e.g. stability of 
reagents, composition of the sample, pH, and temperature) any variation which could affect 
the analytical result should be indicated. 
Table 6 summarizes the use and the limitations of the qualitative screening tests most 
frequently used at present to detect antibiotic residues in milk. As seen in Table 6 all 
screening tests should be validated according to official validation guidelines before their 
routine use in practice. In fact, in some countries such as France or Belgium, validation of 
analytical screening tests to detect residues of antibiotics in accredited official laboratories is 
required to be approved for use in official milk quality programmes. 
3.3. Use of screening tests in sheep and goat’s milk 
Screening methods currently available for the detection of antibiotic residues in milk 
have been developed and optimized for the use in cow's milk but there are no specific 
methods to be used in sheep and goat’s milk. However, the different characteristics of milk 
from these species with regard to cow milk may sometimes lead to incorrect results using 
these control methods. 
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Table 6. Antibiotic qualitative screening tests: use and limitations 
Type of test All screening tests:  
Immuno- or cell based 
Microbial growth inhibition  
in solution/in agar 
Rapid tests : lateral flow device 
"dipstick" or "strip test" 
ELISA 
Antibiotic coverage  
& fitness for purpose 
Make sure test detects antibiotics used 
where the milk is produced.  
Check sensitivity/ specificity data provided 
by suppliers vs. required local regulatory 
limits. 
Reasonable to good detection of ß-
lactams.  
Some antibiotics not detected at 
MRL (e.g. some amino-glycosides, 
tetracyclines and most 
sulfonamides) 
Several types: mono- and multifamily 
tests. One line per family  
Sometimes not all compounds of a 
family are detected at or below MRL  
Generic : targets one antibiotic family - the 
response of individual compounds varies 
and is expressed as % cross-reactivity  
Specific: targets selectively single drug  
e.g. banned antibiotics 
Critical factors Test storage (cold chain), Incubation time or  
temperature 
Operator variability in case of visual 
reading 
Operator variability in case of visual 
reading 
Sample preparation: test recoveries with 
fortified or incurred samples (reference 
samples) 
Strength  Broad spectrum Very quick Delivers estimated concentration 
Controls/ precautions Follow supplier instructions Carefully monitor expiry dates. 
Detection capability may change 
over shelf life 
    
  Positive & negative controls are highly 
recommended to test operators ability to 
execute the test properly 
Neg control: blank milk 
Pos control: provided by supplier or 
prepared by spiking standard into 
blank milk 
Neg control: blank milk 
Pos control: provided by supplier or 
prepared by spiking standard into 
blank milk 
Positive antibiotic standard solution or 
solutions for calibration curve included in 
the test kit 
Interferences leading to false 
negatives 
Test does not have the right 
selectivity/sensitivity profile (see fitness for 
purpose) 
Acidic pH (sour milk) can give false 
negatives with tests using pH 
indicator 
Extreme compositions affecting flow 
rate (e.g. high lipid content) 
Losses during sample preparation  
  Betalactamase can decrease beta-lactam 
concentrations* 
    
Interferences leading to false 
positives 
Cross contamination during sample 
preparation or incubation 
Preservatives or other additives 
with inhibitory action  give false 
positive results  
Cross-reactivity vs. antibiotics from 
other  families 
Cross-reactivity vs. antibiotics from same 
or other  families or matrix background 
signal when working close to LOD 
 Extreme milk compositions (somatic cell 
count, protein, fat content have been 
reported to affect test results - to be 
assessed during validation)* 
High pH (>7), extreme composition, 
free fatty acids Pseudonomiatoxins 
can cause false-positive test results 
 Matrix interferences 
Validation level Suppliers validate tests for selectivity, 
specificity, detection capability, robustness 
following official bodies guidelines. This data 
is available to end users  
CRL guidelines for the validation of 
qualitative tests 2010/01/201 
CRL guidelines for the validation of 
qualitative screening tests 
2010/01/202 
As detailed in the Commission Decision 
2002/657/EC2 
Source: IDF (2013a) 
                                               
 * note: this is also true for confirmatory analysis 
1 GUIDELINES FOR THE VALIDATION OF SCREENING METHODS FOR RESIDUES OF VETERINARY MEDICINES, COMMUNITY REFERENCE LABORATORIES 
RESIDUES (CRLs), 20/1/2010 http://ec.europa.eu/food/food/chemicalsafety/residues/Guideline_Validation_Screening_en.pdf 
2 COMMISSION DECISION of 12 August 2002 implementing Council Directive 96/23/EC concerning the performance of analytical methods and the interpretation of results  
http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2002:221:0008:0036:en:pdf 
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With regard to microbial screening test sensitivity, studies carried out in sheep milk 
as well as goat’s milk indicate that these methods are suitable for the detection of beta-
lactam antibiotics but that they are not suitable for other antimicrobial groups such as 
tetracyclines, aminoglycosides, or quinolones, as the detection capability (CCβ) for these 
substances is higher than the MRLs established by legislation (Althaus et al., 2001a; 
Althaus et al., 2003a; Montero et al., 2005; Linage et al., 2007; Sierra et al., 2009a,b). 
As for specificity of microbial screening tests, studies performed using sheep milk 
samples, found, in general, a large number of false-positive results, especially if milk 
samples are spiked with a preservative. Thus, Molina et al. (2003b), indicate a specificity 
of 96.3 and 97.7 % for the microbial screening tests BRT (AiM) and Delvotest SP (DSM 
Food Specialties), respectively, when antibiotic-free sheep milk samples were analysed 
without preservative. After the application of a heat treatment (85 °C for 10 min) to 
inactivate the natural inhibitors present in milk, an increase of test specificity, obtaining 
values of 99.0 and 98.7 %, respectively, was achieved, being very similar to those 
reported by Roca et al. (2007) for these same screening tests using milk from cows (99 
and 98 % for the BRT and Delvotest SP, respectively). However, in sheep milk samples 
spiked with azidiol, Molina et al. (2003b) obtained lower specificity values (90.2 and 91 % 
for the BRT and Delvotest SP tests, respectively), even after the heat treatment (BRT: 
94.8 % and Delvotest SP: 95.3 %), indicating that the growth of the microorganism-test 
was affected by the inhibitor effect of the preservative. In all case, azidiol interferences 
could be minimised by prolonging the incubation time (Zorraquino et al., 1997; Molina et 
al., 1999). 
Most commercial microbial screening tests are based on milk diffusion through a 
culture medium, usually containing agar, nutrients and a standardized number of spores of 
a thermophile microorganism together with a dye type redox or acid-base indicator. 
However, the growth of this bacterium may be affected by other factors such as natural 
inhibitors present in milk (Carlsson and Björck, 1989), as higher somatic cell count (Cullor 
et al., 1992) or the presence of other substances such as detergents and disinfectants 
(Schiffmann et al., 1992). 
Sheep milk contains a larger amount of natural inhibitors than cow milk (Althaus et 
al., 2001b; Park et al., 2007), which could explain the lower specificity values obtained for 
this species. Also, it presents a higher fat and protein contents than cow or goat's milk, 
complicating its diffusion through the culture medium content in the method, which has 
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also been linked to a larger number of questionable and positive results using the BRT and 
Delvotest tests (Althaus et al., 2003b). Also, higher SCC in sheep milk samples has been 
related to the occurrence of false-positive results in the same microbiological tests 
(Althaus et al., 2003b). 
In goat's milk, just as in sheep milk, differences in the milk composition with respect 
to cow milk, also suggest that microbial inhibitor tests for the detection of antibiotics may 
not be suitable for this species (Hozová and Minarovičová, 2001). Thus for example, the 
elevated somatic cell count (SCC) in goat's milk with respect to cow milk even in the 
absence of intra-mammary infections (Paape et al., 2007; Mehdid et al., 2013), prompted 
Contreras et al. (1997) to examine whether this factor could interfere with the detection of 
antibiotic residues using the microbial inhibitor tests Charm BsDA, Delvotest P and 
Delvotest SP. These authors found that the three methods presented a specificity of 100 
% (no positive results) in samples with high SCC as well as low SCC, which led the 
authors to suggest that they were appropriate for antibiotic screening in goat’s milk. 
However, Zeng et al. (1996) by studying the performance of the Delvotest P test with 
goat's milk obtained 7 % false-positive results in Delvotest P in comparison with Charm 
BsDA acting as a reference test. Neither did these authors observe interferences due to 
SCC in the BsDA, Delvotest P and Delvotest SP microbiological methods. 
The receptor-binding assays, known as rapid receptor tests, have been validated 
with cow milk samples showing higher specificity, lower false-positive rates and CCβs at or 
below MRLs for most antibiotics at which they are directed. Hence, Žvirdauskiene and 
Salomskiene (2007), indicated that the Betastar test (Neogen Corporation), a specific 
receptor-binding assay to detect beta-lactam residues in milk, was able to detect 
benzylpenicillin, oxacillin, ampicillin, at or below the MRLs set out in legislation. With this 
same rapid test and following a simplified trial procedure, Reybroeck et al. (2010) obtained 
a high sensitivity to different beta-lactam antibiotics in different types of milk (UHT, 
sterilized, reconstituted in powder, thawed) as well as a high specificity and a very small 
percentage of false-positive results. Also, Perme et al. (2010), obtained good sensitivity 
results with the TwinsensorBT test, a rapid assay for the simultaneous detection of beta-
lactam and tetracycline residues in milk samples. However, data on related performance 
characteristics of rapid receptor tests in sheep and goat’s milk are still rather limited. 
In goat's milk, Contreras et al. (1997) indicated a specificity of 100 % (no false-
positive results) when analysing individual milk samples from goats by the SNAP 
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Betalactam test (IDEXX Laboratories), a receptor-binding assay to detect beta-lactam 
residues in milk. Also, Zeng et al. (1998) obtained a specificity of 96.7 % for the same test 
using raw commingled goat’s milk. In terms of sensitivity, the SNAP Betalactam test was 
able to detect amoxicillin, ampicillin, benzylpenicillin, cloxacillin, cephapirin and ceftiofur at 
or below safety limits (Tolerance/Salfe Levels) established by USFDA (FDA, 2005). 
However, hitherto no data on the performance of rapid receptor tests in sheep milk have 
been published. Neither have studies about the potential interference of the preservative 
azidiol on the response of this type of tests been carried out. 
In spite of the lack of data concerning rapid receptor tests in these species, their 
implementation in the screening of sheep and goat’s milk has increased in recent years, 
due to new legislative requirements and the need for fast results. However, as 
recommended by the E47 group "Antimicrobials and other veterinary residues" of the IDF, 
studies in sheep and goat’s milk are to be continued to ensure good practices in this 
sector. 
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Objectives 
 
 
 

Objectives 
Antimicrobials can result in residues in foodstuffs of animal origin such as milk 
and therefore, it is necessary to establish an analytical strategy using appropriate 
methodologies for their detection and prevent them from reaching consumers. In Spain 
Real Decreto 752/2011 establishes the rules for the quality control of raw milk from 
sheep and goats, which includes the mandatory control of the presence of antibiotic 
residues in different steps of the production system. 
Microbial screening tests are widely used in raw sheep and goat’s milk quality 
control. As a result of the changes made in recent years to improve detection capability 
there are currently new versions available that have, however, not been evaluated with 
milk from small ruminants. On the other hand, specific receptor-binding tests are also 
routinely used for the rapid screening of beta-lactams in milk due to the new legislative 
requirements. Nevertheless, information about the suitability of rapid receptor tests 
using milk from small ruminants is very limited. Neither has the effect the preservative 
azidiol, authorized by Spanish regulation in milk sampling, can have on the response of 
receptor-binding tests been studied. 
The evaluation of the currently available screening tests is essential in order to 
establish the most appropriate analytical strategy that allows detecting the greatest 
number of the substances most commonly used in the treatment of infectious diseases 
in dairy sheep and goats and ensure the safety of the milk and dairy products. 
Therefore, the following objectives of this thesis are: 
Objective 1. To assess the microbial inhibitor tests for screening antibiotics in 
sheep and goat’s milk. 
Objective 2. To evaluate the receptor-binding assays for screening beta-lactam 
and tetracycline residues in sheep and goat’s milk. 
Objective 3. To determine the most appropriate analytical strategy in Spain for 
the detection of antimicrobial residues in sheep and goat’s milk. 
These objectives are pursued through various experiments presented in the 
Results section in the form of three chapters corresponding to each of the three 
objectives established. 
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Abstract 
The performance of different microbial tests currently employed for screening antibiotic 
residues in milk was investigated using sheep and goat milk. Detection capability (CCβ) 
of the BRT MRL, Delvotest MCS SP-NT, Delvotest MCS Accelerator, and the Eclipse 
100 tests was calculated according to European Commission Decision 657/2002. All 
the tests were able to detect most β-lactam antibiotics assessed in sheep as well as 
goat milk. For non-β-lactam drugs, only 20 % of substances were detected at or below 
their respective maximum residue limits (MRL). Microbial screening tests showed an 
elevated percentage of non-compliant outcomes (4.8-10 %) when antimicrobial-free 
sheep milk samples were analysed. The positive results were related to elevated 
somatic cell counts (SCC) in milk. However, test responses were unaffected by goat 
milk properties when individual antimicrobial-free milk samples were checked along the 
entire lactation, and false-positive outcomes recorded were below 5 % in all cases. In 
conclusion, microbial screening tests are an efficient tool for the detection of β-lactams 
in raw milk from sheep and goats. Nevertheless, they are inefficient to detect most non-
β-lactam drugs employed by veterinarians for therapeutic and prophylactic treatments 
of infectious diseases in ovine and caprine livestock. Therefore, the periodical use of 
more sensitive microbial methods for these substances or the application of specific 
methods on a different analytical basis would be convenient. Thus, the detection range 
in screening could be widened and the safety of milk and dairy products from small 
ruminants would be guaranteed. 
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1. Introduction 
Microbial inhibitor tests are routinely applied in the control of the presence of 
antibiotic residues in raw milk as they are relatively inexpensive, user-friendly, and able 
to detect a great variety of antimicrobials in a large number of milk samples. 
Most current microbial screening tests were initially developed to detect beta-
lactams in cow milk and are based on the inhibition of Geobacillus stearotermophilus 
var. calidolactis being highly sensitive to these substances. Efforts to improve test 
sensitivity, in particular towards non-beta-lactam drugs, has been made by different 
authors who proposed some modifications such as the addition of chelating agents or 
antifolates, such as trimethoprim, into the culture medium, to enhance the detection of 
tetracyclines and sulphonamides in milk, respectively (Adriany et al.,1995; Langeveld 
et al., 2005). In recent years, manufacturers have improved some performance 
characteristics of microbial methods, especially the time required for the analyses, and 
sensitivity to different substances, and new versions of these tests are now available 
(ISO/IDF, 2010). 
Different studies on the sensitivity of microbial screening tests have been 
carried out in the last two decades by different researchers using sheep and goat’s milk 
(Althaus et al., 2003a; Molina et la., 2003; Sierra et al., 2009a,b), demonstrating that 
these tests are able to detect beta-lactams at or below the maximum residue limits 
(MRLs) established by European legislation (EC, 2010), however they are not suitable 
for other drugs. 
Although beta-lactams are widely used to treat mastitis and other infections in 
dairy sheep and goats, other antimicrobials like tetracyclines, quinolones or 
aminoglycosides, are often used for therapeutic and prophylactic treatments in these 
species. Therefore, knowledge of the detection capabilities (CCβs) of currently 
available microbial tests for these substances is relevant to assure the safety of milk of 
these species. 
Moreover, sheep and goat milk is characterized by a higher fat and protein 
content than cow milk (Park et al., 2007) as well as by an elevated content of natural 
inhibitors such as immunoglobulins, lactoferrin, or lysozyme (Crosson et al., 2010) and 
higher somatic cell count (SCC) even in absence of intra-mammary infections (Paape 
et al., 2007) that might interfere in the response of microbial inhibitor tests. In fact, 
some authors have also studied the specificity of several microbial tests obtaining 
higher false non-compliant rates when using individual sheep’s milk samples (Althaus 
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et al., 2003b). In goat milk, information about the effect of the milk characteristics on 
the microbial test response is more limited (Contreras et al., 1997). 
Antibiotic residues have negative repercussions on the technological properties 
of milk as they can totally or partially inhibit fermentation procedures required when 
making cheese and yoghurt (Packham et al., 2001). Sheep and goat milk is basically 
destined for the elaboration of fermented products, and antibiotics in milk can thus 
affect the production process; also, as residues of variable amounts may remain in the 
final products, their consumer safety might be compromised (Oliver et al., 2011); 
therefore it seems necessary to establish control measures to rule out the presence of 
these substances above legally established limits, employing suitable screening tests 
for this purpose. 
The aim of this study was to assess the performance of new versions of some 
microbial screening tests to detect antimicrobial residues in sheep and goat milk 
according to European Commission Decision 657/2002 (EC, 2002). 
2. Material and methods 
2.1. Microbial inhibitor tests 
The screening tests used were the BRT MRL (Analytik in Milch Produktions-und 
Vertriebs-GmbH, Munich, Germany), Delvotest MCS SP-NT (DSM Food Specialties, 
Delft, the Netherlands), Delvotest MCS Accelerator (DSM Food Specialties), and 
Eclipse 100 (Zeulab, Zaragoza, Spain). All tests were conducted according to the each 
manufacturer’s instructions. Negative (antibiotic-free milk) and positive (antibiotic-free 
milk spiked with 4µg/Kg of benzylpenicillin) control samples were also included in all 
the experimental plates. Interpretation of the test results were carried out independently 
by three trained technicians assessing visually the colour change after incubation, and 
classifying milk samples as positive (blue) or negative (yellow). Samples showing a 
doubtful colour change were classified as questionable. For the Delvotest MCS 
Accelerator (DA) test, the results were classified instrumentally using the Delvotest 
Accelerator device (DSM Food Specialties). 
2.2. Milk samples 
Antibiotic-free milk samples were obtained from the experimental flocks of 
Manchega ewes of Universidad de Castilla-La Mancha (Albacete, Spain), and 
Murciano-Granadina goats of Universitat Politècnica de València (Valencia, Spain). 
Animals had a good health status and had not received any veterinary drugs, neither 
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before nor along the experimental period. Neither was medicated feed used in their 
diet. 
All milk samples were analysed for gross composition (MilkoScan 6000, Foss. 
Hillerd, Denmark), somatic cell count (Fossomatic 5000, Foss), total bacterial count 
(Bactoscan FC, Foss), and pH value (pHmeter, Crison, Barcelona, Spain). 
2.3. Antimicrobials and spiked milk samples 
The list with the total antimicrobial substances assayed is shown in Table 1. 
Antimicrobials were dissolved (1 mg/ml) at the time when analyses were carried out to 
avoid problems related to instability. Spiked milk samples were prepared following the 
recommendations of the International Dairy Federation (ISO/IDF, 2003), and tested 
simultaneously applying the microbial screening tests immediately after spiking. 
2.4. Detection capability (CCβ) 
Detection capability (CCβ) of the four microbial screening tests was investigated 
following the “Guidelines for the validation of screening methods for residues of 
veterinary medicines” proposed by Community Reference Laboratories for residues 
(CRLs, 2010), which supplements Commission Decision nº 657/2002 (EC, 2002) and 
defines the CCβ as the lowest antibiotic concentration assessed which produces at 
least 95 % positive results (false compliant results ≤ 5 %). To calculate the CCβ of 
microbial screening tests, antimicrobial-free milk samples from sheep and goats were 
collected in the mid-lactation period to be used as “negative milk” as, according to the 
recommendations of the International Dairy Federation (ISO/IDF, 2003), such samples 
show good hygienic quality and a characteristic gross composition. 
Antimicrobial-free milk samples were spiked individually with different 
substances at 0.5xMRL, 0.75xMRL, and 1xMRL equivalent drug concentration, and 
analysed 20, 40 or 60 times, respectively, by the different microbial tests. 
2.5. Interferences related to milk matrix constituents 
To investigate the effect of the milk constituents on the microbial test response, 
individual milk samples free of antimicrobials collected periodically thorough the milking 
period were used. Sheep milk samples (n= 250) were obtained on a two-week basis at 
the morning milking from the first week after weaning until the end of lactation 
(sampling: days 35 to 170 post-partum). Goat milk samples (n= 350) were also 
collected every two weeks from the second week post-partum during a period of seven 
months (sampling: days 15 to 200 post-partum). 
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Table 1. Antimicrobials used to evaluate microbial screening tests in sheep and goat milk 
aSigma-Aldrich Química, S.A. (Madrid, Spain) 
bFatro, S.p.A. (Bologna, Italy) 
cACS Dobfar, S.p.A. (Milan, Italy) 
dToronto Research Chemicals, Inc. (Toronto, Canada) 
eAcros Organics (Geel, Belgium) 
*Commercial reference not available 
Antimicrobials Distributor Commercial reference Solvent 
Beta-lactams     
Amoxicillin Sigma-Aldricha A8523 H2O 
Ampicillin Sigma-Aldricha A9518 H2O 
Benzylpenicillin Sigma-Aldricha PENNA H2O 
Cloxacillin Sigma-Aldricha C9393 H2O 
Dicloxacillin Sigma-Aldricha D9016 MeOH / H2O 
Nafcilin Sigma-Aldricha N3269 MeOH / H2O 
Oxacillin Sigma-Aldricha 46589 MeOH / H2O 
Cefacetrile Fatrob * H2O 
Cefalonium Sigma-Aldricha 32904 NaOH 0.1N /H2O
Cefapirin Sigma-Aldricha 43989 H2O 
Desacetylcefapirin ACS Dobfarc * H2O 
Cefazolin Sigma-Aldricha C5020 H2O 
Cefoperazone Sigma-Aldricha 32426 NaOH 1N / H2O
Cefquinome Sigma-Aldricha 32472 H2O 
Ceftiofur Sigma-Aldricha 34001 NaOH 0.1N / H2O
Desfuroylceftiofur TRCd D289980 MeOH / H2O 
Cephalexin Sigma-Aldricha C4895 H2O 
Aminoglycosides    
Gentamicin Sigma-Aldricha G3632 H2O 
Neomycin Sigma-Aldricha N1876 H2O 
Streptomycin Sigma-Aldricha S6501 H2O 
Macrolides    
Erythromycin Sigma-Aldricha E6376 EtOH / H2O 
Lincomycin Sigma-Aldricha 31727 H2O 
Tylosin Sigma-Aldricha T6271 H2O 
Quinolones    
Enrofloxacin Sigma-Aldricha 33699 AcOH 5% / H2O
Ciprofloxacin Sigma-Aldricha 17850 HCl 0.1N 
Marbofloxacin Sigma-Aldricha 34039 H2O 
Sulphonamides    
Sulfadiazine Sigma-Aldricha S6387 H2O 
Sulfadimethoxine Sigma-Aldricha S7385 H2O 
Sulfametazine Sigma-Aldricha S5637 H2O 
Tetracyclines    
Chlortetracycline Sigma-Aldricha C4881 NaOH 0.1N / H2O
4-epichlortetracycline Acrose 268235000 MeOH / H2O 
Oxytetracycline Sigma-Aldricha O4636 HCl 0.1N / H2O
4-epioxytetracycline Acrose 25771 MeOH / H2O 
Tetracycline Sigma-Aldricha T3258 HCl 0.1N / H2O
4-epitetracycline Acrose 233125000 MeOH / H2O 
Others    
Colistin Sigma-Aldricha C4461 H2O 
Trimethoprim Sigma-Aldricha 92131 EtOH 
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All samples were analysed simultaneously, in three replicates, by the four tests, 
and non-compliant outcomes were recorded as interferences. Samples showing 
positive and questionable results in at least two replicate analyses were finally 
recorded as non-compliant results. 
2.6. Statistical analysis 
To investigate the effect of the milk matrix constituents on the microbial test 
response, a logistic regression model was applied. Statistical analysis was carried out 
employing the stepwise option of the logistic procedure of the SAS software (version 
9.2, 2001; SAS Institute, Inc., Cary, NC), using the following logistic model: 
Lij= logit [Pi] = β0 + β1[SL] + β2[pH] + β3[F] + β4[P] + β5[L] + β6[TS] + β7[logSCC] 
+ β8[logBC] + εij (Eq. 1) 
where: Lij is the logistic model; [Pi] is the probability for the response category 
(positive/negative); β0 is the intercept; βi are the estimate parameters for the model; 
[SL] is the lactation stage effect (day); [pH] is the pH effect; [F] is the fat content effect; 
[P] is the protein content effect; [L] is the lactose content effect; [TS] is the total solids 
content effect; [logSCC] is the somatic cell count effect; [logBC] is the bacterial count 
effect; εij is the residual error. 
3. Results and discussion 
3.1. Detection capability (CCβ) 
The CCβ of the BRT MRL, Delvotest MCS SP-NT, Delvotest MCS DA, and 
Eclipse 100 tests in sheep milk were shown in Table 2. On average, these tests allow 
the detection of 83.8 % beta-lactam substances at or below the required safety level 
(70.6 %: BRT MRL, and 88.2 %: Delvotest MCS SP-NT, Delvotest MCS DA, and 
Eclipse 100). Only cefquinome and cefoperazone could not be detected by any test at 
MRL equivalent antibiotic concentration. Moreover, the BRT MRL test could neither 
detect ceftiofur, its metabolite desfuroylceftiofur, and cephalexin at their respective 
MRL. In goat milk, the CCβ results for beta-lactam substances (Table 3) were similar to 
those previously reported for sheep milk (76.4 %: BRT MRL, and 82.3 %: Delvotest 
MCS SP-NT; Delvotest MCS DA, and Eclipse 100) the BRT MRL test being the least 
sensitive for the detection of these substances. 
The sensitivity of microbial tests to detect beta-lactams has improved in the last 
years. Thus, for instance, the detection levels of these tests for widely used antibiotics 
such as benzylpenicillin or ampicillin was above MRLs (Heeschen and Blüthgen, 1991) 
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Table 2. Detection capability (CCβ) of microbial screening tests for the detection of 
antimicrobials in sheep milk 
aMRL: Maximum Residue Limit (µg/Kg) established by EC Regulation Nº 37/2010 (EC, 2010); 
bCCβ: Detection Capability (lower antimicrobial concentration which produces at least 95 % 
positive results); *: marker residue. MRL not established 
Antimicrobial MRL
a 
(µg/Kg) 
CCβb
(µg/Kg)
BRT 
MRL
Delvotest 
SP-NT
Delvotest 
DA
Eclipse 
100 
Beta-lactams       
Amoxicillin 4 4 3 3 3 
Ampicillin 4 3 3 3 4 
Benzylpenicillin 4 3 3 3 4 
Cefacetrile 125 ≤ 63 ≤ 63 ≤ 63 ≤ 63 
Cefalonium 20 20 ≤ 10 20 20 
Cefapirin 60 ≤ 30 ≤ 30 ≤ 30 ≤ 30 
Deacetylcefapirin * ≤ 30 ≤ 30 ≤ 30 ≤ 30 
Cefazolin 50 ≤ 25 ≤ 25 ≤ 25 ≤ 25 
Cefoperazone 50 > 50 > 50 > 50 > 50 
Cefquinome 20 > 20 > 20 > 20 > 20 
Ceftiofur 100 > 100 100 100 100 
Desfuroylceftiofur * > 100 75 100 100 
Cephalexin 100 > 100 ≤ 50 ≤ 50 ≤ 50 
Cloxacillin 30 23 ≤ 15 ≤ 15 23 
Dicloxacillin 30 ≤ 15 ≤ 15 ≤ 15 23 
Nafcillin 30 ≤ 15 ≤ 15 ≤ 15 ≤ 15 
Oxacillin 30 ≤ 15 ≤ 15 ≤ 15 ≤ 15 
Aminoglycosides      
Gentamicin 100 100 >100 >100 >100 
Neomycin 1,500 ≤ 750 ≤ 750 ≤ 750 > 1,500 
Streptomycin 200 > 200 > 200 > 200 > 200 
Macrolides      
Erythromycin 40 40 > 40 > 40 > 40 
Lincomycin 150 > 150 > 150 > 150 > 150 
Tylosin 50 ≤ 25 ≤ 25 ≤ 25 ≤ 25 
Quinolones      
Enrofloxacin 100 > 100 > 100 > 100 > 100 
Ciprofloxacin * > 100 > 100 > 100 > 100 
Marbofloxacin 75 > 75 > 75 > 75 > 75 
Sulphonamides      
Sulfadiazine 100 >100 75 75 75 
Sulfadimethoxine 100 ≤ 50 ≤ 50 75 100 
Sulfametazine 100 > 100 >100 >100 > 100 
Tetracyclines      
Chlortetracycline 100 >100 >100 >100 >100 
4-epichlortetracycline * >100 >100 >100 >100 
Oxytetracycline 100 >100 >100 >100 >100 
4-epichlortetracycline * >100 >100 >100 >100 
Tetracycline 100 >100 >100 >100 >100 
4-epitetracycline * >100 >100 >100 >100 
Others      
Colistin 50 > 50 > 50 > 50 > 50 
Trimethoprim 50 > 50 > 50 > 50 > 50 
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Table 3. Detection capability (CCβ) of microbial screening tests for the detection of 
antimicrobials in goat milk 
aMRL: Maximum Residue Limit (µg/Kg) established by EC Regulation Nº 37/2010 (EC, 2010); 
bCCβ: Detection Capability (lower antimicrobial concentration which produces at least 95 % 
positive results); *: marker residue. MRL not established 
Antimicrobial MRL
a 
(µg/Kg) 
CCβb
(µg/Kg)
BRT 
MRL
Delvotest 
SP-NT
Delvotest 
DA
Eclipse 
 100 
Beta-lactams       
Amoxicillin 4 3 4 4 4 
Ampicillin 4 2 2 3 4 
Benzylpenicillin 4 2 2 2 2 
Cefacetrile 125 ≤ 63 ≤ 63 ≤ 63 ≤ 63 
Cefalonium 20 15 15 15 15 
Cefapirin 60 ≤ 30 ≤ 30 ≤ 30 ≤ 30 
Deacetylcefapirin * ≤ 30 ≤ 30 ≤ 30 ≤ 30 
Cefazolin 50 ≤ 25 ≤ 25 ≤ 25 ≤ 25 
Cefoperazone 50 > 50 > 50 > 50 > 50 
Cefquinome 20 > 20 > 20 > 20 > 20 
Ceftiofur 100 > 100 > 100 > 100 > 100 
Desfuroylceftiofur * 100 100 100 100 
Cephalexin 100 > 100 75 ≤ 50 ≤ 50 
Cloxacillin 30 23 23 23 23 
Dicloxacillin 30 ≤ 15 ≤ 15 ≤ 15 ≤ 15 
Nafcillin 30 ≤ 15 ≤ 15 ≤ 15 ≤ 15 
Oxacillin 30 ≤ 15 ≤ 15 ≤ 15 ≤ 15 
Aminoglycosides      
Gentamicin 100 100 >100 >100 >100 
Neomycin 1,500 ≤ 750 ≤ 750 ≤ 750 > 1,500 
Streptomycin 200 > 200 > 200 > 200 > 200 
Macrolides      
Erythromycin 40 40 > 40 > 40 > 40 
Lincomycin 150 > 150 > 150 > 150 > 150 
Tylosin 50 50 ≤ 25 50 50 
Quinolones      
Enrofloxacin 100 > 100 > 100 > 100 > 100 
Ciprofloxacin * > 100 > 100 > 100 > 100 
Marbofloxacin 75 > 75 > 75 > 75 > 75 
Sulphonamides      
Sulfadiazine 100 >100 ≤ 50 75 ≤ 50 
Sulfadimethoxine 100 ≤ 50 ≤ 50 ≤ 50 100 
Sulfametazine 100 > 100 > 100 >100 > 100 
Tetracyclines      
Chlortetracycline 100 >100 >100 >100 >100 
4-epichlortetracycline * >100 >100 >100 >100 
Oxytetracycline 100 >100 >100 >100 >100 
4-epichlortetracycline * >100 >100 >100 >100 
Tetracycline 100 >100 >100 >100 >100 
4-epitetracycline * >100 >100 >100 >100 
Others      
Colistin 50 > 50 > 50 > 50 > 50 
Trimethoprim 50 > 50 > 50 > 50 > 50 
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while they are currently detected at or below legally stipulated levels (Stead et al., 
2008). However, their sensitivity for some cephalosporins such as cefquinome, 
cephalexin or cefoperazone remains still inadequate (Sierra et al., 2009a). It should be 
noted that within the beta-lactam antibiotics family, penicillins are most widely used by 
veterinarians to treat mastitis in dairy small ruminants (Ferrini et al., 2010), 
cephalosphorins being less used in these species. Therefore the sensitivity results 
obtained in this study confirm the suitability of microbial inhibitor tests for screening 
residues of penicillins in sheep and goat milk. 
For non-beta-lactam drugs, the CCβ was above MRL for all antimicrobial 
substances except for neomycin, tylosin and sulfadimetoxine that were detected in 
sheep milk at or below regulatory limits (Table 2). In contrast to the other tests, the 
BRT MRL test was also able to detect gentamicin at erythromycin at their MRLs. In 
goat milk, the CCβ for antimicrobial families other than β-lactams was also above their 
MRLs in most cases (Table 3). Thus, microbial inhibitor tests only allowed, on average, 
the detection of 20 % of non-beta-lactam drugs at or below the safety level in sheep 
milk as well in goat milk (25 %: BRT MRL, 20 %: Delvotest MCS SP-NT, and Delvotest 
MCS DA, and 15 %: Eclipse 100). Although manufacturers have improved the 
sensitivity of microbial inhibitor tests for certain drugs, they still remain inefficient for the 
detection of antibiotics such as tetracyclines, quinolones, and aminoglycosides (Sierra 
et al., 2009b), usually employed in the therapy and veterinary prophylaxis in ovines and 
caprines, representing a potential food safety risk. 
3.2. Interferences related to the milk matrix effect  
To study the effect of milk composition on the microbial test response, individual 
milk samples free of antimicrobials were collected throughout the lactation period. Milk 
samples presented a wide range of variation in milk quality parameters (Table 4). 
Microbial screening tests showed an elevated percentage of non-compliant 
results (up to 10 %) when antimicrobial-free sheep milk samples were assayed (Table 
5). For this species, logistic regression analysis showed that an increase in SCC was 
associated with an elevation in the predicted likelihood of positive outcomes for all the 
microbial screening tests (Figure 1), in which the BRT MRL test response was the least 
affected by this parameter. These results were in agreement with those obtained by 
others (Cullor et al., 1992) who also observed a significant effect of SCC on the 
frequency of positive results for different screening methods using individual milk 
samples from cows. 
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Table 4. Quality parameters of individual milk samples free of antimicrobials used to 
evaluate the effect of the matrix constituents on the microbial test response 
aSD: standard deviation; bMin: minimum; cMax: maximum; dLog SCC: logarithm of somatic cell 
count; eLog BC: logarithm of bacterial count 
It is important to mention that in control quality programmes raw bulk milk 
samples are usually analysed, not individual milk, presenting a minor range of variation 
in all quality parameters and very low percentages of non-compliant results (Comunian 
et al., 2010). However, the test responses were unaffected by goat milk properties, 
including SCC, when antimicrobial-free milk samples were analysed; and the false-
positive outcomes recorded were below 5 % in all cases (Table 5). These results could 
be related with the particularity of goats in which high SCCs might be due to non-
infectious factors such as stress or oestrus, among others, which do not lead to 
modifications in plasma-component concentration of known antimicrobial activity, 
characteristic of mastitis processes (Andrew et al., 1997). 
Figure 1. Effect of the somatic cell count (SCC) on the false non-compliant outcomes of 
microbial screening tests using sheep milk 
Parameter 
Individual sheep milk 
(n=250)  
Individual goat milk 
(n=350) 
Mean SDa Minb Maxc  Mean SD Min Max 
pH 6.66 0.08 6.54 6.92  6.79 0.09 6.25 7.02 
Fat (%) 6.38 2.05 2.42 12.68  5.57 1.15 3.23 9.59 
Protein (%) 5.83 0.73 4.55 7.82  3.74 0.49 2.44 5.36 
Lactose (%) 5.03 0.35 3.87 5.67  4.65 0.31 2.90 5.38 
Total solids (%) 18.06 2.71 12.51 26.53  14.66 1.53 11.05 19.48 
Log SCCd 5.01 0.48 4.00 7.27  5.77 0.42 4.88 7.19 
Log BCe 4.83 0.72 3.78 6.96  4.55 0.40 4.00 6.36 
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Table 5. Microbial inhibitor test results in individual sheep and goat milk samples free of 
antimicrobials 
aP: positive; bQ: questionable; cN: negative; dC (%): percentage of compliant outcomes; *: only 
two categories of test results in the Delvotest MCS DA 
4. Conclusions 
Microbial inhibitor tests using Geobacillus stearothermophilus var. calidolactis 
as a microorganism are efficient to detect beta-lactams in raw milk from small 
ruminants avoiding that such substances reach consumers. However, in spite of the 
improvements made in these tests along the last decade, they continue to be inefficient 
for other drugs, such as tetracyclines, quinolones or macrolides, usually employed for 
therapeutic and prophylactic treatments in dairy livestock. Therefore, the periodical use 
of more sensitive microbial methods towards these substances or the application of 
specific methods on different analytical bases would be convenient, which would widen 
the detection range in screening and guarantee the quality of milk and dairy products 
from small ruminants. 
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Abstract 
This article presents a microbiological system composed of a “BT” bioassay (Beta-
lactams and Tetracyclines) and a “QS” bioassay (Quinolones and Sulfonamides). The 
“BT” bioassay contains spores of Geobacillus stearothermophilus, bromocresol purple 
and cloramphenicol in a culture medium (incubation time: 2.45 h), while the “QS” 
bioassay uses spores of Bacillus subtilis, trifenyltetrazolium - toluidine blue and 
trimethoprim in a suitable culture medium (incubation time: 5.5 h). The detection 
capability (CCβ) of 27 antimicrobial agents in ovine milk was determined by logistic 
regression models. Thus, the “BT” bioassay detects amoxicillin, ampicillin, 
benzylpenicillin, cloxacillin, oxacillin, cephalexin, cefoperazone, ceftiofur, 
chlortetracycline, oxytetracycline, tetracycline, neomycin, gentamicin and tylosin, while 
“QS” bioassay detects: ciprofloxacin, enrofloxacin, marbofloxacin, sulfadiazine, 
sulfadimethoxine, sulfamerazine, sulfamethazine, sulfamethoxazole, sulfathiazole, 
erythromycin, lincomycin and spiramycin at levels close to their respective maximum 
residue limits (MRLs). The simultaneous use of both bioassays detects a large number 
of antibiotics in milk given each method’s adequate complementary sensitivity. 
Keywords: ovine milk; system; bioassay; detection 
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1. Introduction 
In recent years, increased use of antibiotics to treat mastitis and other diseases 
of small ruminants was observed due to the intensification of milk production (Buswell 
and Barber, 1989). 
The presence of antibiotic residuals in milk poses a potential risk for the 
consumers as they may cause allergic type reactions, and may interfere with intestinal 
flora and the development of resistance to antibiotics (Demoly and Romano, 2005; 
Dewdney et al., 1991; Currie et al., 1998; Wilke et al., 2005). Furthermore, antibiotic 
residues in milk can lead to important losses in fermented products, such as cheese-
making (Mourot and Loussourorn, 1981; Brady and Katz, 1988; Packham et al., 2001; 
Berruga et al., 2007). 
Therefore, monitoring antibiotic residues is very important in controlling food 
safety. For these reasons, several control authorities such as the European Union 
(Council Directive, 2009) and Codex (Codex Alimentarius, 2009) determine the 
Maximum residue limit (MRL) for the presence of specified veterinary residues in milk. 
To this end, several commercially available tests have been developed for the 
swiftly and precisely detect of the presence of antibiotic residuals in milk (Toldra and 
Reig, 2006). Many of the screening tests are based on the inhibition of Geobacillus 
stearothermophilus var. calidolactis caused by the presence of drug residues. 
However, this bacteria does not have sensitivity to detect many of the antibiotics used 
to treat livestock such as quinolones (Montero et al., 2005), spiramycin, lincomycin 
(Linage et al., 2007), erythromycin and streptomycin (Molina et al., 2003; Althaus et al., 
2002, 2003). 
In addition, rapid methods are specific to small groups of antibiotics, but cannot 
increase the number of molecules to be controlled (Althaus et al., 2001; Roca et al., 
2009). 
Given the absence of a single ideal screening method that is sensitive to a large 
number of antimicrobial agents in ovine milk, the objective of this study was to evaluate 
the application of a microbiological system that uses two bacteria test (Geobacillus 
stearothermophilus and Bacillus subtilis) to detect a larger number of antibiotics in milk 
and to ensure consumer food safety. 
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2. Materials and methods 
2.1. Preparation of microplates 
The “BT” bioassay (G. stearothermophilus): Plate Count Agar (Difco, Ref. 
247940) culture medium (6.25 g/l casein peptone, 2.25 g/l yeast extract and 15 g/l 
agar) fortified with glucose (10 g/l; Sigma, Ref 158968) was used. The culture medium 
was sterilized to 121 ºC for 15 min. Then, it was cooled to 501 ºC and the pH was 
adjusted to a value of 7.00.1. Once prepared, the spores suspension of G. 
stearothermophilus var. calidolactis C-953 (107 spores/ml, Merck, Ref. 1.11499), 
bromocresol purple indicator (0.05 mg/l, Mallinckrodt, Ref. 2090) and chloramphenicol 
(400 g/ml, Sigma Aldrich, Ref. C0378) were added in accordance with Nagel et al. 
(2009). 
The “QS” bioassay (B. subtilis): Müeller Hinton (38 g/l, Biokar Diagnostics, Ref. 
BK048HA) culture medium fortified with glucose (10 g/l; Sigma Aldrich, Ref. G7528), 
trimethoprim (400 mg/l; Sigma Aldrich, Ref. T7883), 2,3,5-tripheyltetrazolium chloride 
(150 mg/l; Sigma Aldrich, Ref. T8877) and toluidine blue (15 mg/l; Sigma Aldrich, Ref. 
198161) was employed. Once prepared, the culture medium was inoculated with the 
spore’s suspension of B. subtilis BGA (Merck, Ref. 1.10649) under sterile conditions in 
accordance with Nagel (2009). 
Then 100 l of the culture medium were added to each individual well of 
microtiter plate using an electronic pipette (Eppendorf Research Pro). Next, these 
microplates were sealed with aluminized film and conserved at 4 ºC until use. 
2.2. Animals and ewe milk samples 
The ewes were fed with natural pastures of Melilotus albus, Trifolium repens 
and Lolium multiflorum, during the lactation period. Individual samples were collected 
from 40 Pampinta (Milchschaff x Corriedale) ewes from the experimental farm at the 
Escuela de Agricultura Ganadería y Granja of the Universidad Nacional del Litoral in 
Argentina (south latitude: 31° 28', west longitude: 60° 55'). Animals did not receive any 
antimicrobial substances, and the samples were collected from ewes in the period 
between 30 and 90 days postpartum, from the recorder jar during morning milking and 
placed in 100 ml sterile plastic containers. Milk samples were kept at 4 ºC throughout 
the experiment. 
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2.3. Antimicrobial solutions and spiked samples 
Drugs for the preparation of antimicrobial solutions were stored and handled 
according to the manufacturers' instructions before use. All the dilutions were prepared 
in 10 ml volumetric flasks at the time when analyses were carried out to avoid possible 
inconvenience due to instability. Antimicrobial solutions were prepared from the 
respective stock solution in a single step using antimicrobial-free milk (IDF, 2002), as 
determined by the “BT” and “QS” bioassays. 
The dose-response curves of the antimicrobial agents were established in line 
with the Codex Alimentarius guidelines (Codex Alimentarius, 2010). To this end, 8 
concentrations were prepared with different levels of each drug (Table 1). For each 
concentration, 24 replicates were prepared using antibiotic-free ovine milk samples 
obtained from individual animals. Then, 50 l milk samples were added to the individual 
wells of the “BT” and “QS” Bioassays. Plates were sealed with adhesive bands and 
incubated at 641 ºC for 2.5 h (“BT” Bioassay) and 401 ºC for 5.5 h (“QS” Bioassay) 
according to the colour change of the negative samples. Visual interpretation was 
carried out by 3 qualified individuals and evaluated as “negative” (BT” bioassay: yellow 
and “QS” bioassay: rose) or “positive” (BT” bioassay: purple and “QS” bioassay: blue). 
For the statistical calculations, those visual results that presented at least 2 
similar interpretations were considered. 
2.4. Detection capability (CCβ) and statistical analysis 
To determine the detection capability (CCβ), 8 beta-lactams (amoxicillin, 
ampicillin, benzylpenicillin, cloxacillin, oxacillin, cephalexin, cefoperazone, ceftiofur), 3 
aminoglycosides (gentamicin, neomycin, streptomycin), 4 macrolides (erythromycin, 
lincomycin, tylosin, spiramycin), 3 quinolones (ciprofloxacin, enrofloxacin, 
marbofloxacin), 6 sulphonamides (sulfadiazine, sulfadimethoxine, sulfamerazine, 
sulfamethazine, sulfamethoxazole, sulfathiazole) and 3 tetracyclines (chlortetracycline, 
oxytetracycline, tetracycline) were analyzed according to Codex Alimentarius 
guidelines (Codex Alimentarius, 2010). 
The results were obtained using the SAS Logistic procedure (SAS, 2001). The 
logistic regression model was also used to calculate the detection limits, as follows: 
Lij = logit [Pi] = 0 + 1 [A]i + ij  (1) 
where: 
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Lij = lineal logistic model; [Pi] = logit [Pp/(1-Pp)]: the probability of a “positive” 
response / probability of a “negative” response); 0, 1 = the coefficients estimated for 
the logistic regression models; [A]i = antimicrobial concentration. ij = residual error. 
The concordance coefficient (SAS, 2001) was applied as a rank correlation 
between the observed responses and the predicted probabilities. 
Table 1. Antimicrobial agent concentrations using for microbiological system 
Antibiotics “BT” bioassay “QS” bioassay 
Beta-lactams   
Amoxicillin 0, 1, 2, 3, 4, 5, 6, 8 0, 1, 2, 4, 6, 8, 10, 12 
Ampicillin 0, 1, 2, 3, 4, 5, 6, 8 0, 5, 10, 20, 30, 40, 50, 60 
Benzylpenicillin 0, 1.0, 1.5, 2.0, 2.5, 3.0, 4.0, 5.0 0, 1.0, 1.5, 2.0, 2.5, 3.0, 4.0, 5.0 
Cloxacillin 0, 10, 15, 20, 25, 30, 40, 60  0, 50, 100, 150, 200, 250,300, 400 
Oxacillin 0, 2, 5, 10, 15, 20, 25, 30 0, 25, 50, 100, 150, 200, 250, 300 
Cephalexin 0, 25, 50, 75, 100, 150, 200, 300 0, 25, 50, 100, 125, 150, 200, 300 
Cefoperazone 0, 50, 75, 100, 150, 200, 300, 400 0, 50, 100, 125, 150, 200, 300, 400 
Ceftiofur 0, 25, 50, 75, 100, 150, 200, 300 0, 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.8* 
Aminoglycosides   
Gentamicin 0, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8* 0, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 1.0* 
Neomycin 0, 0.5, 1.0, 1.5, 2.0, 2.5, 3.0, 4.0* 0, 2, 3, 4, 5, 6, 7, 8* 
Streptomycin 0, 1, 2, 3, 4, 5, 6, 7* 0, 1, 2, 3, 4, 5, 6, 7* 
Macrolides   
Erythromycin 0, 0.05, 0.1, 0.15, 0.2, 0.25, 0.3, 0.4* 0, 10, 20, 30, 40, 50, 60, 70 
Lincomycin 0, 0.1, 0.15, 0.20, 0.25, 0.30, 0.40, 0.50* 0, 0.10, 0.15, 0.20, 0.25, 0.30, 0.40, 0.50
Tylosin 0, 25, 50, 75, 100, 125, 150, 200 0, 60, 80, 100 ,120, 140, 160, 180 
Spiramycin 0, 1, 2, 3, 4, 5, 6, 7* 0, 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7* 
Quinolones   
Ciprofloxacin 0, 1.0, 1.5, 2.0, 2.5, 3.0, 4.0, 5.0* 0, 50, 100, 150, 200, 250, 300, 400 
Enrofloxacin 0, 1.0, 1.5, 2.0, 2.5, 3.0, 4.0, 5.0* 0, 50, 100, 150, 200, 250, 300, 400 
Marbofloxacin 0, 2.0, 2.5, 3.0, 4.0, 5.0, 6.0, 7.0* 0, 50, 100, 150, 200, 250, 300, 400 
Sulphonamides   
Sulfadiazine 0, 10, 20, 30, 40, 50, 60, 80* 0, 50, 100, 200, 300, 400, 500, 600 
Sulfadimethoxine 0, 0.5, 0.8, 1.0, 1.3, 1.5, 2.0, 3.0* 0, 50, 100, 200, 300, 400, 500, 600 
Sulfamerazine 0, 10, 15, 20, 25, 30, 35, 40*  0, 50, 100, 200, 300, 400, 500, 600 
Sulfamethazine 0, 10, 20, 30, 40, 50, 60, 80* 0, 50, 100, 200, 300, 400, 500, 600 
Sulfamethoxazole 0, 5, 10, 15, 20, 25, 30, 35* 0, 50, 100, 200, 300, 400, 500, 600 
Sulfathiazole 0, 5, 10, 15, 20, 25, 30, 35* 0, 50, 100, 200, 300, 400, 500, 600 
Tetracyclines   
Clortetracycline 0, 50, 100, 150, 200, 300, 400, 500  0, 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7* 
Oxytetracycline 0, 25, 50, 75, 100, 150, 200, 300 0, 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7* 
Tetracycline 0, 25, 50, 75, 100, 150, 200, 300 0, 0.1, 0.2, 0.4, 0.6, 0.8, 1.0, 1.2* 
Units: g/l or *mg/l 
The CCβ were estimated as concentrations at which 95 % of the positive results 
(Codex Alimentarius, 2010). 
3. Results and discussion 
Table 2 shows the results obtained by applying the logistic regression model to 
the visual interpretations of the “BT” and “QS” bioassays for the 27 antimicrobials 
analyzed in sheep milk. 
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The “1” parameters indicate the slopes of the dose-response curves. 
Therefore, high values of this coefficient show a good sensitivity of the bacteria test to 
detect a particular antibiotic in milk.  
The “BT” bioassay presents high “1” coefficients values to beta-lactam 
antibiotics, tetracyclines, tylosin and neomycin, while the “QS” bioassay offers high 
values for this coefficients for most beta-lactams (except cloxacillin, cefoperazone and 
ceftiofur), macrolides, quinolones and sulphonamides. 
 The high “1” coefficients values, which use G. stearothermophilus for the 
detection of tylosin and beta-lactam antibiotics in ovine milk, were indicated with the 
BRT AiM (Molina et al., 2003), Delvotest SP (Althaus et al., 2002), Charm Blue-Yellow 
(Linage et al., 2007) and Eclipse 100ov (Montero et al., 2005) methods. In addition, the 
last two methods presented high “1” parameters to sulfonamides. For the “QS” 
bioassay, Nagel (2009) indicated high “1” coefficients values when analyzing samples 
of cow's milk fortified with sulphonamides. 
The concordance coefficients obtained by applying of the logistic model were 
high for both bioassays. They fell between 70.49 % for amoxicillin (“BT” bioassay) and 
91.67 % for sulfadimethoxine (“BT” bioassay), demonstrating the correct adjustment 
achieved by the logistic model. 
The detection capability (CCβ), calculated as concentrations which produce 
95% of the positive results in dose-response curves (Codex Alimentarius, 2010), are 
summarized in Table 3. 
As regards the beta-lactam antibiotics analyzed, the “BT” bioassay presented 
similar CCβ to the respective MRLs (except cefoperazone), while the “QS” bioassay 
detected only to penicillin residues at the MRL level. The detection capability for the 
“BT” bioassay for beta-lactams were similar to the values calculated for BRT AiM 
(amoxicillin, CCβ= 6 g/l; ampicillin, CCβ= 6 g/l; benzylpenicillin, CCβ= 2 g/l; 
cloxacillin, CCβ= 51 g/l; cephalexin, CCβ= 270 g/l; cefoperazone, CCβ= 92 g/l and 
ceftiofur, CCβ= 120 g/l) for Molina et al. (2003), Eclipse 100ov (amoxicillin, CCβ= 7 
g/l, benzylpenicillin, CCβ= 5 g/l; cloxacillin, CCβ= 68 g/l; cephalexin, CCβ= 115 g/l 
and cefoperazone, CCβ= 110 g/l) for Montero et al. (2005), and Charm Blue-Yellow 
(ampicillin, CCβ= 5-6 g/l; benzylpenicillin, CCβ= 3-4 g/l; cloxacillin, CCβ= 33-42 g/l; 
cephalexin, CCβ= 160-202 g/l; cefoperazone, CCβ= 73-82 g/l and ceftiofur, CCβ= 
96-107 g/l) for Linage et al. (2007), which also used G. stearothermophilus as the 
bacteria test. However, Althaus et al. (2002) indicated lower detection capability when 
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using the Delvotest SP test with ovine milk samples (amoxicillin, CCβ= 3 g/l; 
ampicillin, CCβ= 2 g/l; benzylpenicillin, CCβ= 1 g/l; cloxacillin, CCβ= 18 g/l; 
cephalexin, CCβ= 40 g/l; cefoperazone, CCβ= 20 g/l and ceftiofur, CCβ= 33 g/l). 
Table 2. Summary of logistic regression model parameters of antibiotics in ovine milk 
for microbiological system 
 
Antibiotics “BT” Bioassay “QS” Bioassay 0 1 C 0 1 C 
Beta-lactams       
Amoxicillin -4,950 2,123 70,49 -4,508 1,324 73,79
Ampicillin -5,652 2,424 74,63 -6,055 0,723 88,29
Benzylpenicillin -10,975 5,270 77,43 -10,320 3,707 71,34
Cloxacillin -4,771 0,308 75,47 -5,406 0,036 66,95
Oxacillin -3,064 0,402 73,02 -5,870 0,133 86,30
Cephalexin -3,237 0,048 79,14 -8,196 0,079 75,82
Cefoperazone -11,619 0,084 75,72 -9,332 0,046 75,71
Ceftiofur -11,421 0,125 88,82 -5,722 0,026 75,54
Aminoglycosides       
Gentamicin -7,959 0,024 74,06 -14,330 0,026 77,02
Neomycin -6,143 0,007 79,30 -16,381 0,003 78,27
Streptomycin -8,749 0,002 86,32 -11,179 0,003 81,25
Macrolides       
Erythromycin -9,732 0,056 78,86 -13,493 0,289 78,23
Lincomycin -11,560 0,044 74,27 -12,445 0,055 78,87
Tylosin -7,572 0,104 76,69 -132,074 0,951 89,08
Spiramycin -8,380 0,003 77,42 -10,915 0,036 86,38
Quinolones       
Ciprofloxacin -8,679 0,005 87,03 -22,162 0,152 88,26
Enrofloxacin -9,809 0,005 86,33 -13,963 0,071 86,56
Marbofloxacin -11,628 0,003 87,17 -11,672 0,051 75,76
Sulphonamides       
Sulfadiazine -4,956 0,000 84,56 -5,850 0,056 80,64
Sulfadimethoxine -16,157 0,001 91,67 -4,449 0,054 78,41
Sulfamerazine -19,487 0,001 86,32 -4,494 0,065 76,74
Sulfamethazine -20,267 0,001 92,65 -3,769 0,034 73,58
Sulfamethoxazole -18,659 0,001 90,78 -5,183 0,066 79,15
Sulfathiazole -20,429 0,001 89,46 -3,749 0,055 79,78
Tetracyclines       
Clortetracycline -8,730 0,043 85,6 -9.254 0.026 82.4
Oxytetracycline -6,611 0,074 72,65 -9,827 0,022 72,38
Tetracycline -6,081 0,058 70,55 -8,053 0,013 76,67
0, 1 = coefficients estimated for the logistic regression models; C: percentage concordance 
coefficients 
 
Of the three aminoglycosides analyzed, only neomycin residues were detected 
by the “BT” bioassay at levels close to the MRL (1,500 g/l), while gentamicin must be 
present at higher concentrations (450 g/l) to be detected by this bioassay. Neither 
bioassay was able to detect streptomycin residues (5,000 g/l for “BT” bioassay and 
4,500 g/l for “SQ” bioassay). It is necessary to emphasize that the BRT AiM (630 g/l 
65 
of neomycin, 3,700 g/l of Gentamicin and 6,000 g/l of streptomycin), Delvotest SP 
(2,600 g/l of neomycin, 1,200 g/l of gentamicin and 6,100 g/l of streptomycin), 
Eclipse 100ov (9,100 g/l of neomycin, 3,140 g/l of gentamicin and 10,100 g/l of 
streptomycin) and Charm Blue-Yellow (444-542 g/l of neomycin, 355-382 g/l of 
gentamicin and 3,063-3,593 g/l of streptomycin) methods obtained appropriate 
detection capability for neomycin (except Eclipse 100ov), high ones for gentamicin, but 
proved inadequate for streptomycin in ovine milk according to Althaus et al. (2002), 
Linage et al. (2007), Molina et al. (2003) and Montero et al. (2005), respectively. 
For macrolides, Table 3 shows that the CC for the “QS” bioassay for 
erythromycin (60 g/l), lincomycin (280 g/l), tylosin (140 g/l) and spiramycin (380 
g/l) were slightly above their respective MRLs, indicating good sensitivity for B. subtilis 
for that family of antibiotics in milk. On the contrary, “BT” bioassay presents a detection 
capability for tylosin (100 g/l) closer to their MRL (50 g/l) if compared to the “QS” 
bioassay. The low sensitivity of G. stearothermophilus to detect erythromycin (630 g/l 
for BRT AiM, 830 g/l for Delvotest SP, 750 g/l for Eclipse 100ov, and 444-522 g/l 
for Charm Blue-Yellow) and spiramycin (18,100 g/l for Eclipse 100ov, and 1,106-
1,346 g/l for Charm Blue-Yellow) was pointed out by those authors. 
Of the three quinolones tested, ciprofloxacin (160 g/l) and enrofloxacin (230 
g/l) were detected by the “QS” bioassay at levels near their MRL (100 g/l), while 
marbofloxacin residues must be present in milk at a higher level (280 g/l) than the 
MRL (75 g/l) to be detected by this method. In contrast, the “BT” bioassay was not 
sensitive to these antibiotics because it presented high CC for ciprofloxacin (2,280 
g/l), enrofloxacin (2,770 g/l) and marbofloxacin (5,540 g/l) in ovine milk. It is 
noteworthy that Montero, Althaus et al. (2005) reported high CC for ciprofloxacin 
(5,100 g/l) and enrofloxacin (4,000 g/l) when using the Eclipse 100ov method to 
analyze ovine milk samples fortified with quinolones. Similarly, Linage et al. (2007) 
reported a wide range (41,000-46,000 g/l) for the enrofloxacin residues analyzed by 
the Charm Blue-Yellow method. 
Once again, these studies indicate that the use of these commercial methods 
containing G. stearothermophilus is inadequate to control quinolones residues in ovine 
milk, and that the use of another bacteria test (i.e. B. subtilis) is necessary. 
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Table 3. Microbiological system detection capability (g/l) for antibiotics in milk 
Antibiotics “BT” Bioassay a  “QS” Bioassay a MRLb 
Beta-lactams    
Amoxicillin 4 6 4 
Ampicillin 4 12 4 
Benzylpenicillin 3 4 4 
Cloxacillin 25 232 30 
Oxacillin 15 66 30 
Cephalexin 128 141 100 
Cefoperazone 174 266 50 
Ceftiofur 115 328 100 
Aminoglycosides    
Gentamicin 450 670 100 
Neomycin 1,360 6,700 1,500 
Streptomycin 5,000 4,500 200 
Macrolides    
Erythromycin 230 60 40 
Lincomycin 330 280 150 
Tylosin 100 140 50 
Spiramycin 4,280 380 200 
Quinolones    
Ciprofloxacin 2,280 160 100 
Enrofloxacin 2,770 230 100 
Marbofloxacin 5,540 280 75 
Sulphonamides    
Sulfadiazine 53,000 157 100 
Sulfadimethoxine 1300 136 100 
Sulfamerazine 23,000 115 100 
Sulfamethazine 35,000 200 100 
Sulfamethoxazole 17,000 123 100 
Sulfathiazole 17,000 122 100 
Tetracyclines    
Clortetracycline 271 470 100 
Oxytetracycline 129 570 100 
Tetracycline 154 840 100 
a Detection capabilities estimated as concentrations at which 95 % of the positive results 
b MRLs (g/l) 
Regarding sulphonamides, Table 3 shows that the “QS” bioassay presented 
similar detection capability (sulfadiazine, CCβ= 157 g/l; sulfadimethoxine, CCβ= 136 
g/l; sulfamerazine, CCβ= 115 g/l; sulfamethazine, CCβ= 200 g/l; sulfamethoxazole, 
CCβ= 123 g/l and sulfathiazole, CC= 122 g/l) to the MRLs. However, the “BT” 
Bioassay did not provide good limits for this family of antibiotics because there was no 
trimethoprim in the culture medium (Nagel et al., 2009). 
 These limits were similar to those reported for the Charm Blue-Yellow test 
(sulfadimethoxine, CCβ= 101-119 g/l; sulfamethazine, CCβ= 309-328 g/l; 
sulfathiazole, CCβ= 122-151 g/l) by Linage et al. (2007), but were lower than the 
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levels obtained for Eclipse 100ov (sulfadimethoxine, CCβ= 170 g/l; sulfamethazine, 
CCβ= 750 g/l, and sulfathiazole, CCβ= 250 g/l) reported by Montero et al. (2005) 
when using G. stearothemophilus instead of B. subtilis. Nevertheless, Althaus et al. 
(2002) calculated lower detection capability (sulfadiazine, CCβ= 88 g/l and 
sulfamethoxazole, CCβ= 44 g/l) than those obtained in this work (Table 3) when 
analyzing ovine milk samples by the Delvotest SP method. 
To synthesize, the Figure 1 shows the detection pattern by the simultaneous 
implementation of "BT" and "QS" bioassays. This scale was constructed by applying 
the logarithmic transformation to CCβ/MRL for each antimicrobial. The interior, central 
and outer polygons correspond to concentrations equivalent to 10xMRL, MRL, and 
0.1xMRL, respectively. 
Figure 1. Detection pattern by simultaneous implementation of “BT” and “QS” 
bioassays. Line 1: 10xCCβ/MRL; Line 2: CCβ/MRL and Line 3: 0.1xCCβ/MRL 
(Note: The figure uses the lowest CCβ of antibiotics listed in Table 3) 
This figure summarizes the adequate detection capability of the microbiological 
system, since most of the antibiotics have detection capability near their corresponding 
MRLs, with the exception of streptomycin. It is noted that the CCβ of the different 
antibiotics analyzed by this microbiological system are located close to central polygon 
(MRL). 
3
2
1
68 
4. Conclusions 
The microbiological system consists of two bioassays using G. 
stearothermophilus and B. Subtilis, which can detect a large number of antibiotics in 
milk (beta-lactams, quinolones, sulphonamides, tetracyclines, erythromycin, 
lincomycin, neomycin, spiramycin and tylosin) if compared with other currently used 
microbiological methods. 
This improved detection of antibiotic residues is achieved by using two bacteria 
tests with complementary sensitivity to detect different antibiotics.  
Therefore, this microbiological system proves to be a valuable tool to control the 
quality of ovine milk. The implementation of this system with two bacteria tests enables 
a more rigorous control of antibiotic residues in milk and, consequently, helps protect 
consumers’ health. 
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Abstract 
The Charm MRL Beta-Lactam and Tetracycline test (Charm MRL BLTET test. Charm 
Sciences Inc., Lawrence, MA) is an immunoreceptor assay utilizing ROSA® (Rapid One 
Step Assay) lateral flow technology that detects beta-lactam and/or tetracycline drugs 
in raw commingled cow milk at or below EU-MRLs. The Charm MRL BLTET test 
procedure was recently modified (dilution in buffer and longer incubation) by the 
manufacturers to be used with raw ewe`s and goat’s milk. In order to assess the Charm 
MRL BLTET test for the detection of beta-lactams and tetracyclines in milk of small 
ruminants, an evaluation study was performed at Instituto de Ciencia y Tecnologia 
Animal (ICTA) of Universitat Politècnica de València (Spain). The test specificity and 
detection capability (CCβ) were studied following Commission Decision 2002/657/EC. 
Specificity results obtained in this study were optimal for individual milk free of 
antimicrobials from ewes (99.2 % for beta-lactams and 100 % for tetracyclines) and 
goats (97.9 % for beta-lactams and 100 % for tetracyclines) along the entire lactation 
period regardless of whether the results were visually or instrumentally interpreted. 
Moreover, no positive results were obtained when a relatively high concentration of 
different substances belonging to antimicrobial families other than beta-lactams and 
tetracyclines were present in ewe’s and goat’s milk. For both types of milk, the CCβ 
calculated was lower or equal to EU-MRL for amoxicillin (4 µg/Kg), ampicillin (4 µg/Kg), 
benzylpenicillin (≤ 2 µg/Kg), dicloxacillin (30 µg/Kg), oxacillin (30 µg/Kg), cefacetrile (≤ 
63 µg/Kg), cefalonium (≤ 10 µg/Kg), cefapirin (≤ 30 µg/Kg), desacetylcefapirin (≤ 30 
µg/Kg), cefazolin (≤ 25 µg/Kg), cefoperazone (≤ 25 µg/Kg), cefquinome (20 µg/Kg), 
ceftiofur (≤ 50 µg/Kg), desfuroylceftiofur (≤ 50 µg/Kg) and cephalexin (≤ 50 µg/Kg). 
However, this test could neither detect cloxacillin nor nafcillin at or below EU-MRL 
(CCβ > 30 µg/Kg). The CCβ for tetracyclines was also lower than EU-MRL for 
chlortetracycline (ewe’s milk: ≤ 50 µg/Kg and goat’s milk: 75 µg/Kg), oxytetracycline (≤ 
50 µg/Kg) and tetracycline (≤ 50 µg/Kg). Regarding the 4-epimers of these 
tetracyclines only 4-epioxytetracycline was detected by the Charm MRL BLTET test 
below EU-MRL (ewe’s milk: 75 µg/Kg and goat’s milk: ≤ 50 µg/Kg). Azidiol had no 
effect on the performance of the test. The Charm MRL BLTET test could be used 
routinely with adapted test procedure for the fast screening of ewe’s and goat’s milk. 
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 1. Introduction 
In dairy sheep and goats, just as in dairy cows, treatment of mastitis and other 
infectious diseases with pharmacological products is a standard practice. In many 
cases, antibiotic milk contamination may be caused by treatments carried out without a 
veterinary prescription and with inadequate knowledge of the suitable dosage, 
administration route or depletion time of the antibiotic substance (Molina et al., 2003a). 
This is partly due to the fact that there are very few drugs on the market specifically 
authorised for the use in lactating small ruminants, particularly goats, and occasionally 
veterinarians can prescribe drugs under ‘cascade’. Due to inter-species differences, 
available bovine data cannot be accurately extrapolated for the use in the dairy ewes 
and goats (Pengor and Kirbis, 2009). 
Drug residues in milk supplies may not only have public health implications 
(Phillips et al., 2004; Sanders et al., 2011) but may also interfere in the manufacture of 
dairy products such as cheeses and yoghurts (Packham et al., 2001; Berruga et al., 
2011). 
In some Mediterranean countries such as Spain, France, Italy and Greece, the 
production of ewe’s and goat’s milk plays a prominent role because of tradition and 
successful commercialization into products such as different cheeses and yoghurt 
(Haenlein, 2001). For this reason, milk quality is mainly evaluated in terms of its 
technological or coagulation properties which can be affected by the presence of 
antibiotic residues in milk. 
To avoid risks related to drug residues, the control of the presence of veterinary 
medicinal products in foodstuffs of animal origin at different stages of the production 
process is legally binding in many countries. The US Food and Drug Administration 
Center for Veterinary Medicine (FDA) established Safe Levels/Tolerance of antibiotic 
residues in milk for the consumer protection (FDA, 2005). In the European Union, the 
regulatory levels or maximum residue limits (EU-MRLs) are defined by Regulation (EC) 
470/2009 (European Union, 2009) and established by Commission Regulation (EU) 
37/2010 (European Union, 2010). 
Currently, numerous screening tests are commercially available to detect all 
kinds of antibiotics in milk (IDF, 2010). Choosing a test depends on the control step 
(farms, dairies or laboratories) and on the antibiotics used in the area of milk 
production. In farms and dairies, receptor binding assays are most commonly applied 
due to their simple and fast response. These methods, based on the use of specific 
receptors to detect antibiotics, were originally designed for the swift detection of beta-
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lactam antibiotics in cow’s milk (Charm and Zomer, 1995). Along recent years these 
tests have been further developed, and there are currently specific receptor binding 
assays available for the detection of various antimicrobials such as tetracyclines, 
gentamicin, enrofloxacin or sulfonamides. Improvements made have also been 
directed at the reduction of the analysis period required and the inclusion of different 
receptors in one test type, having resulted in combined tests capable of detecting 
various groups of antibiotics simultaneously. 
The Charm MRL Beta-Lactam and Tetracycline test (Charm Sciences Inc., 
Lawrence, MA) is an immunoreceptor assay utilizing ROSA® (Rapid One Step Assay) 
lateral flow technology that detects beta-lactam and/or tetracycline drugs in raw 
commingled cow milk at or below EU-MRLs. This test is widely used for screening 
cow’s milk, and the test procedure was recently modified by the manufacturers to be 
used with raw milk from ewes and goats. 
In order to assess the Charm MRL BLTET test for the detection of beta-lactams 
and tetracyclines in milk of small ruminants, an evaluation study was performed at 
Instituto de Ciencia y Tecnologia Animal (ICTA) of Universitat Politècnica de València 
(Spain). The test specificity and detection capability (CCβ) were studied following 
Commission Decision 2002/657/EC (European Union, 2002). 
2. Materials and methods 
2.1. Milk samples 
In order to obtain antibiotic-free milk samples along the entire lactation period, 
the experimental flocks of Manchega ewes of Universidad de Castilla-La Mancha 
(Albacete, Spain) and Murciano-Granadina goats of Universitat Politècnica de València 
(Valencia, Spain) were used. Animals had a good health status and did not receive any 
veterinary treatment neither before nor during the experimental period. 
2.2. Test specificity. 
Commission Decision 2002/657/EC (European Union, 2002) describes specificity as 
the ability of a method to distinguish between the analyte being measured and other 
related substances including the matrix constituents. According to this EC Regulation 
specificity for the Charm MRL BLTET test was investigated using two approaches: the 
false-positive rate was calculated when antibiotic-free milk samples were analyzed, and 
the study of possible interferences related to the presence of substances belonging to 
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 antimicrobial families other than beta-lactams and tetracyclines in milk samples (cross-
reaction) was carried out. 
To calculate the false-positive rate of the Charm MRL BLTET test individual 
milk samples (200 ml) from 25 ewes and 25 goats were collected fortnightly along the 
entire lactation period. Ewe’s milk samples were obtained at the morning milking from 
the first week after weaning until the end of lactation (5 months). Goat’s milk was 
collected from the second week postpartum during a period of seven months. 
Milk samples were analyzed using MilkoScan 6000 (Foss, Hiller∅d, Denmark) 
to determine their chemical composition (fat, protein and total solids); SCC (somatic 
cell count) was obtained using Fossomatic 5000 (Foss, Hiller∅d, Denmark); BC 
(bacterial count) was determined using Bactoscan FC (Foss, Hiller∅d, Denmark) and 
the pH value was measured by a conventional pHmeter (Crison, Barcelona, Spain). 
Antibiotic-free milk samples (n= 250 for ewes and n= 350 for goats) were tested 
employing the Charm MRL BLTET test to assess the test specificity with each species. 
Samples giving positive results were retested (three replicates). Only samples showing 
positive results in at least two replicate analyses were classified as positive. Specificity 
was calculated as the percentage of negative samples with respect to the total of 
samples analyzed. 
To check for interferences related to antimicrobial substances other than beta-
lactams and tetracyclines (cross-reaction), 20 individual raw milk samples free of 
antimicrobials, 10 for ewes and 10 for goats, were collected in the mid-lactation period. 
Milk samples were spiked individually with a relatively high concentration of different 
drugs and analyzed by Charm MRL BLTET test. In agreement with Reybroeck et al. 
(2010), the drug concentration in milk samples was 10xEU-MRL, and one substance 
was chosen from each of the most important groups of antimicrobials: neomycin 
(aminoglycosides), lincomycin (lincosamides), erythromycin (macrolides), colistin 
(polimyxins), enrofloxacin (quinolones) and sulfadiazine (sulfonamides). 
2.3. Detection Capability (CCβ). 
The International Dairy Federation (IDF, 2002) establishes the requirements for 
the milk samples selected for use as “negative milk” in the evaluation studies of 
screening tests for antibiotics detection. These requirements have been established 
only for cow's milk. However, if a test is applied for milk of an animal species other than 
cows, the requirements with respect to the status of the animal should be adjusted 
accordingly. 
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Individual milk samples (200 ml) were collected in the mid-lactation period from 
40 ewes (more than 60 days and below 90 days postpartum) and 40 goats (more than 
90 days and below 150 days postpartum). The samples were refrigerated at 4 ºC and 
were analyzed to determine their pH, chemical composition and hygienic quality within 
24 h after milking, using the analytical methods mentioned previously. For Manchega 
ewes’ milk, fat content was between 5 % and 9 %, protein between 4.7 % and 8 % and 
total solids between 15 % and 22 %. Concerning hygienic quality, somatic cell count 
was < 300x103 cell/ml and bacterial count was < 105 cfu/ml. The pH value for ewe’s 
milk samples was between 6.6 and 6.8. For milk from Murciano-Granadina goats, fat 
content was between 3.3 % and 7 %, protein between 3.1 % and 4.7 %, and total 
solids between 12 % and 17 %. Somatic cell count was < 750x103 cell/ml, and bacterial 
count was < 105 cfu/ml. The pH value for goats’ milk was between 6.5 and 6.8. 
Selected antibiotic-free milk samples were analyzed by the Charm MRL BLTET 
test, and the samples giving negative results were spiked with different beta-lactams 
and tetracyclines to calculate the detection capability (CCβ) of this test. 
Detection capability (CCβ) was calculated according to the “Guidelines for the 
validation of screening methods for residues of veterinary medicines” proposed for 
Community Reference Laboratories Residues (CRLs, 2010). This guideline document 
supplements Commission Decision 2002/657/EC, and defines CCβ as the 
concentration at which only ≤ 5 % false compliant results remain. For authorized 
analytes, the concentration at which a screening test categorizes the sample as 
“screen positive” (potentially non-compliant) and triggers a confirmatory test is called 
Screening Target Concentration (STC) and it must be at or below EU-MRL. If the STC 
is set at half EU-MRL, the occurrence of one or no false-compliant results following the 
analysis of at least 20 “screen positive” control samples is sufficient to demonstrate that 
CCβ is below EU-MRL and below or equal to 50 % of EU-MRL. If STC is set between 
50 % and 90 % of EU-MRL, at least 40 “screen positive” control samples with no more 
than 2 false-non compliant results will be sufficient to demonstrate that CCβ is below 
EU-MRL. If STC approaches EU-MRL (below 10 % of EU-MRL) a maximum of 60 
replicates with no more than 3 false-non compliant results is required to demonstrate 
that CCβ is fit for this purpose. Antibiotic concentrations used for the calculation of the 
CCβ of the Charm MRL BLTET test were initially 0.5xEU-MRL (20 replicates); 
0.75xEU-MRL (40 replicates) and 1xEU-MRL (60 replicates), respectively, only when 
necessary. 
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 2.4. Effect of preservative azidiol. 
To evaluate the effect of the preservative azidiol on the response of the Charm 
MRL BLTET test, antibiotic-free milk samples from 25 ewes and 25 goats were used. 
Individual milk samples were divided into two aliquots; one without preservative and 
one with azidiol; and analyzed by the Charm MRL BLTET test. Thereafter, each milk 
sample was spiked with benzylpenicillin and oxytetracycline at EU-MRL (4 µg/Kg and 
100 µg/Kg, respectively) and analyzed again by the Charm MRL BLTET test. 
Azidiol was prepared and used according to the Spanish regulation (Real 
Decreto 752/2011) which stipulates the composition (0.75 g chloramphenicol, 10 ml 
ethanol, 18 g sodium azide, 45 g trisodium citrate 5.5H2O, 0.35 g bromophenol blue, in 
1000 ml of distilled water) and the dosage of this preservative in ewe’s and goat’s milk 
(133 µl per 40 ml of raw milk). 
2.5. Antibiotics and spiked milk samples 
The antibiotics used in this study were stored and handled according to the 
manufacturer’s instructions before use. 
Drugs were dissolved (1mg/ml) in water in a 25 ml volumetric flask at the time 
when analyses were carried out. In some cases the use of a small amount of a suitable 
solvent was necessary before adding water. Table 1 summarizes antibiotic commercial 
references and the solvent employed for the preparation of antibiotic stock solutions. 
Spiked milk samples were prepared following the recommendations of the 
International Dairy Federation (IDF, 2002) and milk analysis was performed within four 
hours after spiking. 
2.6. Test procedure 
The Charm MRL BLTET test (Charm Sciences, Inc., Lawrence, MA) was 
employed following the manufacturer’s instructions. For ewes and goats, 300 µl of milk 
sample was mixed with 300 µl of the dilution buffer (Sheep milk dilution buffer or Goat 
milk dilution buffer, respectively. Charm Sciences, Inc.) and refrigerated for 10 minutes. 
Thereafter, 300 µl of the mixture were placed in the sample compartment of the strip 
placed in the ROSA Incubator (Charm Sciences, Inc.). The incubation time was set at 
56 ºC for 16 minutes (two sets of 8 minutes), and results were interpreted visually by 
three trained laboratory technicians and with the ROSA® Reader (ROSA® Pearl 
Reader. Charm Sciences, Inc.). 
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The Charm MRL BLTET test uses receptors that bind beta-lactam and 
tetracycline drugs. As milk flows through the test strip, unreacted receptors bind at the 
BL and/or TET position and form a visible reddish test line. A weaker intensity BL or 
TET line forms when beta-lactam and/or tetracycline drugs are present in the milk 
sample. 
Table 1. Antimicrobials used to evaluate the Charm MRL BLTET test in ewe’s and 
goat’s milk 
Antimicrobials Distributor Commercial reference Solvent 
Aminoglycosids    
Neomycin Sigma-Aldrich1 N1876 H2O 
Beta-lactams    
Amoxicillin Sigma-Aldrich A8523 H2O 
Ampicillin Sigma-Aldrich A9518 H2O 
Benzylpenicillin Sigma-Aldrich PENNA H2O 
Cloxacillin Sigma-Aldrich C9393 H2O 
Dicloxacillin Sigma-Aldrich D9016 MeOH / H20 
Nafcilin Sigma-Aldrich N3269 MeOH / H20 
Oxacillin Sigma-Aldrich 46589 MeOH / H20 
Cefacetrile Fatro2 * H2O 
Cefalonium Sigma-Aldrich 32904 NaOH 0.1N /H2O 
Cefapirin Sigma-Aldrich 43989 H2O 
Desacetylcefapirin ACS Dobfar3 * H2O 
Cefazolin Sigma-Aldrich C5020 H2O 
Cefoperazone Sigma-Aldrich 32426 NaOH 1N / H2O 
Cefquinome Sigma-Aldrich 32472 H2O 
Ceftiofur Sigma-Aldrich 34001 NaOH 0.1N / H2O 
Desfuroylceftiofur TRC4 D289980 MeOH / H20 
Cephalexin Sigma-Aldrich C4895 H2O 
Lincosamides    
Lincomycin Sigma-Aldrich 31727 H2O 
Macrolides    
Erythromycin Sigma-Aldrich E6376 EtOH / H20 
Polimyxins    
Colistin Sigma-Aldrich C4461 H2O 
Quinolones    
Enrofloxacin Sigma-Aldrich 33699 AcOH 5% / H20 
Sulfonamides    
Sulfadiazine Sigma-Aldrich S6387 H2O 
Tetracyclines    
Chlortetracycline Sigma-Aldrich C4881 NaOH 0.1N / H2O 
4-epichlortetracycline Acros5 268235000 MeOH / H20 
Oxytetracycline Sigma-Aldrich O4636 HCl 0.1N / H2O 
4-epioxytetracycline Acros 25771 MeOH / H20 
Tetracycline Sigma-Aldrich T3258 HCl 0.1N / H2O 
4-epitetracycline Acros 233125000 MeOH / H20 
1Sigma-Aldrich Química, S.A. (Madrid, Spain) 
2Fatro, S.p.A. (Bologna, Italy) 
3ACS Dobfar, S.p.A. (Milan, Italy) 
4Toronto Research Chemicals, Inc. (Toronto, Canada) 
5Acros Organics (Geel, Belgium) 
*Commercial reference not available 
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 The visual interpretation of the results was carried out by comparing the BL and 
TET lines with the C (control) line. If both lines are darker than or equal to the C line, 
the milk sample is negative (antibiotic-free). If either the BL or TET line is lighter than 
the C line or the BL or TET line does not form, the sample is positive (likely antibiotic 
presence). 
The performance of the reader system was checked daily by low and high 
calibration strips and by testing negative and positive control standards 
(benzylpenicillin: 4 µg/Kg and oxytetracycline: 100 µg/Kg; Charm MRL BLTET Positive 
tablet. Charm Sciences, Inc.) prior to testing samples. Milk samples giving a reader 
value ≤ 0 were considered negative, while milk samples giving a reader value > 0 were 
considered positive. 
2.7. Statistical analysis 
To assess the effect of the reading system used for the interpretation of the test 
results (visual or instrumental) on the test response, a chi-square test was employed. 
When an expected frequency was < 5 the Fisher’s exact test was applied. A significant 
difference was defined by p < 0.05. Statistical analysis was performed using SAS 
(version 9.2, 2001; SAS Institute, Inc., Cary, NC). 
3. Results and discussion 
3.1. Test Specificity 
Table 2 summarizes the chemical composition and hygienic quality of the 
individual milk samples used to assess the false-positive rate of the Charm MRL 
BLTET test. Mean milk sample quality parameters were similar to those reported by 
other authors for ewe’s (Requena et al., 2010) and goat’s milk (Salama et al., 2003). 
Table 2. Quality parameters of ewe’s and goat’s milk samples obtained along the entire 
lactation period 
1 SD: standard deviation; 2 Min: minimum; 3 Max: maximum; 4 BC: bacterial count; 5 SCC: somatic 
cell count 
Parameter 
Ewe’s milk 
(n= 250) 
 Goat’s milk 
(n= 350) 
Average SD1 Min2 Max3  Average SD1 Min2 Max3 
pH 6.67 0.08 6.52 6.92  6.78 0.09 6.55 7.13 
Fat (%) 6.38 1.94 2.42 12.68  5.74 1.16 3.31 10.61 
Protein (%) 5.81 0.72 4.55 7.82  3.82 0.48 2.68 6.03 
Total solids (%) 18.02 2.54 12.51 26.53  15.0 1.51 12.13 20.48 
BC4 (x103 cfu/ml) 566 1,508 6 9,999  74 306 10 4,829 
SCC5 (x103 cell/ml) 687 2,667 10 20,581  975 1,737 37 16,837 
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According to the instrumental interpretation (Table 3), specificity of the Charm 
MRL BLTET test with adapted assay procedure for the detection of beta-lactam 
antibiotics (BL line) was 99.2 % for ewes’ milk (a false-positive rate of 0.8 %) and 97.9 
% for goats’ milk (a false-positive rate of 2.1 %). Specificity was 100 % for the detection 
of tetracyclines (TET line) in ewes’ and goats’ milk (no false-positive results). In all 
cases, the specificity calculated according to the visual interpretation of the results was 
slightly lower than that obtained by the ROSA® Reader, but no statistically significant 
differences were found (p > 0.05). 
Table 3. Specificity (false-positive rate) of the Charm MRL BLTET test in antibiotic-free 
milk from ewes and goats with adapted test procedure 
 
Milk samples Test line 
Results 
Visual Instrumental 
P Q N S (%) P N S (%) 
Ewes 
(n = 250) 
BL 2 1 247 98.8 2 248 99.2 
TET 0 0 250 100 0 250 100 
Goats 
(n = 350) 
BL 7 2 341 97.4 7 343 97.9 
TET 0 1 349 99.7 0 350 100 
P: positive, Q: questionable, N: negative, S (%): Specificity = negatives/total x 100 
Specificity results obtained in this study were optimal for both types of milk and 
indicate that the characteristics of the milk do not influence the test response. The few 
goat’s milk samples that were classified as positive (7 false-positive results) had 
standard characteristics of the Murciano-Granadina breed. The mean values for the 
quality parameters considered were: pH: 6.73, fat: 6.47 %, protein: 4.12 %, total solids: 
16.04 %, SCC: 519x103 cell/ml and BC: 62x103 cfu/ml. 
There is only a limited number of evaluation studies of receptor binding assays 
in ewe’s and goat’s milk available. Reybroeck et al. (2010) for the Betastar (1+1) test 
(Neogen Corporation, Lansing, MI) obtained a specificity of 96.8 % for ewes’ milk (1 out 
of 31 antibiotic-free milk samples) and 96.5 % for goats’ milk (1 out of 29). The same 
result (96.7 %) was obtained by Zeng et al. (1998) for the SNAP Betalactam test 
(IDEXX Laboratories, Westbrook, ME) using raw commingled goats’ milk (1 out of 30). 
Comparing our results with those reported by other authors with different 
receptor binding assays from Charm Sciences, Inc. (Lawrence, MA), Berruga et al. 
(2009) using the Charm MRL BLTET test in ewe’s milk obtained a lower specificity for 
the detection of beta-lactam antibiotics (90 %) and a similar specificity (99 %) for 
tetracyclines. Although these authors also used individual ewe’s milk for the evaluation 
of this test, it must be emphasized that they followed the same procedure 
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 recommended for cow’s milk (no buffer dilution used and incubation time at 56 ºC for 8 
minutes) which could explain the differences observed. 
Specificity of the Charm MRL BLTET test obtained in this study with adapted 
test procedure for individual goat’s milk (97.4 % and 97.9 % for visual or instrumental 
interpretation, respectively) was similar to that found by Reybroeck et al., (2011) using 
the beta-lactam screening test Charm MRL-3 test (Charm Sciences, Inc.) with 
individual cow’s milk samples (97.6 %). This low false-positive rate (between 2.1 % and 
2.6 %) could be related to the use of individual milk samples, since these same authors 
calculated a specificity of 99.3 % when analyzing farm milk samples from cows. On the 
contrary, for ewes’ and goats’ milk a high incidence of false-positive results (10 out of 
12 and 6 out of 8, respectively) was obtained, suggesting that the Charm MRL 3 test is 
not suitable for the detection of beta-lactam antibiotics in non-cow milk samples. Also, 
Salter et al. (2011), indicate for the Charm 3 SL3 β-Lactam test (Charm Sciences, Inc.) 
a specificity of 100 % for raw commingled milk from cows. 
Regarding the cross-reaction study for the Charm MRL BLTET test, no positive 
results were obtained when a relatively high concentration (10xEU-MRL) of different 
substances belonging to antimicrobial families other than beta-lactams and 
tetracyclines were present in ewe’s and goat’s milk. These results are similar to those 
found by Reybroeck et al. (2011) and Salter et al. (2011) who neither found 
interferences due to the presence of other non-beta-lactam antimicrobials in milk from 
cows using the Charm MRL-3 test and Charm 3 SL3 β-Lactam test (Charm Sciences, 
Inc.), respectively. 
3.2. Detection capability (CCβ) 
Detection capability results (CCβ values) of the Charm MRL BLTET with 
adapted test procedure for different beta-lactams and tetracyclines in ewe’s and goat’s 
milk were evaluated. The CCβ values calculated according to the visual interpretation 
of the results were the same as those obtained by the ROSA® Reader and are 
summarized in Tables 4 and 5. 
For both types of milk, the CCβ calculated was lower than EU-MRL for 
benzylpenicillin (≤ 2 µg/Kg), cefacetrile (≤ 63 µg/Kg), cefalonium (≤ 10 µg/Kg), cefapirin 
(≤ 30 µg/Kg), desacetylcefapirin (≤ 30 µg/Kg), cefazolin (≤ 25 µg/Kg), cefoperazone (≤ 
25 µg/Kg), ceftiofur (≤ 50 µg/Kg), desfuroylceftiofur (≤ 50 µg/Kg) and cephalexin (≤ 50 
µg/Kg). For amoxicillin (4 µg/Kg), ampicillin (4 µg/Kg), dicloxacillin (30 µg/Kg), oxacillin 
(30 µg/Kg) and cefquinome (20 µg/Kg) the Charm MRL BLTET CCβ was equal to EU-
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MRL. However, this test could neither detect cloxacillin nor nafcillin at or below EU-
MRL (CCβ > 30 µg/Kg). 
Table 4. Detection capability (CCβ values) of the Charm MRL BLTET test for antibiotics 
in ewe’s milk with adapted test procedure 
 
1STC: Screening Target Concentration 
2According to the CRLs (2010) STC= 0.5xEU-MRL: 20 samples; STC= 0.75xEU-MRL: 40 
samples; STC= 1xEU-MRL: 60 samples 
3sum of cefapirin and desacetylcefapirin 
4sum of all residues retaining the beta-lactam structure expressed as desfuroylceftiofur 
5sum of parent drug and its 4-epimer 
*marker residue. EU-MRL not established 
The CCβ for tetracyclines was also lower than EU-MRL for chlortetracycline 
(ewe’s milk: ≤ 50 µg/Kg) and goat’s milk: 75 µg/Kg), oxytetracycline (≤ 50 µg/Kg) and 
tetracycline (≤ 50 µg/Kg). Regarding the 4-epimers of these tetracyclines, only 4-
epioxytetracycline was detected by the Charm MRL BLTET test below EU-MRL (ewe’s 
milk: 75 µg/Kg and goat’s milk: ≤ 50 µg/Kg). For 4-epichlortetracycline and 4-
epitetracycline the CCβs were above EU-MRL (CCβ > 100 µg/Kg). 
 
Antimicrobials  EU-MRL (µg/Kg) 
STC1 
(µg/Kg) 
Positive/Total 
samples2 
Positive 
Results 
(%) 
CCβ 
(µg/Kg) 
Beta-lactams      
Amoxicillin 4 4 57/60 95 4 
Ampicillin 4 4 58/60 97 4 
Benzylpenicillin 4 2 19/20 95 ≤ 2 
Cloxacillin 30 30 11/60 18 > 30 
Dicloxacillin 30 30 57/60 95 30 
Nafcilin 30 30 22/60 37 > 30 
Oxacillin 30 30 59/60 98 30 
Cefacetrile 125 63 20/20 100 ≤ 63 
Cefalonium 20 10 20/20 100 ≤ 10 
Cefapirin 603 30 20/20 100 ≤ 30 
Desacetylcefapirin * 30 20/20 100 ≤ 30 
Cefazolin 50 25 20/20 100 ≤ 25 
Cefoperazone 50 25 20/20 100 ≤ 25 
Cefquinome 20 20 60/60 100 20 
Ceftiofur 1004 50 20/20 100 ≤ 50 
Desfuroylceftiofur * 50 20/20 100 ≤ 50 
Cephalexin 100 50 20/20 100 ≤ 50 
Tetracyclines      
Chlortetracycline 1005 50 20/20 100 ≤ 50 
4-epichlortetracycline * 100 0/60 0 > 100 
Oxytetracycline 1005 50 20/20 100 ≤ 50 
4-epioxytetracycline * 75 40/40 100 75 
Tetracycline 1005 50 20/20 100 ≤ 50 
4-epitetracycline * 100 0/60 0 > 100 
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 Table 5. Detection capability (CCβ values) of the Charm MRL BLTET test for antibiotics 
in goat’s milk with adapted test procedure 
1STC: Screening Target Concentration 
2According to the CRLs (2010) STC= 0.5xEU-MRL: 20 samples; STC= 0.75xEU-MRL: 40 
samples; STC= 1xEU-MRL: 60 samples 
3sum of cefapirin and desacetylcefapirin 
4sum of all residues retaining the beta-lactam structure expressed as desfuroylceftiofur 
5sum of parent drug and its 4-epimer 
*marker residue. EU-MRL not established 
These results (CCβ ≤ EU-MRL) are similar to those obtained by Reybroeck et 
al. (2011) using the Charm MRL-3 test (Charm Sciences, Inc.) to detect beta-lactams in 
cow’s milk samples; the only exception being cloxacillin which was also detected by 
these authors at a concentration below EU-MRL (14 µg/Kg). Salter et al. (2011) also 
obtained appropriate sensitivity with the Charm 3 SL3 β-lactam test (Charm Sciences, 
Inc.) according to Safe Level/Tolerance as stipulated by the US FDA (2005).  
3.3. Effect of azidiol on the test response 
The presence of azidiol in milk samples had no influence on the response of the 
Charm MRL BLTET test. All the antibiotic-free milk samples from ewes and goats 
spiked with azidiol were clearly negative (Figure 1) regardless of the system used for 
Antimicrobials  EU-MRL (µg/Kg) 
STC1 
(µg/Kg) 
Positive/Total 
samples2 
Positive 
Results 
(%) 
CCβ 
(µg/Kg) 
Beta-lactams      
Amoxicillin 4 4 57/60 95 4 
Ampicillin 4 4 58/60 97 4 
Benzylpenicillin 4 2 20/20 100 ≤ 2 
Cloxacillin 30 30 9/60 15 > 30 
Dicloxacillin 30 30 58/60 97 30 
Nafcillin 30 30 18/60 30 > 30 
Oxacillin 30 30 60/60 100 30 
Cefacetrile 125 63 20/20 100 ≤ 63 
Cefalonium 20 10 20/20 100 ≤ 10 
Cefapirin 603 30 20/20 100 ≤ 30 
Desacetylcefapirin * 30 20/20 100 ≤ 30 
Cefazolin 50 25 20/20 100 ≤ 25 
Cefoperazone 50 25 20/20 100 ≤ 25 
Cefquinome 20 20 60/60 100 20 
Ceftiofur 1004 50 20/20 100 ≤ 50 
Desfuroylceftiofur * 50 20/20 100 ≤ 50 
Cephalexin 100 50 20/20 100 ≤ 50 
Tetracyclines      
Chlortetracycline 1005 75 38/40 95 75 
4-epichlortetracycline * 100 0/60 0 > 100 
Oxytetracycline 1005 50 20/20 100 ≤ 50 
4-epioxytetracycline * 50 20/20 100 ≤ 50 
Tetracycline 1005 50 19/20 95 ≤ 50 
4-epitetracycline * 100 8/60 13 > 100 
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the interpretation of the results. No interference was observed neither with milk 
samples spiked with benzylpenicillin (4 µg/Kg) nor with oxytetracycline (100 µg/Kg) no 
matter whether the interpretation of the results was made visually or instrumentally. 
Figure 1. Effect of azidiol in ewe’s and goat’s milk samples on the results of the Charm 
MRL BLTET test 
So far, there is no study on the influence of preservatives on the performance of 
the receptor binding assays for the detection of antibiotics in milk available. Only 
studies with microbial inhibitor tests have been carried out as the presence of 
preservatives may interfere with the growth of the microorganism in the test, increasing 
the incidence of questionable or false-positive results (Molina et al., 2003b). 
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 The results obtained in this study show the suitability of the Charm MRL BLTET 
test for the detection of antibiotic residues of beta-lactams and tetracyclines in ewe’s 
and goat’s milk. The Charm MRL BLTET test was neither influenced by the distinct 
composition of ewe’s and goat’s milk, characterised by an elevated fat and protein 
contents when compared to cow’s milk, nor by the high somatic cell count which some 
authors related to false positive results in the microbial screening tests (Althaus et al., 
2003) and receptor binding assays (Contreras et al., 1997). 
These results are of great relevance for ovine and caprine milk quality control 
programs. The Charm MRL BLTET test enables the fast and efficient control of 
antibiotics in farms and the dairy industry, thus guaranteeing the absence or presence 
below legally established EU-MRLs of most beta-lactams and tetracyclines. Moreover, 
the Charm MRL BLTET test was not affected by the presence of the preservative 
azidiol in milk samples, which also allows its use in milk quality control laboratories 
which normally analyze ewe’s and goat’s milk with azidiol. 
The only aspects of the test which could possibly be improved are the test 
duration (16 minutes), which is relatively long when compared to other protein receptor 
binding tests usually applied in cow’s milk (1-9 minutes), and the need to dilute the 
ewe’s and goat’s milk samples with a specific buffer before analysis. In this sense, it is 
worth mentioning that the manufacturers are currently working on a new version of the 
Charm MRL BLTET test that does no require the buffer and with a shorter incubation 
time taking advantage of the high specificity and adequacy of receptors used in the 
ROSA® Charm technology. 
4. Conclusions 
The Charm MRL BLTET test displays a high specificity for the detection of 
antibiotics in ewe’s and goat’s milk with adapted test procedure regardless of whether 
the interpretation of the results is carried out visually or instrumentally. The Detection 
capability (CCβ values) obtained for the Charm MRL BLTET test indicates a high 
sensitivity to most beta-lactam antibiotics considered except for cloxacillin and nafcillin. 
As for tetracyclines the Charm MRL BLTET test was also able to detect 
chlortetracycline, oxytetracycline, tetracycline and 4-epioxytetracycline at or below EU-
MRL. Azidiol had no effect on the performance of the test. 
The great performance characteristics of the Charm MRL BLTET test makes it 
suitable to be included in ewe's and goat's milk quality programs as a fast routine 
method on farms and in the dairy industries. 
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Abstract 
The aim of this study was to evaluate some receptor-binding assays to detect antibiotics 
in sheep milk. Specificity of the Betastar Combo, SNAP and TwinsensorBT tests was 
optimal using inhibitor-free bulk sheep milk (99-100 %), and no differences between the 
visual or instrumental classification were found. For individual sheep milk free of 
antibiotics, specificity was elevated by the Betastar Combo and SNAP tests. However, 
lower specificity was obtained by the TwinsensorBT test, especially in the last weeks of the 
lactation period. Regarding cross-reactions, interferences related to drugs other than β-
lactams and tetracyclines were not detected. Furthermore, the use of azidiol, as a 
preservative of milk, had no effect on the test. In all cases, the CCβ (Detection capability) 
was able to detect most β-lactams and tetracyclines at or below MRLs (Maximum 
Residues Limits). In conclusion, the receptor-binding tests evaluated showed a very good 
performance in the detection of antibiotics in sheep milk, thus being suitable for milk 
quality control programmes. 
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 1. Introduction 
In Mediterranean countries, sheep milk production has traditionally been destined 
for the manufacture of cheese, often as raw milk. Cheese quality is closely related to milk 
composition but also to hygienic aspects such as somatic cell count, bacteriology or 
presence of antibiotic residues, currently legislated by EC Regulation Nº 853/2004 (EC, 
2004) and EC Regulation Nº 1662/2006 (EC, 2006). 
The use of antibiotics in dairy sheep to treat mastitis and other infectious diseases 
is a common veterinary practice that presents a high risk of contamination of the milk 
supply if appropriate measures are not taken. The implications of the presence of 
antibiotic residues in milk as a result of veterinary treatments have been documented, 
including negative effects on consumer’s health such as allergies or the generation of 
antibiotic resistance (Dewdney et al., 1991; Oliver et al., 2011), and on the manufacturing 
processes of fermented products (Packham et al., 2001; Berruga et al., 2008). 
For the screening of milk samples for antibiotic residues, there are various 
methods available (ISO/IDF, 2010), to detect numerous substances above the maximum 
residue limits (MRLs) regulated by EC Regulation Nº 37/2010 (EC, 2010). Beta-lactam 
and tetracycline antibiotics are the most frequently used for the treatment of bacterial 
infections in livestock, as a consequence, quality control programmes are mainly focusing 
on the detection of these antibiotics in milk. At present, rapid screening tests based on the 
use of specific receptors are widely used, especially in farms and in the dairy industry 
where a fast response is required. Receptor-binding assays have been validated for the 
use in raw bulk milk from cows (Perme et al., 2010; Reybroeck et al., 2010; Salter et al., 
2011), but information on the performance of these tests in sheep milk is rather limited. 
The chemical composition of ewe’s milk differs significantly from cow's milk which could 
affect the response of these screening tests. Moreover, in milk quality laboratories 
different preservatives (e. g. bronopol, azidiol) are usually employed in milk sampling 
(Elizondo et al., 2007; Gonzalo et al., 2010). For milk quality control programs, Spanish 
regulation (BOE, 2011) established the use of azidiol as a preservative in milk sampling. 
Azidiol is a bacteriostatic agent containing sodium azide and chloramphenicol, among 
other reagents. For this reason, it has been linked with lower specificity rates when 
microbial screening tests to detect antibiotics in sheep milk are applied (Molina et al., 
2003). However, information about the effect of the preservative azidiol on the response 
of the receptor-binding tests is practically non-existent. 
The aim of this work was to assess the suitability of some commercial receptor-
binding tests to detect beta-lactams and tetracyclines in sheep milk with azidiol and in 
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preservative-free sheep milk samples. The evaluated parameters were specificity (false-
positive rate and cross-reactions) and detection capability (CCβ) investigated for each of 
the tests considered, in agreement with the EC Commission Decision 2002/657 (EC, 
2002). 
2. Material and Methods 
2.1. Receptor-binding assays 
The screening assays used were the Betastar Combo test (Neogen Corporation, 
Lansing, MI, USA), SNAP Βetalactam test (IDEXX Laboratories, Westbrook, ME, USA), 
SNAP Tetracycline test (IDEXX Laboratories) and TwinsensorBT test (Unisensor, Liege, 
Belgium), which employ binding reagents and have similar reaction mechanisms. The 
Betastar Combo and TwinsensorBT tests allow for simultaneous detection of both beta-
lactam and tetracycline antibiotics in milk samples, and the SNAP tests used, namely 
SNAP Βetalactam and SNAP Tetracycline tests, are specific for beta-lactams or 
tetracyclines, respectively. Test procedures in general include two stages: 1) preliminary 
incubation of the binding reagents with the milk sample results in the interaction of the 
antibiotics, if present and 2) the milk solution is transferred onto an 
immunochromatographic medium by which a colored signal development takes place 
when passing the various binding positions. Specific binding reagents that do not interact 
with antibiotic residues during preliminary incubation are bound at the corresponding 
binding positions and colored lines or spots appear. 
Milk samples were analysed following the test procedures given by the 
manufacturers. Results were classified as positive or negative both visually, by three 
trained technicians, and instrumentally. 
For visual classification of the Betastar Combo test results, the intensity of the 
different red test lines was compared. If the intensity of the antibiotic test line, BL (beta-
lactam) and/or TE (tetracycline), was greater than or equal to the control line, the milk 
sample was classified as negative. However, if the antibiotic test line was weaker than the 
control line, the milk sample was classified as positive. For the TwinsensorBT test, visual 
interpretation of the results was made in a similar fashion, although in that case a sample 
was considered positive when the intensity of the antibiotic test line (BL and/or TE) was 
as distinct as or lighter in color than the control line. Visual interpretation of the two SNAP 
test results was made as follows: a blue sample spot darker than or equal to the control 
spot was negative, and a sample spot lighter than the control spot was positive. For a 
valid test, it is necessary that the control line or control spot appears after the incubation 
time. If the control marker is not visible, the test is considered invalid. 
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 For instrumental classification of the test results, specific reader systems provided 
by the different laboratories were employed. Thus, dipsticks or specific devices were 
inserted into the corresponding reader immediately after the required incubation period, 
and numerical data were recorded. Table 1 summarizes the available information about 
the reader systems employed to categorize the test results. The performance of the 
reader systems was checked on a daily basis by testing a negative and positive control 
(benzylpenicillin: 4 µg/kg and oxytetracycline: 100 µg/kg) just before milk analysis. 
Table 1. Reader systems employed to categorize the receptor-binding test results as 
positive or negative (antibiotic-free) 
Reader Manufacturer Cut-off Test result classification Negative Low positive Positive 
Accuscan III Neogen Corporation (Lansing, MI, USA) 1.0 ≥ 1.0 - < 1.0 
SNAPshot IDEXX Laboratories (Westbrook, ME, USA) 1.06 < 1.06 - ≥1.06 
Readsensor Unisensor (Liege, Belgium) 1.10 > 1.10 0.9 – 1.10 < 0.90 
2.2. Antibiotics and spiked milk samples 
Amoxicillin (A8523), ampicillin (A9518), benzylpenicillin (PENNA), cloxacillin 
(C9393), dicloxacillin (D9016), nafcillin (N3269), oxacillin (46589), cefalonium (32904), 
cefapirin (43989), cefazolin (C5020), cefoperazone (32426), cefquinome (32472), 
ceftiofur (34001), cephalexin (C4895), chlortetracycline (C4881), colistin (C4461), 
enrofloxacin (33699), erythromycin (E6376), lincomycin (31727), neomycin (N1876), 
oxytetracycline (O4636), sulfadiazine (S6387), and tetracycline (T3258) were provided by 
Sigma-Aldrich Química, S.A. (Madrid, Spain). Desfuroylceftiofur (D289980) was supplied 
by Toronto Research Chemicals, Inc. (Toronto, Canada) and 4-epichlortetracycline 
(268235000), 4-epioxytetracycline (25771), and 4-epitetracycline were furnished by Acros 
Organics (Geel, Belgium). Finally, desacetylcefapirin and cefacterile, not commercially 
available, were kindly provided by Fatro S.p.A. (Bologna, Italy) and ACS Dobfar, S.p.A. 
(Milan, Italy), respectively. 
For use, antibiotics were dissolved (1 mg/ml) in water or in an appropriate solvent 
(AcOH 5 % for enrofloxacin; EtOH for erythromycin; MetOH for desfuroylceftiofur, 
nafcillin, oxacillin and the 4-epimers of tetracyclines; NaOH 0.1N for cefalonium, ceftiofur 
and chlortetracycline) in a 25 ml volumetric flask at the time when analyses were carried 
out to avoid problems related to instability. 
Spiked milk samples were prepared following International Dairy Federation 
recommendations (ISO/IDF, 2002) and tested by the different receptor-binding tests 
immediately after spiking. 
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2.3. Test Specificity 
Specificity of the receptor-binding tests was investigated by calculating the 
percentage of false-positive results for each of them, and also, studying the potential 
cross-reaction interferences related to the presence of antibiotic substances other than 
beta-lactams and tetracyclines in milk. The effect of the preservative azidiol was also 
studied. 
2.3.1. False-positive results 
For each screening test, the false-positive rate was calculated by analysing 
individual sheep’s milk free of antibiotics, and bulk milk samples from commercial dairy 
sheep farms. Individual milk samples free of antibiotics (n= 250) were obtained from 25 
sheep, during the entire lactation period, belonging to the experimental flock of Manchega 
breed sheep of the Universidad of Castilla-La Mancha (Spain). Milk sampling was carried 
out fortnightly at morning milking, from the first week after weaning (35 days post-partum) 
until the end of the lactation period (170 days post-partum). Bulk milk samples (n= 100) 
were obtained from various commercial farms with Manchega sheep in the Castilla-La 
Mancha region (Spain). Bulk milk samples were analysed prior to use by the microbial 
inhibitor test Delvotest SP-NT MCS (DSM Food Specialties, Delft, the Netherlands) to 
assure the absence of inhibitors in milk. 
Sheep milk samples were kept at 4 ºC before analysis (no longer than 48 h). Milk 
composition (fat, protein, lactose and total solids) was determined by MilkoScan 6000 
(Foss, Hiller∅d, Denmark). Somatic cell count (SCC) and bacterial count (BC) were 
determined with a Fossomatic 5000 (Foss) and Bactoscan FC (Foss), respectively. Milk 
pH was measured by a conventional pH-meter (Crison, Barcelona, Spain). 
All sheep milk samples were analysed by the investigated receptor-binding assays 
to evaluate the false-positive rate. For both types of milk (individual or bulk sheep milk), 
samples giving positive results were re-tested, in three replicates, and samples showing 
positive results in at least two replicate analyses, were recorded finally, as positive. 
For each screening test, the specificity rate was calculated as the percentage of 
negative results divided by the total number of samples analysed. 
2.3.2. Effect of azidiol on the tests performance 
Spanish legislation (BOE, 2011) establishes the use of azidiol as a preservative in 
milk sampling for official quality control, its composition (0.75 g chloramphenicol, 10 ml 
ethanol, 18 g sodium azide, 45 g trisodium citrate 5.5 H2O, 0.35 g bromophenol blue, in 
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 1000 ml of distilled water), and its dosage in sheep milk samples (133 µl per 40 ml of raw 
milk sample). 
The effect of azidiol on the response of the Betastar Combo, SNAP and 
TwinsensorBT tests was evaluated as follows: individual milk samples free of antibiotics 
from 20 sheep in the mid-lactation period were collected, milk samples were then divided 
into two aliquots (one preservative-free and one with azidiol) and analysed by each of the 
fast screening tests, in duplicate, to assess interferences on the test specificity. 
To investigate the effect of the preservative on the sensitivity of the receptor-
binding tests, the same antibiotic-free milk samples with azidiol and without preservative 
were spiked with benzylpenicillin and oxytetracycline at their MRLs (4 µg/kg and 100 
µg/kg, respectively) and re-analysed with the corresponding test. 
2.3.3. Cross-reactions 
To assess possible interferences related to the presence of antibiotics other than 
beta-lactams and tetracyclines in milk (cross-reactions), 20 antibiotic-free sheep milk 
samples collected in the mid-lactation period, were spiked individually with a relatively 
high concentration of each selected drug, and tested simultaneously by the four assays 
investigated. In agreement with Reybroeck et al. (2010), the drug concentration in milk 
samples was 10xMRL, and one substance was chosen from each of the most important 
groups of antibiotics: neomycin (aminoglycosides), benzylpenicillin (β-lactams), 
lincomycin (lincosamides), erythromycin (macrolides), colistin (polimyxins), enrofloxacin 
(quinolones) and sulfadiazine (sulphonamides). 
2.4. Detection capability (CCβ) 
CCβ of the receptor-binding tests was calculated by spiking antibiotic-free milk 
samples with different antibiotic substances according to the “Guidelines for the validation 
of screening methods for residues of veterinary medicines” proposed by Community 
Reference Laboratories for residues (CRLs, 2010). 
The guideline document defines the CCβ as the lowest antibiotic concentration 
assessed which produces at least 95 % positive results (false compliant results ≤ 5 %), 
and establishes a calculation procedure based on two premises: antibiotic concentration 
tested should be at or below MRL, and the total number of milk samples to be analysed 
depends on their relationship with the corresponding MRL (Table 2). Following these 
recommendations, the lowest antibiotic concentration assessed in this study was 
0.5xMRL in twenty replicates, 0.75xMRL in forty replicates, and 1xMRL in sixty replicates 
only when necessary. 
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Sheep milk samples free of antibiotics used in this study as negative milk showed 
a good hygienic quality and a gross composition characteristic of sheep milk, according to 
the International Dairy Federation recommendations (ISO/IDF, 2002). 
Table 2. Guidelines for the calculation of the Detection capability (CCβ) according to 
Community Reference Laboratories for residues (CRLs, 2010) 
STC1 
(μg.kg-1) 
 Number of 
replicates 
 False-
compliants 
permitted 
(≤ 5 %) 
 CCβ2 
(μg.kg-1) 
STC = 0.5 MRL3  20  1  ≤ 0.5 MRL 
0.5 MRL < STC ≤ 0.90 
MRL 
 40  2  0.5 - 0.9 MRL 
0.90 MRL > STC ≤ 1 MRL  60  3  > 0.9 – 1 MRL 
1STC: Screening Target Concentration. For authorized analytes, the concentration at which a 
screening test categorizes the sample as “screen positive” (potentially non-compliant); 2CCβ: 
Detection Capability. Antibiotic concentration at which only ≤ 5 % false compliant results remain; 
3MRL: Maximum Residue Limit established in EC Regulation Nº 37/2010 
2.5. Statistical analysis 
Statistical analysis was performed using SAS (version 9.2, 2001; SAS Institute, 
Inc., Cary, NC, USA). To evaluate the differences between the two systems of 
classification of the test results (visual vs instrumental), a chi-square test was employed. 
When an expected frequency was < 5, Fisher’s exact test was applied. A significant 
difference was defined by P < 0.05. 
A logistic regression model was applied to investigate the effect of milk quality 
parameters and stage of lactation period on the response of the receptor-binding assays 
that showed a false-positive rate > 5 %. Statistical analysis was carried out employing the 
stepwise option of the logistic procedure of the SAS (SAS, 2001). Variables were 
analysed using the following logistic model: 
Lij= logit [Pi] = β0 + β1[SL] + β2[pH] + β3[F] + β4[P] + β5[L] + β6[TS] + β7[logSCC] 
+ β8[logBC] + ε ij (1) 
where: Lij is the logistic model; [Pi] is the probability for the response category 
(positive/negative); β0 is the intercept; β i are the estimate parameters for the model; [SL] 
is the lactation stage effect (day); [pH] is the pH effect; [F] is the fat content effect; [P] is 
the protein content effect; [L] is the lactose content effect; [TS] is the total solids content 
effect; [logSCC] is the somatic cell count effect; [logBC] is the bacterial count effect; ε ij is 
the residual error. 
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 3. Results and Discussion 
3.1. Test Specificity 
The chemical composition and hygienic quality of the sheep milk samples used in 
the specificity study are summarized in Table 3, being consistent with those cited by other 
authors for sheep's milk quality parameters (Barron et al., 2001). 
Table 3. Chemical composition and hygienic quality parameters of sheep milk samples 
used in the specificity study (false-positive rate) 
1Log SCC: logarithm of somatic cell count; 2Log BC: logarithm of bacterial count 
As shown in Table 4, the specificity rate for beta-lactam antibiotic detection using 
the Betastar Combo test was 100 % (no positive results) for individual sheep milk and 
also for bulk sheep milk. No significant differences were found between the visual and 
instrumental interpretation of the test results. Similar results were obtained by Sternesjö & 
Johnsson (2003) using the Betastar test (Neogen Corporation), another version of the 
assay for fast detection of beta-lactam residues in cow’s milk. For tetracycline detection 
using the Betastar Combo test in individual sheep milk, the specificity rate was calculated 
as 98.8 % (3 non-compliant results of 250 milk samples) for either result classification 
system. No positive results were obtained for sheep bulk milk samples (specificity of 100 
%). 
The specificity rate according to the instrumental interpretation of the SNAP 
Βetalactam test results was 96.8 % (a false-positive rate of 3.2 %) for individual sheep 
milk, and 99 % for sheep bulk milk samples (a false-positive rate of 1 %). When 
interpretation of the results was carried out visually, specificity decreased slightly for 
individual milk samples (95.6 %), although the differences found were not statistically 
significant. These results differ that those reported by Bell et al. (1995), using bulk milk 
from cows, who obtain a higher specificity rate for the visual interpretation of the test 
results (98.4 % instrumentally, and 99.4 % visually). In raw commingled milk from goats, 
Zeng et al. (1998) found a lower specificity rate with the instrumental method (96.7 %). 
Parameter Individual milk (n = 250) 
 Bulk milk (n = 100) 
Mean SD Min Max  Mean SD Min Max 
pH 6.66 0.08 6.54 6.92  6.68 0.06 6.57 6.89 
Fat (%) 6.38 2.05 2.42 12.68  7.30 0.72 5.63 10.13 
Protein (%) 5.83 0.73 4.55 7.82  5.49 0.25 5.01 6.75 
Lactose (%) 5.03 0.35 3.87 5.67  4.70 0.19 4.05 5.07 
Total solids (%) 18.06 2.71 12.51 26.53  17.76 0.84 15.99 23.01 
Log SCC1 5.01 0.48 4.00 7.27  6.02 0.26 5.37 6.94 
Log BC2 4.83 0.72 3.78 6.96  5.35 0.49 4.23 6.66 
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Table 4. Specificity of the Betastar Combo, SNAP, and TwinsensorBT tests in sheep milk 
Test Antibiotic2 
Specificity1 (%) 
Individual sheep milk 
(n = 250) 
 Bulk sheep milk 
(n = 100) 
Visual Instrumental  Visual Instrumental 
Betastar Combo BL 100 100  100 100 TE 98.8 98.8  100 100 
SNAP BL 95.6 96.8  99 99 TE 100 100  100 100 
TwinsensorBT BL 87.2 86.4  100 100 TE 100 100  100 100 
1Specificity = negatives results/total results x 100; 2BL: β-lactam; TE: Tetracycline 
In some cases, for the SNAP Βetalactam test, an increase of the analysis time 
was observed, especially at the end of the lactation period, possibly due to the 
concentration of the main components of milk that slows down the progress of the sample 
on the nitrocellulose strip. 
The specificity rate was optimal for individual sheep milk (100 %) for the SNAP 
Tetracycline test, both visually and instrumentally. Neither had any false-positive results 
obtained for the SNAP Tetracycline test in ovine bulk milk. 
Regarding the results for the detection of beta-lactam antibiotics using the 
TwinsensorBT test, the specificity for individual milk samples was 87.2 % and 86.4 % for 
visual or instrumental interpretation, respectively. The differences found were not 
statistically significant and could be related to the different perception of the colored test 
lines. This low specificity rate is mainly due to the high number of positive results found in 
the last weeks of the milking period. Therefore, test specificity was optimal (96–100 %) 
until 110 days postpartum and began to decline at 125 days of lactation (specificity of 90 
%), reaching the minimum values (approximately 40 %) in the late stages of lactation 
period. These results may be related to changes in milk composition in the last stage of 
lactation, as a result of the decline in milk production. A logistic regression analysis was 
carried out to evaluate the lactation stage as well as milk characteristic effects on the 
response of the TwinsensorBT test in an attempt to explain the high rate of false-positive 
results. A significant effect of the lactation stage (P < 0.01) and a decrease in the pH 
value (P < 0.01) on the false-positive rate of the TwinsensorBT test were found. The 
statistical results obtained suggest that the probability to obtain non-compliant results 
using individual sheep milk free of antibiotics is much greater at the end of the milking 
period (≥ 125 days post-partum), especially in those milk samples having a lower pH 
value (Figure 1). 
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 However, no false-positive results were obtained when bulk milk samples were 
analysed (specificity 100 %) regardless of whether the results were visually or 
instrumentally interpreted. These results are in agreement with Perme et al. (2010), who 
also obtained a specificity rate of 100 % using bulk cow milk. 
 
 
 
 
 
 
 
 
 
 
 
Figure1. Effect of the lactation stage and pH value of individual sheep milk 
samples on the specificity of the TwinsensorBT test 
Azidiol had no effect on the performance of the receptor-binding tests assessed. 
No change in negative or positive results was observed, either visually or instrumentally, 
when antibiotic-free milk, and samples spiked with antibiotics, with and without azidiol 
(Table 5) were analysed. However, using the SNAP Βetalactam test, a delay in the 
appearance of the colored spots was observed when milk with azidiol were analysed, 
which makes a prolonged incubation period necessary. In addition, the colored spots had 
a lower intensity, making the visibility of the control spot more difficult, which may in turn 
complicate the visual interpretation of the results. 
With respect to the cross-reactivity experiment, no positive results were obtained 
when a relatively high concentration of different drugs other than beta-lactams and 
tetracyclines were present in sheep milk. These results were in accordance with those 
obtained by Reybroeck et al. (2010) and Salter et al. (2011) using different receptor-
binding assays to detect beta-lactam antibiotics in cow milk. 
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Table 5. Effect of azidiol on the performance of Betastar Combo, SNAP, and 
TwinsensorBT tests 
 
Test Test 
line1 
Antibiotic-free milk 
(n = 20) 
 Antibiotic spiked milk 
(n = 20) 
NAZ2 AZ3  NAZ2 AZ3 
Betastar 
Combo 
BL 8.494±4.15 8.863±2.65  0.003±0.00 0.008±0.00 
TE 6.775±4.27 7.718±2.88  0.309±0.23 0.224±0.19 
SNAP BL -0.77±0.15 -0.58±0.22  4.50±0.84 4.66±0.80 
TE -0.63±0.14 -0.30±0.06  3.37±0.79 3.70±0.73 
TwinsensorBT BL 1.53±0.30 1.78±0.24  0.09±0.05 0.08±0.01 
TE 3.00±0.20 2.65±0.18  0.01±0.01 0.01±0.01 
1BL: β-lactam line, TE: tetracycline line; 2NAZ: without azidiol; 3AZ: with azidiol 
3.2. Detection capability (CCβ) 
Table 6 summarizes the CCβ of the receptor-binding tests. The Betastar Combo 
test presents a CCβ at or below MRL for all beta-lactam antibiotics tested, except for 
ceftiofur, and cephalexin, being above their respective MRLs. Desfuroylceftiofur could not 
be detected at 100 µg/kg equivalent antibiotic concentration. For tetracyclines, the CCβ 
obtained by the Betastar Combo test was equal to MRL for chlortetracycline, 
oxytetracycline and tetracycline. However, the 4-epimers of these tetracyclines were not 
detected at 100 µg/kg antibiotic concentration in all cases. These results are in agreement 
to those reported by Reybroeck et al. (2010) using the Betastar (1+1) test (Neogen 
Corporation) in cow milk. Shuren and Knappstein (2004), and Žvirdauskiene and 
Salomskiene (2007) also indicate that the Betastar test is able to detect benzylpenicillin, 
amoxicillin and ampicillin at or below their respective MRLs. At the moment, there are no 
published studies on the CCβ of the Betastar Combo test to detect tetracyclines in milk. 
As shown in Table 6, the SNAP Βetalactam test was able to detect all the beta-
lactam antibiotics tested at or below their respective MRLs. These results are similar to 
those obtained by Shuren and Reichmuth (1998) using the SNAP Βetalactam test with 
cow milk, except for amoxicillin which could not be detected by these authors at or below 
MRL. Regarding tetracyclines, the CCβ of the SNAP Tetracycline test was at or below 
MRL for chlortetracycline, oxytetracycline, and tetracycline. However, the CCβ of this test 
was above 100 µg/kg for the 4-epimers considered. 
The CCβ of the TwinsensorBT test obtained in this study was lower than MRL for 
all the beta-lactams tested except for cephalexin, and nafcillin. For tetracyclines, the 
TwinsensorBT test was able to detect chlortetracycline, oxytetracycline, and tetracycline at 
or below MRL. In contrast, this test could not detect 4-epichlortetracycline, or 4-
epioxytetracycline, or 4-epitetracycline at 100 µg/kg equivalent antibiotic concentration. 
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 These results are in accordance to those reported by Perme et al. (2010) in their study on 
the performance of the TwinsensorBT test in cow milk, who could not detect nafcillin or 
cephalexin at their respective MRLs. 
Table 6. Detection capability (CCβ) of the Betastar Combo, SNAP and TwinsensorBT tests 
for beta-lactams and tetracyclines in sheep milk 
1MRL: Maximum Residue Limit established by EC Regulation Nº 37/2010; 2 CCβ (µg/kg): 
antibiotic concentration that produces at least 95 % positive results; 3SNAP tests: SNAP 
Betalactam test and SNAP Tetracycline test; 4sum of cefapirin and desacetylcefapirin; 5sum of 
all residues retaining the β-lactam structure expressed as desfuroylceftiofur; 6sum of parent 
drug and its 4-epimer; *marker residue. MRL not established 
4. Conclusions 
Despite the differences in terms of chemical composition and hygienic quality of 
milk from sheep to cows which could have affected the performance of these screening 
tests, the results obtained indicate that all the receptor-binding tests assessed are 
suitable for use in raw sheep milk. Thus, the Betastar Combo, SNAP Betalactam, SNAP 
Tetracycline and TwinsensorBT tests, presented high specificity values (≥ 99 %) for the 
Antibiotics MRL
1 
(µg/kg) 
CCβ2 (µg/kg) 
Betastar Combo SNAP3 TwinsensorBT 
Beta-lactams     
Amoxicillin 4 4 4 4 
Ampicillin 4 3 3 ≤ 2 
Benzylpenicillin 4 ≤ 2 ≤ 2 3 
Cloxacillin 30 ≤ 15 20 ≤ 15 
Dicloxacillin 30 ≤ 15 ≤ 15 ≤ 15 
Nafcillin 30 ≤ 15 30 > 30 
Oxacillin 30 ≤ 15 30 ≤ 15 
Cefacetrile 125 ≤ 63 ≤ 63 ≤ 63 
Cefalonium 20 ≤ 10 20 ≤ 10 
Cefapirin 604 ≤ 30 ≤ 30 ≤ 30 
Cefazolin 50 50 ≤ 25 ≤ 25 
Desacetylcefapirin * ≤ 30 ≤ 30 ≤ 30 
Cefoperazone 50 ≤ 25 ≤ 25 50 
Cefquinome 20 ≤ 10 ≤ 10 20 
Ceftiofur 1005 > 100 ≤ 50 ≤ 50 
Desfuroylceftiofur * > 100 ≤ 50 ≤ 50 
Cephalexin 100 > 100 ≤ 50 > 100 
Tetracyclines     
Chlortetracycline 1006 100 100 100 
4-epichlortetracycline * > 100 > 100 > 100 
Oxytetracycline 1006 100 ≤ 50 75 
4-epioxytetracycline * > 100 > 100 > 100 
Tetracycline 1006 100 75 100 
4-epitetracycline * > 100 > 100 > 100 
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detection of beta-lactams and tetracyclines in bulk sheep milk. Also, individual sheep milk 
samples were analysed successfully with the SNAP and Betastar Combo tests. The 
TwinsensorBT test not should be used with this type of milk, especially at the end of the 
lactation period because of the high probability of finding false-positive results. Azidiol as 
a preservative had no influence on the test performance and neither did the presence of 
antibiotics other than beta-lactams and tetracyclines in milk. In addition, the CCβ of the 
tests investigated was at or below MRL for most antibiotics considered. In general, no 
significant differences were found between visual and instrumental interpretation of the 
test results, which allows the use of these tests with or without a specific reader. In 
conclusion, the Betastar Combo test (Neogen Corporation), the SNAP Βetalactam test 
(IDEXX Laboratories), the SNAP Tetracycline test (IDEXX Laboratories) and the 
TwinsensorBT test (Unisensor), are suitable for routinary screening of antibiotics in bulk 
milk from ovine livestock. 
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Abstract 
The suitability of different receptor-binding assays to detect antibiotics in raw goat milk 
was investigated. Detection capability (CCβ) of most beta-lactams and tetracyclines 
assessed applying the Betastar Combo, the SNAP Betalactam, the SNAP Tetracycline 
and the TwinsensorBT tests was at or below maximum residue limits (MRLs) 
established by European legislation. Regarding test specificity, cross-reactions with 
antibiotics other than beta-lactams and tetracyclines were not found, and no false-
positive results were obtained for the Betastar Combo and the SNAP tests when goat 
bulk milk samples were analyzed. For the TwinsensorBT test, the false-positive rate was 
1 %. The performance of the Betastar Combo and the SNAP tests was practically 
unaffected by the milk quality parameters using individual goat milk collected along the 
entire lactation period (false-positive rate ≤ 5 %). However, a larger number of positive 
results was obtained by the TwinsensorBT test in this type of milk samples (> 10 %), 
especially in the last weeks of lactation. Interferences related to the use of the 
preservative azidiol were not observed in any case. Neither were any significant 
differences found in relation to the interpretation method (visual vs instrumental) 
applied. In general, the response of the Betastar Combo, SNAP and TwinsensorBT 
tests was optimal for the analysis of caprine bulk milk, thus they may be used in a 
satisfactory manner to monitor milk for the presence of beta-lactam and tetracycline 
residues in quality control programs. 
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Abstract 
The production systems of the Spanish dairy sheep and goats sectors have 
been intensified in recent years, and in this context the use of antimicrobials to treat 
and prevent infectious diseases is a widespread practice that can result in the 
contamination of the milk supply. Mastitis is undoubtedly the infectious disease most 
frequently treated with antibiotics in dairy sheep and goat livestock, using primarily 
beta-lactam drugs, while macrolides constitute the second most important group of 
antimicrobials applied. Therefore, substances belonging to these groups are the most 
probable residues in raw milk from these species. Other substances such as 
tetracyclines and quinolones are less commonly used in mastitis treatments, however, 
they are usually employed in other respiratory, digestive and reproductive diseases 
requiring antibiotic therapy in small ruminants. For sheep and goat’s milk, Spanish 
regulation establishes the control of the presence of antibiotic residues using methods 
that detect, at least, beta-lactam drugs. Microbial inhibitor tests using Geobacillus 
stearothermophilus var. calidolactis and specific receptor-binding assays are widely 
used for screening antibiotics in milk. Taking into account the frequency of use of 
antibiotics commonly employed by veterinarians to treat and prevent mastitis in 
lactation, detection rates of screening tests routinely applied in Spain have been 
evaluated in order to propose an analytical strategy based on the use of these methods 
to detect residues of antibiotics in a simple and economic manner. In general, the use 
of a single test allows detecting 62.8-82.4 % of the antibiotics employed. For sheep 
milk, the total detection range achieved with microbial tests was significantly higher 
than that reached with rapid receptor tests. However, no significant differences 
between the two types of methods were found when goat's milk was analysed. In both 
types of milk, the simultaneous use of two screening tests with a different analytical 
basis increases the total detection range significantly, reaching values ≥ 90 % in some 
cases (81.5-90.1 % for sheep and 84.7-92.6 % for goats). However, the periodical use 
of screening tests able to detect quinolones, macrolides or aminoglycosides would be 
recommended in order to carry out a more efficient screening and ensure the safety of 
milk and dairy products from sheep and goats. 
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1. Introduction 
The Mediterranean basin is an important producer of sheep and goat’s milk that 
is traditionally almost exclusively destined for the elaboration of dairy products, in 
particular cheese. Many of these products are elaborated according to stipulations 
concerning the protected designation of origin (PDO), the protected geographical 
indication (PGI), or traditional specialties guaranteed, internationally recognised, with 
high milk quality standards, especially in the case of products made from raw milk 
(Scintu and Piredda, 2007). 
The quality of sheep and goat’s milk has increased significantly, not only in 
terms of their fat- and protein contents, but also with regard to hygienic quality. In this 
sense, the establishment of Community legislation concerning the hygiene of foodstuffs 
of animal origin intended for human consumption (Regulation EC Nº 853/2004 and 
amendments) and the introduction of a payment system based on the quality of the 
milk from these species (Pirisi et al., 2007) have decisively contributed to milk quality 
improvement. 
The Spanish dairy sheep and goats sectors have become far more productive 
in the last decades thanks to greater specialisation and improved production facilities. 
Although the number of livestock farms has been significantly reduced, the production 
of goat’s milk has remained stable, while the production of sheep milk has increased 
considerably (MAGRAMA, 2013). In this context, the use of antimicrobials to treat and 
prevent infectious diseases in small dairy ruminants is a widespread practice that, if 
guidelines of good practices are not obeyed (IDF, 2013), can result in the 
contamination of the milk supply. 
Antimicrobials should be applied under veterinary prescription using authorized 
products and respecting the dose, the routes of administration and withdrawal periods 
recommended by the manufacturers. However, the availability of drugs indicated for 
the use in lactating dairy sheep and goats is quite limited, which conditions the off-label 
use of some antibiotics by veterinarians. Adequate withdrawal periods in milk from 
these species in off-label treatments are unknown in many cases which, therefore, 
increases the risk of residues of these substances in milk (Pengov and Kirbis, 2009). 
The control of the presence of residues of veterinary agents in animal products 
for human consumption above maximum residue limits (MRLs) established by 
legislation (Regulation UE Nº 37/2010) is mandatory in countries of the European 
Union (Regulation EC Nº 853/2004 and amendments). Antibiotic residues in milk and 
dairy products pose a risk to the health of consumers as they can cause allergic 
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reactions in individuals sensitive to certain groups of antimicrobials, as well as generate 
antimicrobial resistance (Sanders et al., 2011). Also, they are problematic for dairies as 
they can interfere with the fermentation processes required for the manufacture of 
certain products such as cheese and yoghurt (Berruga et al., 2011). 
For screening antibiotic residues in the milk supply there are currently various 
analytical methods commercially available (ISO/IDF, 2010). Of all the screening 
methods available, microbial inhibitor tests using Geobacillus stearothermophilus var. 
calidolactis stand out due to their common use in control laboratories and rapid 
receptor tests for being widely used in farms and dairies given their swiftness of 
response. 
Regarding sheep and goat’s milk, Spanish regulation (Real Decreto 752/2011) 
establishes the control of the presence of antibiotic residues prior to the loading of milk 
into the tanker, if a risk for the consumer is suspected, using methods that detect at 
least beta-lactam drugs. In dairies, the control of the presence of beta-lactam residues 
must be carried out in all the tankers containing raw milk. Similarly, at control 
laboratories the use of screening tests able to detect at least beta-lactam drugs at MRL 
equivalent antibiotic concentration is also legally required. Whenever a non-compliant 
result is obtained, the milk sample must be re-tested applying another test with a 
similar detection profile and a different analytical basis. 
Mastitis is undoubtedly the infectious disease most frequently treated with 
antibiotics in dairy sheep and goats, using primarily beta-lactam drugs, while 
macrolides constitute the second most important group of antimicrobials applied 
(Berruga et al., 2008). Therefore, substances belonging to these two antibiotic families 
are the most probable residues in raw milk from these species. Other substances such 
as tetracyclines and quinolones are less commonly used in mastitis treatments; 
however, they are usually employed in other respiratory, digestive and reproductive 
diseases requiring antibiotic therapy in small ruminants. Therefore, in order to carry out 
effective screening of raw milk from sheep and goats, it would be desirable to have 
analytical methods available to detect the most frequent drugs currently used in 
veterinary medicine in Spain. 
For this reason, the objective of this study was to evaluate an analytical strategy 
based on the use of different commercially screening methods routinely employed in 
Spain to detect antibiotic substances most commonly applied in a simple and economic 
manner. 
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2. Material and methods 
2.1. Milk samples 
Antibiotic-free milk samples were obtained from the experimental flocks of 
Manchega sheep of Universidad de Castilla-La Mancha (Albacete, Spain), and 
Murciano-Granadina goats of Universitat Politècnica de València (Valencia, Spain). 
Animals had a good health status and had not received any veterinary drugs, neither 
before nor along the experimental period. Neither was medicated feed used in their 
diet. 
Individual milk samples (200 ml) were collected in the mid-lactation period from 
40 sheep (more than 60 days and below 90 days postpartum) and 40 goats (more than 
90 days and below 150 days postpartum). All milk samples were analysed for gross 
composition (MilkoScan 6000, Foss, Hillerd, Denmark), somatic cell count 
(Fossomatic 5000, Foss), total bacterial count (Bactoscan FC, Foss), and pH value 
(pHmeter, Crison, Barcelona, Spain) to check their suitability to be used as “negative 
milk” according to the IDF recommendations (ISO/IDF, 2002 and 2003). 
2.2. Antibiotic Screening tests 
Microbial inhibitor tests and receptor-binding assays most commonly used in 
Spain for screening antibiotics in sheep and goat’s milk were employed in this study. 
The microbial inhibitor tests used were the BRT MRL (Analytik in Milch 
Produktions-und Vertriebs-GmbH, Munich, Germany), Delvotest MCS SP-NT (DSM 
Food Specialties, Delft, the Netherlands), Delvotest MCS Accelerator (DSM Food 
Specialties), and Eclipse 100 (Zeulab, Zaragoza, Spain). 
The receptor-binding assays were the Betastar Combo test (Neogen 
Corporation, Lansing, MI, USA), the Charm MRL BLTET test (Charm Sciences, Inc., 
Lawrence, MA), the SNAP Βetalactam test (IDEXX Laboratoires, Westbrook, ME, 
USA), the SNAP Tetracycline test (IDEXX Laboratories), and the TwinsensorBT test 
(Unisensor, Liege, Belgium), which employ binding reagents and have similar reaction 
mechanisms. The Betastar Combo, Charm MRL BLTET and TwinsensorBT tests allow 
to simultaneously detect both beta-lactam and tetracycline antibiotics in milk samples, 
and the SNAP tests used, namely SNAP Βetalactam, and SNAP Tetracycline, are 
specific for beta-lactams and tetracyclines, respectively. 
All tests were conducted according to the manufacturer’s instructions. The test 
results were classified as positive or negative both, visually by three trained 
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technicians, and instrumentally by specific devices provided by manufacturers, except 
for the Delvotest MCS Accelerator which only instrumental reading was performed. 
2.3. Antimicrobials and spiked milk samples 
Antimicrobials most employed by veterinarians to treat and prevent mastitis in 
dairy sheep and goats were selected for this study. In agreement to Berruga et al. 
(2008) who surveyed veterinarians for information on antimicrobial treatments most 
commonly applied in Spain to treat and prevent infectious diseases in dairy sheep and 
goats, a total of 26 substances was investigated: amoxicillin (A8523), ampicillin 
(A9518), benzylpenicillin (PENNA), cloxacillin (C9393), cefalonium (32904), cefapirin 
(43989), cefazolin (C5020), cefoperazone (32426), cefquinome (32472), ceftiofur 
(34001), cephalexin (C4895), enrofloxacin (33699), erythromycin (E6376), gentamicin 
(G3632), lincomycin (31727), marbofloxacin (34039), neomycin (N1876), 
oxytetracycline (O4636), spiramycin (59132), streptomycin (S6501), sulfadiazine 
(S6387), sulfadimethoxine (S7385), sulfametazine (S5637), tetracycline (T3258) and 
tylosin (T6271) were supplied by Sigma-Aldrich Química, S.A. (Madrid, Spain). 
Cefacetrile, not commercially available, were kindly provided by Fatro S.p.A. (Bologna, 
Italy). 
Commercial drugs were stored and handled as indicated by the manufacturers. 
For use, were dissolved (1 mg/ml) at the time when analyses were carried out to avoid 
problems related to instability. 
Spiked milk samples were prepared following the recommendations of the 
International Dairy Federation (ISO/IDF, 2002 and 2003), and tested simultaneously by 
the different screening tests immediately after spiking. For each drug, 60 replicates of 
antibiotic-free milk spiked at MRL equivalent antibiotic concentration were made using 
sheep and goat’s milk, respectively. All antimicrobial substances were tested by the 
four microbial inhibitor tests considered. For rapid receptor tests only beta-lactams and 
tetracyclines were analysed because they were designed specifically for the detection 
of these drugs. 
The test sensitivity was calculated for each antibiotic substance as the 
percentage of positive results on the total of milk samples analyzed. 
2.4. Calculation of the total detection rate for screening tests 
Taking into account the frequency of use of each “a” antimicrobial substance 
(Fa), calculated from data provided by Berruga et al. (2008) and the “t” test sensitivity 
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for each antibiotic at MRL equivalent concentration (SMRLt,a), the detection rates of 
each screening test (DRt,a (%)= Fa·SMRLt,a) were calculated. 
Subsequently, the total detection rate for each screening test (TDRt) was 
calculated according to the following mathematical expression: 
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2.5. Calculation of the total detection rate through the simultaneous use of two 
screening tests 
The total detection rate resulting from the simultaneous use of two screening 
tests (TDRt1+t2) was calculated by adding the detection rate of the screening method 
presenting the highest sensitivity for each antibiotic substance as shown in the 
following expression: 
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where: 
ataat SMRLFttDR ,1,1 .)2/1(  : Detection rate presented by test t1 for a 
given antibiotic a, not detected by test t2 (or the sensitivity of t2 is below that of 
t1); ataat SMRLFttDR ,2, .)1/2(  : Detection rate presented by test t2 for a given 
antibiotic a, not detected by test t1 (or the sensitivity of t1 is below that of t2). 
2.6. Statistical analysis 
The total detection rates obtained for microbial inhibitor tests and receptor-
binding assays were compared through the non-parametric Mann-Wilcoxon test in 
order to establish significant differences (p < 0.05) between them or their possible 
combinations. Statistical analysis was performed using the Statgraphics software 
(Statgraphics Centurion XVI). 
3. Results and discussion 
3.1. Detection rates of antimicrobials in sheep milk 
Table 1 summarizes the frequency of use of antibiotics most commonly applied 
in Spain to treat mastitis in dairy sheep, the sensitivities of the microbial screening tests 
and the detection rates calculated for each antibiotic substance depending on its 
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frequency of use (DRM,A). Information related to rapid receptor tests is presented in 
Table 2. 
Table 1. Detection rate of antibiotics reached by microbial screening tests in sheep milk 
 
Antimicrobials F1 
 SMRL2 (%) DR3 (%) 
 BRT MRL 
Delvotest
SP-NT 
Delvotest
DA 
Eclipse
100 
BRT 
MRL 
Delvotest 
SP-NT 
Delvotest 
DA 
Eclipse
100 
Beta-lactams           
Benzylpenicillin 29.10  100 100 100 100 29.10 29.10 29.10 29.10 
Amoxicillin 15.00  100 100 100 100 15.00 15.00 15.00 15.00 
Cloxacillin 14.20  100 100 100 100 14.20 14.20 14.20 14.20 
Ceftiofur 3.10  45 100 100 100 1.40 3.10 3.10 3.10 
Ampicillin 2.40  100 100 100 95 2.40 2.40 2.40 2.28 
Cephalexin 2.40  47 100 100 100 1.13 2.40 2.40 2.40 
Cefquinome 1.60  0 0 0 0 0.00 0.00 0.00 0.00 
Cefoperazone 1.60  58 77 32 15 0.93 1.23 0.51 0.24 
Cefazolin 0.80  100 100 100 100 0.80 0.80 0.80 0.80 
Cefalonium 0.80  100 100 100 100 0.80 0.80 0.80 0.80 
Cefapirin 0.80  100 100 100 100 0.80 0.80 0.80 0.80 
Cefacetrile 0.80  100 100 100 100 0.80 0.80 0.80 0.80 
Macrolides           
Erytromycin 6.70  96 17 8 5 6.43 1.14 0.54 0.34 
Tylosin 6.40  100 100 100 100 6.40 6.40 6.40 6.40 
Spiramicin 3.90  0 0 0 0 0.00 0.00 0.00 0.00 
Lincomicin 1.80  82 23 68 5 1.48 0.41 1.22 0.09 
Tetraciclinas           
Oxitetracycline 2.30  0 5 25 32 0.00 0.12 0.58 0.74 
Tetracycline 0.50  0 3 0 0 0.00 0.00 0.00 0.00 
Quinolones           
Enrofloxacin 3.80  2 0 0 0 0.08 0.00 0.00 0.00 
Marbofloxacin 1.20  0 0 0 8 0.00 0.00 0.00 0.10 
Aminoglycosides           
Streptomicin 0.30  16 0 0 8 0.05 0.00 0.00 0.02 
Gentamicin 0.30  100 17 15 5 0.30 0.05 0.05 0.02 
Neomycin 0.10  100 100 100 70 0.10 0.10 0.10 0.07 
Sulphonamides           
Sulfametoxine 0.10  80 33 55 93 0.08 0.03 0.06 0.09 
Sulfadiazine 0.10  60 100 100 100 0.06 0.10 0.10 0.10 
1F: Frequency of use of antimicrobials in mastitis treatments calculated from data provided by Berruga et al. (2008); 2SMRL: 
Sensitivity of screening tests at Maximum Residue Limits (MRL) equivalent antibiotic concentration; 3DR: Detection rate for 
each antimicrobial substance considered 
As shown in Table 1, although microbial screening tests have the same 
analytical basis they display different sensitivities in the detection of antibiotic 
substances. Thus, for example, molecules such as benzylpenicillin, cefalonium or 
tylosin are detected by all microbial inhibitor tests (sensitivity of 100 %), while there are 
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molecules that are only detected by some methods and not by others. Thus, for 
example, the BRT MRL test has lower specificity for ceftiofur and cephalexin than the 
Delvotest MCS SP-NT, Delvotest MCS DA and Eclipse 100 tests; however, it is the 
only microbial test able to detect erythromycin and gentamicin at MRL equivalent 
concentration in sheep milk. 
In general, microbial screening tests present a high sensitivity for the detection 
of beta-lactam antibiotics (Beltrán et al., 2014). Thus, the detection rates for this group 
of antimicrobials are higher than those obtained for families other than beta-lactams, 
especially for drugs belonging to the tetracycline and quinolone groups that were not 
detected by any of the microbial tests considered. 
Table 2. Detection rate of antibiotics reached by receptor-binding assays in sheep milk 
 
Antimicrobials 
F1 
SMRL2 (%) DR3 (%) 
Charm 
MRL 
Betastar
Combo 
SNAP4
Twin- 
sensor
Charm
MRL 
Betastar Combo SNAP4 
Twin- 
sensor
Beta-lactams          
Benzylpenicillin 29.10 100 100 100 100 29.10 29.10 29.10 29.10 
Amoxicillin 15.00 95 98 98 97 14.25 14.70 14.70 14.55 
Cloxacillin 14.20 18 100 100 100 2.55 14.20 14.20 14.20 
Ceftiofur 3.10 100 92 100 100 3.10 2.85 3.10 3.10 
Ampicilin 2.40 97 100 100 100 2.33 2.40 2.40 2.40 
Cefalexin 2.40 100 0 100 0 2.40 0.00 2.40 0.00 
Cefquinome 1.60 100 100 100 100 1.60 1.60 1.60 1.60 
Cefoperazone 1.60 100 100 100 100 1.60 1.60 1.60 1.60 
Cefazolin 0.80 100 95 100 100 0.80 0.78 0.80 0.80 
Cefalonium 0.80 100 100 95 100 0.80 0.80 0.76 0.80 
Cephapirin 0.80 100 100 100 100 0.80 0.80 0.80 0.80 
Cefacetrile 0.80 100 100 100 100 0.80 0.80 0.80 0.80 
Tetracyclines          
Oxitetracycline 2.30 100 97 100 100 2.30 2.23 2.30 2.30 
Tetracycline 0.50 100 97 100 97 0.50 0.49 0.50 0.49 
1F: Frequency of use of antimicrobials in mastitis treatments calculated from data provided by Berruga et al. (2008); 2SMRL: 
Sensitivity of screening tests at MRL equivalent antibiotic concentration, 3DR: Detection rate for each antimicrobial substance 
considered; 4SNAP: SNAP tests are considered here as a combined test able to detect beta-lactams and tetracyclines 
simultaneously 
Similar results were reached with the receptor-binding assays studied. Of all the 
beta-lactams and tetracyclines used in lactating dairy sheep, some molecules, for 
instance, ampicillin, benzylpenicillin and cefoperazone, among others, are detected by 
all the rapid receptor tests considered (Table 2). On the contrary, there are substances 
that are only detected by some tests and not by others, as, for example cloxacillin, 
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which is detected by the Betastar Combo, SNAP and TwinsensorBT tests but only to a 
very low extent by the Charm MRL BLTET method. 
Using Equation 1 presented in the Materials and Methods section, the total 
detection rate for screening tests (TDRt) was calculated and is summarized in Table 3. 
Table 3. Total detection rate (TDR) of antibiotics reached by screening tests in 
sheep milk 
Microbial tests TDR (%)  Receptor-binding assays TDR (%) 
BRT MRL 82.1  Charm MRL BLTET 62.8 
Delvotest MCS SP-NT 78.9  Betastar Combo 72.2 
Delvotest MCS DA 78.8  SNAP1 74.9 
Eclipse 100 77.2  TwinsensorBT 72.4 
1SNAP: SNAP tests are considered here as a combined test able to detect beta-lactams 
and tetracyclines simultaneously 
As shown in Table 3, of the four microbial inhibitor tests to detect antibiotics in 
milk, the BRT MRL test has the highest total detection rate (82.1 %) compared with the 
Delvotest MCS SP-NT, Delvotest MCS DA and Eclipse 100 tests. In this respect it 
should be mentioned that the BRT MRL test uses Mueller Hinton as culture medium 
and black brilliant as redox indicator unlike the other three tests containing Plate count 
agar and bromocresol purple as acid-base indicator. These differences could be 
related to the greater sensitivity towards some antimicrobial substances belonging to 
families other than beta-lactams. 
Concerning the rapid receptor tests evaluated, the SNAP test presented a 
higher total detection rate than the Betastar Combo, Charm MRL BLTET, and 
TwinsensorBT tests (Table 3) due to its greater sensitivity to cephalexin, while the 
Charm MRL BLTET test displayed the lowest total detection rate given its low 
sensitivity towards cloxacillin. It should be noted that the receptor-binding assays used 
in this study are designed for the specific detection of beta-lactams and tetracyclines 
and therefore, drugs belonging to other groups of antibiotics cannot be detected by 
these tests; which explains the relatively low detection percentages obtained (62.8 - 
74.9 %) with this test type when all antimicrobials are considered. 
When comparing the total detection rates achieved with microbial and rapid 
receptor screening tests, respectively, through the Mann-Wilcoxon contrast test, 
significant differences between the two types of assays were found (W= 16.0 and p= 
0.030), i.e. a broader spectrum of detection was achieved with microbial screening 
tests (77.2 - 82.1 vs 62.8 - 74.9 %, respectively). This is due to the fact that mastitis 
therapy in sheep makes an appreciable use of macrolides using substances such as 
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erythromycin (6.7 %), tylosin (6.4 %) and lincomycin (1.8 %), some of which are 
detected by the microbial screening tests assessed but not by the rapid receptor tests. 
Concerning the simultaneous use of two screening methods trying to improve 
the percentage of total detection of antibiotics in sheep milk, the results obtained for the 
different combinations possible are presented in Table 4. 
Table 4. Detection rates of antibiotics reached with the simultaneous use of two 
screening tests in sheep milk 
1SNAP: SNAP tests are considered here as a combined test able to detect beta-lactams and 
tetracyclines simultaneously 
As shown in Table 4, the simultaneous use of two microbiological screening 
methods made the detection of a range between 78.9 and 85.9 % of the molecules 
considered possible, presenting no statistically significant differences with respect to 
that obtained with the use of a single screening test belonging to this group (W= 20.5 
and p= 0.087). Similarly, the combination of two rapid screening tests based on the use 
of specific receptors neither increased the detection range of antibiotics in sheep milk 
(W= 20.0 and p= 0.1056) with respect to the use of a single test. Therefore, it can be 
concluded that the simultaneous use of two methods having the same analytical basis 
does not improve the detection of antibiotic substances commonly used in dairy ovines. 
On the other hand, the combination of two methods with a different analytical 
basis, i.e. a microbial test together with a receptor-binding test, resulted in a broader 
detection spectrum (81.5-90.1 %) which was statistically significant with respect to that 
obtained with a single microbial or a rapid test (W= 15.6812 and p= 0.0005) allowing, 
therefore, a more efficient control of antibiotic residues in sheep milk. 
3.2. Detection of antimicrobials in goat’s milk 
Tables 5 and 6 summarize the frequencies of use, sensitivities at MRLs of 
microbial inhibitor tests and receptor-binding assays, respectively, as well as their 
 Betastar Charm SNAP1 Twinsensor BRT Delvotest Delvotest DA Eclipse 
Betastar  74.5 74.9 72.6 88.5 83.4 83.5 82.2 
Charm   84.9 74.8 90.1 83.5 83.6 85.4 
SNAP    74.9 90.1 83.5 83.6 82.3 
Twinsensor     88.8 83.4 83.6 81.5 
BRT      85.5 85.7 85.9 
Delvotest       80.1 79.5 
Accelerator        78.9 
Eclipse         
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detection rates for the different antibiotics usually applied in the treatment of mastitis in 
goats. 
As explained previously for sheep milk, microbial screening tests display a high 
sensitivity for the detection of beta-lactam antibiotics (Table 5), and can also detect 
some of the remaining substances considered at legally established safety levels. On 
the other hand, beta-lactam and tetracycline antibiotics are widely detected by rapid 
receptor tests reaching total detection rates higher than those indicated previously for 
sheep milk (Table 6). 
Table 5. Detection rate of antibiotics reached by microbial screening tests in goat’s milk 
 
Antimicrobials F1 
 SMRL2 (%) DR3 (%) 
 BRT MRL 
Delvo 
SP-NT
Delvo
DA 
Eclipse
100 
BRT 
MRL 
Delvo 
SP-NT
Delvo 
DA 
Eclipse 
100 
Beta-lactams           
Benzylpenicillin 30.00  100 100 100 100 30.00 30.00 30.00 30.00 
Amoxicillin 20.00  100 100 97 95 20.00 20.00 19.40 19.00 
Cloxacillin 10.00  100 100 100 97 10.00 10.00 10.00 9.70 
Ceftiofur 3.60  47 80 73 92 1.69 2.88 2.63 3.31 
Ampicillin 2.10  100 100 100 100 2.10 2.10 2.10 2.10 
Cephalexin 1.40  35 100 100 100 0.49 1.40 1.40 1.40 
Cefquinome 0.70  33 28 12 3 0.23 0.20 0.08 0.02 
Cefoperazone 0.70  48 83 58 28 0.34 0.58 0.41 0.20 
Cefazolin 0.70  100 100 100 100 0.70 0.70 0.70 0.70 
Cefalonium 0.70  100 100 100 100 0.70 0.70 0.70 0.70 
Cefapirin 0.70  100 100 100 100 0.70 0.70 0.70 0.70 
Cefacetrile 0.70  100 100 100 100 0.70 0.70 0.70 0.70 
Macrolides           
Erytromycin 5.10  100 45 10 17 5.10 2.30 0.51 0.87 
Tylosin 3.20  100 100 100 95 3.20 3.20 3.20 3.04 
Spiramicin 2.20  0 0 0 0 0.00 0.00 0.00 0.00 
Lincomicin 1.20  55 40 80 3 0.66 0.48 0.96 0.04 
Tetraciclinas           
Oxitetracycline 8.20  38 20 30 47 3.12 1.64 2.46 3.85 
Tetracycline 1.60  0 5 5 5 0.00 0.08 0.08 0.08 
Quinolones           
Enrofloxacin 3.60  0 0 0 0 0.00 0.00 0.00 0.00 
Marbofloxacin 0.70  0 0 0 0 0.00 0.00 0.00 0.00 
Aminoglycosides           
Gentamicin 1.20  97 13 5 5 1.16 0.16 0.06 0.06 
Neomycin 1.20  100 100 100 65 1.20 1.20 1.20 0.78 
Streptomicin 0.40  25 5 5 25 0.10 0.02 0.02 0.10 
1F: Frequency of use of antimicrobials in mastitis treatments calculated from data provided by Berruga 
et al. (2008); 2SMRL: Sensitivity of screening tests at MRL equivalent antibiotic concentration, 3DR: 
Detection rate for each antimicrobial substance considered 
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The total detection rates for screening tests using goat’s milk are presented in 
Table 7. The BRT and the SNAP tests displayed the highest percentages of drugs 
detected for the two test types considered. 
Table 6. Detection rate of antibiotics reached by receptor-binding assays in goat’s milk 
Antimicrobials F1 
SMRL2 (%) DR3 (%) 
Charm 
MRL 
Betastar
Combo 
SNAP4
Twin- 
sensor 
Charm 
MRL 
Betastar 
Combo 
SNAP4 
Twin- 
sensor 
Beta-lactams          
Benzylpenicillin 30.00 100 100 100 100 30.00 30.00 30.00 30.00 
Amoxicillin 20.00 95 100 100 100 19.00 20.00 20.00 20.00 
Cloxacillin 10.00 15 100 100 100 1.50 10.00 10.00 10.00 
Ceftiofur 3.60 100 90 100 100 3.60 3.24 3.60 3.60 
Ampicilin 2.10 97 100 100 100 2.04 2.10 2.10 2.10 
Cefalexin 1.40 100 5 100 0 1.40 0.07 1.40 0.00 
Cefquinome 0.70 100 100 100 100 0.70 0.70 0.70 0.70 
Cefoperazone 0.70 100 100 100 100 0.70 0.70 0.70 0.70 
Cefazolin 0.70 100 97 100 100 0.70 0.68 0.70 0.70 
Cefalonium 0.70 100 100 100 100 0.70 0.70 0.70 0.70 
Cephapirin 0.70 100 100 100 100 0.70 0.70 0.70 0.70 
Cefacetrile 0.70 100 100 100 100 0.70 0.70 0.70 0.70 
Tetracyclines          
Oxitetracycline 8.20 100 100 100 100 8.20 8.20 8.20 8.20 
Tetracycline 1.60 95 100 100 100 1.52 1.60 1.60 1.60 
1F: Frequency of use of antimicrobials in mastitis treatments calculated from data provided by Berruga et al. (2008); 2SMRL: 
Sensitivity of screening tests at MRL equivalent antibiotic concentration, 3DR: Detection rate for each antimicrobial substance 
considered, 4SNAP: SNAP tests are considered here as a combined test able to detect beta-lactams and tetracyclines 
simultaneously 
The total detection range of microbial inhibitor tests (77.4 - 82.3 %) and that of 
rapid receptor tests (71.6 - 82.4 %) are similar, although receptor-binding assays detect 
only beta-lactam and tetracycline antibiotics, while microbial methods can also detect 
other drugs such as neomycin, gentamicin, or sulphonamides. Therefore, from a food 
safety point of view, the application of one test only seems insufficient as an 
appreciable percentage of antibiotic residues remain undetected and could thus reach 
the consumer. 
The application of the Mann-Wilcoxon test to compare the total detection ranges 
obtained in both groups of the screening tests did not show significant differences (W= 
0.3806 and p= 0.7166), indicating that they could be used interchangeably with similar 
levels of detection. For this reason, when a rapid response is required (i.e. the control 
of antibiotic residues in farms and dairies), the use of a receptor-binding assay would 
be appropriate, while in case of a large number of milk samples to be checked, the use 
of the microbial test would be recommendable and also more economical. 
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Table 7. Total detection rate (TDR) of antibiotics reached by screening tests in 
goat’s milk 
1SNAP: SNAP tests are considered here as a combined test able to detect beta-lactams 
and tetracyclines simultaneously 
The simultaneous use of two microbial screening tests (Table 8) does not lead 
to an improvement of the total detection ranges in comparison to the use of a single 
test (W = 21.0 and p = 0.069) leaving a percentage of undetected residues ranging 
from 14.4 to 20.1 %. 
Table 8. Detection rates of antibiotics reached with the simultaneous use of two 
screening tests in goat’s milk 
 
 Betastar Charm SNAP1 Twinsensor BRT Delvotest Accelerator Eclipse
Betastar  81.2 82.4 79.9 90.3 88.2 86.8 84.7 
Charm   82.4 81.2 90.7 88.5 86.5 84.7 
SNAP    82.4 92.6 88.6 87.2 88.1 
Twinsensor     91.7 87.0 87.0 86.1 
BRT      84.7 84.5 85.6 
Delvotest       80.4 81.6 
Accelerator        79.9 
Eclipse         
1SNAP: SNAP tests are considered here as a combined test able to detect beta-lactams and 
tetracyclines simultaneously 
Similarly, when applying the Mann-Wilcoxon test to compare the total detection 
rates obtained by the application of a single rapid receptor test (Table 4) with those 
calculated when two receptor-binding assays were used simultaneously (Table 8), 
significant differences were not found (W= 21.0 and p= 0.069). Therefore, a 
combination of two rapid receptor tests does not increase the detection range, and a 
percentage of undetected substances between 17.6 and 20.1 % remains. 
On the contrary, when the detection ranges achieved through the simultaneous 
use of receptor-binding assays and microbial inhibitor tests are calculated (84.7 to 92.6 
%), it can be observed that the total detection rates are higher than those calculated 
when using only a rapid receptor test (ranging between 71.6 and 82.4 %, W = 93.0 and 
p= 0.001) or only a microbial method (77.4 and 82.3 %, W = 96.0 and p= 0.0004). 
Microbial tests TDR (%)  Rapid receptor tests TDR (%) 
BRT MRL 82.3  Charm MRL BLTET 71.6 
Delvotest MCS SP-NT 79.1  Betastar Combo 79.5 
Delvotest MCS DA 77.4  SNAP 82.4 
Eclipse 100 77.4  TwinsensorBT 79.8 
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Hence, the application of two screening tests with a different analytical basis leads to a 
significant improvement in milk safety as a greater percentage of the potential antibiotic 
residues in milk is detected. 
It should be kept in mind that Spanish legislation (Real Decreto 752/2011) 
currently centers the analytical strategy for the control of the presence of antibiotics in 
sheep and goat’s milk mainly on the detection of beta-lactams. Therefore, the 
effectiveness of the analytical strategy currently applied by most operators in the sector 
for screening antibiotics in raw milk from sheep and goats, is rather appropriate as it 
allows achieving elevated detection ranges, above 90 % in most cases, both in dairy 
sheep (microbial tests: 92.8-97.4 %, rapid tests: 82.9-99.6 %) and goats (microbial 
tests: 94.9-98.1 %, rapid tests: 86.6-100 %), respectively, owing to the higher 
sensitivity of these screening tests for beta-lactam drugs. 
In the case of cow milk, Spanish legislation (Real Decreto 1728/2007) centers 
the control of the presence of beta-lactam and tetracycline residues on obligatory 
checks of all tankers used by the dairy industry for the presence of beta-lactams. In the 
case of tetracyclines, these checks are carried out on an obligatory basis in one out of 
five tankers, assuring that all routes are checked on a monthly basis. 
If the specific detection of tetracycline residues were included as a requirement 
for screening antibiotics in sheep and goat's milk, the effectiveness of the analytical 
strategy would decline slightly for sheep (microbial tests: 89.6-94.5 %, rapid tests: 83.4-
99.6 %) and goat’s milk (microbial tests: 87.3-89.3 %, rapid tests: 88.2-100 %), 
respectively, because although the receptor-binding assays are able to detect 
oxitetracycline and tetracycline at their respective MRLs, microbial screening tests are 
less sensitive to these substances at safety levels and, therefore, the total detection 
rate is reduced. 
When considering all the substances potentially present in milk as residues, the 
decline in the effectiveness of the current analytical strategy is more pronounced, 
obtaining a percentage of undetected residues ranging from 9.9 to 18.5 % for sheep, 
and from 7.4 to 15.3 % for goats, respectively, mainly related to drugs belonging to the 
quinolone and macrolide families as the screening tests present a lower sensitivity 
towards these substances. Thus, the periodical implementation of screening tests more 
sensitive to these substances would be convenient increasing the spectrum of 
detection and minimize the risks derivate of the presence of these residues in milk. 
4. Conclusions 
The simultaneous use of two screening tests with a different analytical basis 
allows achieving a broader coverage of the antimicrobial substances used to treat and 
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prevent mastitis in dairy sheep and goats which pose the greatest risk of appearing in 
milk. However, taking in to account that antibiotic agents such as quinolones, 
macrolides or aminoglycosides are not detected by the screening tests assessed and 
are also used to treat mastitis or another respiratory, reproductive or digestive 
diseases, the improvement of the analytical strategy through the periodical 
implementation of screening tests able to detect these substances at safety levels, 
would be recommended. Besides establishing a suitable control strategy, it should not 
be forgotten that the application of a code of good dairy farming practices concerning 
the use of veterinary drugs should be adhered to in order to avoid the presence of 
residues in milk and dairy products 
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Chapter 6 
General discussion 
 
 
 General discussion 
1. General aspects 
Antibiotic therapy is an effective and useful method of treating bacterial 
infections in dairy livestock. Used appropriately, antibiotics help to maintain animal 
health and well-being as well as milk production and reduce the risk of pathogenic 
bacteria in milk. The improper use of drugs in the treatment of lactating dairy animals 
can result in milk containing drug residues above target Maximum Residue Limits 
(MRLs), making milk unsuitable for human consumption and for dairy product 
manufacturing. 
The presence of antibiotic residues in milk has negative repercussions on the 
technological properties as they can totally or partially inhibit fermentation procedures 
required when making cheese and yoghurt (Packham et al., 2001). Sheep and goats 
milk are basically destined for the elaboration of fermented products, and antibiotics in 
milk can thus affect the production process; also, as residues of variable amounts may 
remain in the final products, consumer safety might be compromised (Oliver et al., 
2011). 
For these reasons, integrated dairy chain management must employ an efficient 
detection system to verify the safety of milk through the application of relevant 
detection methods at key steps of the chain to rule out the presence of these 
substances above legally established limits. 
Qualitative antibiotic screening tests are most frequently used along the dairy 
chain from farm to dairy processing. Results are obtained as positive or negative and 
the most widely used tests can be classified in two categories: microbial inhibitor tests 
and receptor-binding assays. These tests have been developed for the use in cow milk 
and, therefore, their validation in sheep and goat’s milk according to guidelines for 
analytical method validation issued by International regulatory authorities is necessary. 
This thesis focuses on the tools currently available on the market to establish an 
appropriate system for the detection of antibiotic residues in sheep and goat’s milk. It 
aims to provide guidance on how to screen antibiotic residues in small dairy ruminants 
within the dairy chain to ensure food safety and, ultimately, to deliver safe dairy 
products to consumers. 
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2. Microbial inhibitor tests 
Microbial inhibitor tests are routinely applied in quality control laboratories to 
check the presence of antibiotic residues in raw milk as they are relatively inexpensive, 
user-friendly, and able to detect a great variety of antimicrobials in a large number of 
milk samples. Most current microbial screening tests were initially developed to detect 
beta-lactams in cow milk and are based on the inhibition of Geobacillus 
stearotermophilus var. calidolactis being highly sensitive to these substances. 
However, they are not suitable for the detection of most drugs belonging to other 
antimicrobial groups. 
To improve test sensitivity, in particular towards non-beta-lactam drugs, various 
authors proposed some modifications such as the addition of chelating agents or 
antifolates, such as trimethoprim, into the culture medium, to enhance the detection of 
tetracyclines and sulphonamides in milk, respectively (Adriany et al.,1995; Langeveld 
et al., 2005). In recent years, manufacturers have improved some performance 
characteristics of microbiological methods, especially the time required for the 
analyses, and sensitivity to different substances, and new versions of these tests are 
now available (ISO/IDF, 2010). 
In fact, the first versions of the microbial screening tests showed good detection 
limits for most beta-lactam antibiotics in sheep milk but did not detect tetracycline and 
quinolone residues. Thus, in a study conducted by Molina et al. (2003a) the BRT test 
(AiM) presented very high detection limits for antimicrobials such as erythromycin (630 
µg/Kg), tylosin (120 µg/Kg), gentamicin (1,200 µg/Kg), neomycin (3,700 µg/Kg), 
sulfadiazine (5,400 µg/Kg), sulfametoxazol (3,200 µg/Kg) and sulfaquinoxalina (6,200 
µg/Kg). However, the current version of this test, BRT MRL test, presents detection 
capabilities (CCβs) at or below regulatory limits (MRLs) for gentamicin, neomycin, 
erythromycin, tylosin and sulfadimethoxine (Beltrán et al., 2014a). 
The Delvotest SP version (DSM Food Specialties) evaluated by Althaus et al. 
(2003a) in sheep milk, presented higher detection limits for tylosin (100 µg/Kg) and 
neomycin (6,200 µg/kg) while its current versions, Delvotest MCS SP-NT and Delvotest 
MCS Accelerator (DSM Food Specialties), are able to detect neomycin (CCβ ≤ 750 
µg/Kg), tylosin (CCβ ≤ 25 µg/Kg), sulfadiazine (CCβ= 75 µg/Kg) and sulfadimethoxine 
(CCβ ≤ 50 µg/Kg) at safety levels (Beltrán et al., 2014a). 
Montero et al. (2005) employing the Eclipse 100ov test (Zeulab) found higher 
detection limits for neomycin (9,100 µg/Kg) and tylosin (230 µg/Kg), respectively. 
However, the latest Eclipse 100 test (Zeulab) also presents a CCβ at MRL for tylosin 
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 (50 µg/Kg) and increased sensitivity (70 %) for the detection of neomycin at MRL 
equivalent to the antibiotic concentration (1,500 µg/Kg) in sheep milk samples. 
Studies conducted by Sierra et al (2009a,b) in goat’s milk also indicate 
detection capabilities at or below maximum residue limits (MRLs) for some beta-lactam 
drugs and lower ability to detect tetracyclines and quinolones. Thus, the BRT (AiM), 
Delvotest SP and Eclipse 100 tests showed higher detection limits for gentamicin (353 
µg/Kg, 353 µg/Kg, and 555 µg/Kg, respectively), erythromycin (174 µg/Kg, 174 µg/Kg 
and 437 µg/Kg, respectively), lincomycin (264 µg/Kg, 264 µg/Kg and 931 µg/Kg, 
respectively), sulfamethazine (555 µg/Kg, 183 µg/Kg and 1,269 µg/Kg, respectively) 
with respect their respective MRLs. 
Based on the results obtained herein, it can be concluded that microbial 
screening tests such as the BRT MRL, the Delvotest MCS SP-NT, the Delvotest MCS 
Accelerator and the Eclipse 100 are suitable for the detection of beta-lactam antibiotics, 
sulphonamides, and some macrolides (erythromycin and tylosin) in sheep and goat’s 
milk. However, Geobacillus stearothermophilus does not display adequate sensitivity to 
detect residues of tetracyclines and quinolones at levels of their MRLs. 
To widen the detection spectrum of antibiotic residues in milk, some authors 
proposed the combinations of different test bacteria, each in an optimal medium, that 
act in a complementary manner to detect a large range of veterinary drugs up to the 
MRL levels (Nows et al., 1999; Gaudin et al., 2004; Althaus et al., 2009). However, 
these screening methods are laborious and require qualified staff for the preparation of 
the petri dishes containing the inoculated culture medium and the interpretation of the 
results from the measurement of the inhibition halos generated as a result of the 
presence of antibiotic residues in milk after, usually, long incubation periods (16-24 h). 
In this sense, Nagel (2013a) proposes the use of chemometric techniques that 
employ multiple logistic regression models and the desirability function to design and 
optimise a microbiological bioassay in microtiter plates with a dichotomous response 
using complementary bacteria such as the Geobacillus stearothermophilus and 
Bacillus subtilis. Thus, B. subtilis acts as a complementary bacterium of G. 
stearothermophilus as it presents a greater sensitivity for the detection of ciprofloxacin, 
enrofloxacin, marbofloxacin, erythromycin, and spiramycin. 
In this thesis the detection system based on the use of two microplates 
containing Geobacillus stearothermophilus and Bacillus subtilis, respectively, in milk 
from sheep has been assessed (Nagel et al., 2012), obtaining good detection limits for 
residues of quinolones (160 µg/l of ciprofloxacin, 230 µg/l of enrofloxacin and 280 µg/l 
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of marbofloxacin) and macrolides (60 µg/l of erythromycin and 380 µg/l of spiramycin) 
when compared with the high detection limits of commercial screening tests using G. 
stearothermophilus. 
Therefore, the combination of different microtiter plates (Althaus et al., 2014) 
could be an alternative of interest to improve the detection rate of potential drug 
residues in milk, in a simple, relatively fast (6 h) and economical manner. 
Recent studies have shown a trend towards the development of more rapid 
microbiological methods using thermophilic bacteria to reduce the total incubation 
period. Nagel et al. (2013b, 2014) using bioassays employing Geobacillus 
thermoleovorans and Geobacillus thermocatenulatus, respectively, reached suitable 
results (CCβ ≤ MRLs) for the detection of beta-lactams in milk in less than 2.5 hours. 
Another important aspect in the evaluation of the performance of microbial 
screening tests is the specificity that considers the probability that the test will be 
negative among samples which do not contain residues of the target analyte. Microbial 
screening tests are not specific for antibiotics and might react with other types of 
inhibitors present in milk (Carlsson et al., 1989; Andrew et al., 1997). Previous studies 
carried out in sheep milk have laid bare apparent interferences related to a high fat 
content, and elevated somatic cell count or the presence of natural inhibitors in milk 
(Althaus et al., 2003b). 
Results obtained in this thesis suggest that microbial screening tests showed an 
elevated percentage of non-compliant results (4.8-10 %) when antimicrobial-free sheep 
milk samples were analysed (Beltrán et al., 2014a) and interferences were related to 
an elevated somatic cell count (SCC) in all cases. These results are in agreement with 
those obtained by others authors (Cullor et al., 1992) who also observed a significant 
effect of SCC on the frequency of positive results for different screening tests using 
individual milk samples from cows. However, the test responses were unaffected by 
goat milk properties, including SCC, when antimicrobial-free milk samples were 
analysed; and the false-positive outcomes recorded were below 5 % in all cases. 
It should be noted that in quality control programmes raw bulk milk samples are 
usually analysed, not individual milk samples, presenting a minor range of variation in 
all quality parameters, and very low percentages of non-compliant results were 
obtained when microbial screening test were used (Comunian et al., 2010). However, 
farmers need sometimes to test individual milk samples from a treated animal to 
ensure that no drug residues will contaminate their production. This is particularly 
recommended when in doubt concerning the observation of good practices in treated 
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 animals (application of withdrawal period, identification of a treated animal, non-cured 
animal, etc.). In this sense, knowing the response of the microbial screening tests when 
using individual samples is essential. The results of the thesis indicate that microbial 
screening tests are not suitable to check drug residues in individual milk samples from 
sheep as they can lead to false-positive results especially for samples containing a 
higher SCC. 
3. Rapid screening tests 
To reduce the test time response bioanalytical methodologies have been 
proposed, employing specific protein receptors to beta-lactams located in cells 
membranes (Charm, 1980 a,b, Degelaen et al., 2003), and including lateral flow 
chromatography in reactive dipsticks (Markovsky, 2001, 2006). 
At present, rapid screening tests based on the use of specific receptors are 
widely used, especially on farms and dairies where a fast response (< 10 minutes) is 
required. Their detection spectrum is normally limited to one group of antibiotics, 
generally beta-lactams or tetracyclines, although in recent years test versions have 
appeared able to detect the two antibiotic groups simultaneously. Receptor-binding 
assays have been validated for the use in raw bulk milk from cows (Perme et al., 2010; 
Reybroeck et al., 2010; Salter et al., 2011), but information on their performance 
characteristics in sheep and goat’s milk is rather limited. 
Some of the rapid receptor tests (the Betastar Combo, Charm MRL BLTET, 
SNAP and TwinsensorBT) have been evaluated for their use in sheep and goat’s milk 
(Beltrán et al. 2013; Beltrán et al., 2014b,c), presenting detection capabilities equal or 
lower to the MRLs for most beta-lactams and tetracyclines. Moreover, although 
receptor-binding test results can be classified using specific readers for a more 
objective interpretation, significant differences were not found between the visual and 
instrumental reading of the results. 
The specificity of rapid receptor tests was optimal in all cases. No cross-
reactions were found when drugs belonging to antimicrobial groups other than beta-
lactams or tetracyclines were present in milk. The false-positive rate was lower even 
when individual sheep and goat’s milk samples were analysed in most cases. Only the 
TwinsensorBT test presented a larger number of positive results (> 10 %) when 
antibiotic-free milk samples from individual sheep and goats were analysed (Beltrán et 
al., 2014b,c), especially in the last weeks of lactation. 
For sheep and goat’s milk quality control programmes, Spanish legislation (Real 
Decreto 752/2011) establishes the use of azidiol as a preservative in milk sampling, 
149 
stipulating its composition and dosage in samples from sheep and goats. The effect of 
azidiol on the test response has been evaluated in microbial screening tests, finding an 
increased occurrence of false positive results in samples spiked with the preservative 
(Molina et al., 2003b), although these interferences can be minimized through the 
extension of the recommended incubation time (Molina et al., 1999). However, 
information on the effect of azidiol on the receptor-binding test response is practically 
non-existent. 
The results herein thesis indicate that azidiol had no effect on the performance 
of the receptor-binding tests assessed in both, sheep and goat’s milk (Beltrán et al., 
2013; Beltrán et al., 2014a,b). No change in negative or positive results was observed, 
neither visually nor instrumentally, when antibiotic-free milk and samples spiked with 
antibiotics, with and without azidiol were analysed. However, using the SNAP 
Βetalactam test, a delay in the appearance of the coloured spots was observed when 
milk with azidiol were analysed, making a prolonged incubation period necessary. In 
addition, the coloured spots had a lower intensity, making the visibility of the control 
spot more difficult, which may in turn complicate the visual interpretation of the results. 
At present, more sensitive, faster, multiple, high–throughput and cost-effective 
methods for the simultaneous determination of residual veterinary drugs in milk are 
being developed. In fact, in 2013, versions of lateral flow chromatographic receptor-
binding tests such as the BetaXpress Milk MRL (Unisensor, Belgium) and the Charm 
MRL 1 (Charm Sciences Inc., USA) were launched, making the detection of beta-
lactams much faster, i.e. requiring only three, respectively, one minute only, and having 
been validated for the routine screening of milk by Reybroeck and Ooghe (2014a,b). 
Other rapid receptor tests for the simultaneous detection of two or more groups 
of antimicrobials have been developed, some of them not yet available in Spain, such 
as SNAP duo (IDEXX Laboratories), TwinexpressBT (Unisensor), Trisensor 
(Unisensor), 4sensor BSCT (Unisensor), 4sensor BTSQ (Unisensor) and 4sensor 
BTGQ (Unisensor). Some of these tests are currently in the process of validation 
according to Commission Decision 2002/657/EC and the Guidelines for the validation 
of screening methods proposed by Community Reference Laboratories for residues 
(CRLs, 2010) at ILVO (Institute for Agricultural and Fisheries Research, Belgium) or 
other accredited laboratories. 
The technological development in recent years has not only focused on 
receptor-binding assays but also on other analytical methods such as ELISA test kits 
(Tecna, Italy; r-Biopharm, Germany; Randox Food Diagnostics, United Kingdom), 
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 biochip array technology (Evidence Investigator, Randox Food Diagnostics) and flow 
cytometry immunoassays (BeadYplex, Unisensor) covering beta-lactams, tetracyclines, 
sulphonamides, macrolides, aminoglycosides, lincosamides, polymyxins and 
quinolones. 
As a consequence of the great analytical advances made, more tools to screen 
antibiotic residues in an easier manner are available at an acceptable cost. 
4. Analytical strategy 
The sampling and testing of antibiotics in milk should be carried out by 
producers, collectors or processors of milk in the context of a national or regional 
control scheme. The European Union is rather vague about how and when the testing 
of antimicrobials must be performed and establishes that each member state ought to 
set up its own system of control of the quality and traceability of milk (Regulation EC Nº 
178/2002). In this sense, Spanish legislation establishes the sampling and testing 
requirements at different stages for raw milk from cows (Real Decreto 1728/2007), 
respectively, raw milk from sheep and goats (Real Decreto 752/2011). 
On farms, Spanish regulation for sheep and goat’s milk has foreseen checks of 
farm bulk tanks when there is doubt or the certainty of the presence of antibiotics 
before loading the milk onto the tanker to prevent contamination. In general, on each 
farm, according to a sampling scheme, a representative sample of farm bulk milk is 
taken before the milk leaves the farm (ex-farm milk). Samples are stored at dairies and 
then collected by an independent laboratory. Depending on the operators, various 
methods are implemented according to the requirements. 
In Spain, ex-farm milk testing by laboratories is enforced by regulation 
(minimum two samples per month) or by agreements between the dairy collector and 
the milk suppliers. The frequency for analysis may vary depending on dairy sector 
specifications, but the more frequently it is checked, the lower the risk of finding 
residues at later stages and ultimately in the final product. 
At dairies, milk from tankers is systematically tested with a rapid test specific for 
beta-lactam antibiotics at each delivery prior to acceptance. If the result is negative, 
milk is unloaded, however, in the case of a positive result in the rapid screening test, 
milk from the tanker will be re-tested another method having the same detection 
patterns and a different analytical basis, i.e. microbial inhibitor test. If the result is 
positive, the milk is withdrawn, considered a category 2 animal by-product and has to 
be destroyed according to the most suitable method. 
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By considering the drugs used in a particular area and the risk of finding 
consecutive residues in milk, operators should choose appropriate screening tests 
depending on the specific circumstances, and the test kit should ideally operate at or 
near the MRL for the antibiotics used. The tests have specified limits of detections 
(CCβ), for targeted drugs covered by their scope. 
In Spain, according to a survey conducted by Berruga et al. (2008) on the main 
causes of the presence of veterinary drug residues in milk from dairy sheep and goats 
livestock, mastitis is undoubtedly the infectious disease most frequently treated with 
antibiotics during the lactation period, using primarily beta-lactam drugs; macrolides 
being the second most important group of antimicrobials applied. Therefore, 
substances belonging to these groups are the most probable residues in raw milk from 
these species. 
For sheep and goat’s milk, Spanish regulation establishes the control of the 
presence of antibiotic residues using methods that detect, at least, beta-lactam drugs. 
Microbial inhibitor tests using Geobacillus stearothermophilus var calidolactis and 
receptor-binding assays specific for the detection of beta-lactams are most widely used 
for screening antibiotics in milk. 
Taking into account the frequency of use of antibiotics commonly employed in 
Spain and the screening test sensitivity at MRLs, total detection rates have been 
calculated. In general, the use of a single test allows detecting 62.8-82.4 % of the 
antibiotics employed. For sheep milk, the total detection range achieved with microbial 
tests was significantly higher than that reached with rapid receptor tests. However, no 
significant differences between the two types of tests were found when goat's milk was 
analysed. In both types of milk, the simultaneous use of two screening tests with a 
different analytical basis increases the total detection range significantly, reaching 
values ≥ 90 % in some cases (81.5-90.1 % for sheep and 84.7-92.6 % for goats, 
respectively). 
However, antibiotics such as enrofloxacin, marbofloxacin, spiramycin, and 
streptomycin also used to treat mastitis and other infectious diseases in sheep and 
goats could not be detected by the screening tests assessed. Therefore, the 
improvement of the analytical strategy through the periodical implementation of 
screening tests able to detect these substances at safety levels would be 
recommended. 
In this sense, for example the implementation of a bioassay using Bacillus 
subtilis as bacteria-test would complement antibiotic coverage achieved by microbial 
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 inhibitor tests using G. stearothermophilus, detecting substances such as erythromycin, 
enrofloxacin and spiramycin at concentrations more next to their respective MRLs. In 
addition, the periodic use of specific rapid methods for the detection of 
aminoglycosides and quinolones could be an alternative to increase the spectrum of 
detection. 
Finally, we must consider that the presence of residues of antimicrobials in milk 
and the strategy used for their detection is dynamic and changes along time. The 
pharmaceutical industry constantly develops new formulae and products for the use in 
veterinary medicine. Also, manufacturers have developed new detection methods with 
an improved performance that have quickly been marketed in recent years. Also, many 
countries, concerned about food safety, implemented new legislative aspects. This 
implies that the analytical strategy should be revised periodically to adapt it to 
veterinary drugs employed by veterinarians in the area of the milk production and the 
new screening methodologies available. 
The implementation of a proper analytical strategy could prevent the presence 
of antibiotic residues from reaching the food chain and, therefore, guarantee the safety 
of milk and dairy products. 
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Chapter 7 
Conclusions 
 
  
Conclusions 
Microbial inhibitor tests using Geobacillus stearothermophilus var. calidolactis such 
as the BRT MRL, the Delvotest MCS SP-NT, the Delvotest MCS Accelerator and the 
Eclipse 100 detect beta-lactam antibiotics and other non-beta-lactam drugs such as 
neomycin, tylosin, sulfadiazine and sulfadimethoxine in an efficient manner. However, they 
were less sensitive towards quinolones and tetracyclines at safety levels. When individual 
milk samples were analysed microbiological tests showed a higher occurrence of non-
compliant results in sheep milk that were related in all cases to an elevated somatic cell 
count (SCC). 
A microbiological system consisting of two bioassays using Geobacillus 
stearothermophilus var. calidolactis and Bacillus subtilis, respectively, presents a better 
sensitivity towards antibiotics such as quinolones, tetracyclines, lincomycin and 
spyramycin, with respect to the application of a commercial test using G. 
stearothermophilus. Therefore, this microbiological system proves to be a valuable tool to 
control ovine milk quality although it could be improved approaching some detection limits 
closer to established maximum residue limits (MRLs). 
The Detection capability (CCβ) obtained for the receptor-binding tests, the Charm 
MRL BLTET, the Betastar Combo, the SNAP Betalactam, the SNAP Tetracycline and the 
TwinsensorBT, was at or below MRL established by European regulation for most 
antibiotics considered indicating a high sensitivity towards beta-lactams and tetracyclines, 
except the CCβ for cloxacillin in the Charm MRL BLTET test and for cephalexin in the 
Betastar Combo and TwinsensorBT tests that were above their MRLs. 
Regarding cross-reactions, interferences related to drugs other than beta-lactams 
and tetracyclines were not detected. Furthermore, the use of azidiol, as a preservative of 
milk, had no effect on the test response. Despite the differences in terms of chemical 
composition and hygienic quality of milk from sheep and goats vs cows, a higher specificity 
was obtained in all cases even when individual milk samples were analysed. Only the 
TwinsensorBT test presented non-compliant results using antibiotic-free milk samples from 
individual animals, especially in the last weeks of lactation. 
Taking into account the performance of screening tests routinely applied in Spain 
and the frequency of use of antibiotics commonly employed by veterinarians in dairy sheep 
and goats, the total detection rates obtained were elevated using a microbial screening 
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test as well as a rapid receptor test although, the best antibiotic coverage was achieved 
with the simultaneous use of two screening tests with a different analytical basis 
(microbiological and receptor-binding tests). However, antibiotics such as enrofloxacin, 
marbofloxacin, spiramycin, and streptomycin are also employed by veterinarians in the 
antibiotic therapy of dairy sheep and goats and are not detected by the screening tests 
considered. To improve the analytical strategy, the periodical implementation of screening 
tests able to detect these substances at safety levels would be recommended to 
guarantee the quality of milk and dairy products from small ruminants. 
162 
